Lung Cancer

Transfer factor in the treatment of carcinoma of the lung.
Author
Kirsh MM; Orringer MB; McAuliffe S; Schork MA; Katz B; Silva J Jr
Address
Source
Ann Thorac Surg, 1984 Aug, 38:2, 140-5
Abstract
From 1976 to 1982, 63 patients with carcinoma of the lung underwent curative pulmonary resection, mediastinal lymph node dissection, and postoperative mediastinal irradiation when indicated. After operation, the patients were randomized by cell type and stage of disease into two groups. Beginning 1 month postoperatively, Group 1 patients (N = 28) received 1 ml of transfer factor that had been extracted from the blood of normal individuals. Subsequent doses were administered at 3-month intervals. Group 2 patients (N = 35) served as controls. There were no significant differences between the two groups with respect to age, sex, extent of resection, histological cell type, or stage of disease. Twenty of the 28 treated patients were alive and free from disease from 7 to 77 months after treatment, whereas 17 of the 35 control patients were free from disease. The 1-year survival for Group 1 was 84% and for Group 2, 81%. The 2-year survival was 78% for Group 1 and 46% for Group 2 (p = 0.045). The survival rates by stage of disease were as follows: Stage I, 15 out of 17 or 88% in Group 1 and 15 out of 23 or 65% in Group 2 (p = 0.097); Stages II and III, 5 out of 11 or 45% in Group 1 and 3 out of 12 or 25% in Group 2 (p = 0.304). The results of the study suggest that the administration of transfer factor to patients who have undergone pulmonary resection for carcinoma of the lung can have a significant impact on the prolongation of life.

Randomized controlled trial of transfer factor immunochemotherapy as an adjunct to surgical treatment for primary adenocarcinoma of the lung.
Author
Fujisawa T; Yamaguchi Y; Kimura H; Arita M; Shiba M; Baba M
Address
Source
Jpn J Surg, 1984 Nov, 14:6, 452-8
Abstract
A total of 102 patients were studied in a randomized controlled trail to evaluate the clinical effect of transfer factor (TF) for primary resected adenocarcinoma of the lung. The TF and Control groups consisted of 50 and 52 randomly chosen patients, respectively. However, 6 and 5 patients were excluded from both groups for various reasons, therefore the total of cases eligible for evaluation were 44 and 47 in the TF and Control groups, respectively. The clinical features of both groups were similar. The survival of the TF group was significantly better than that of Controls in Stage I cases (p less than 0.05), however, there was no significant difference in patients in Stages II, III and IV. Significant differences were found between the TF and Control groups in curative resection cases (p less than 0.05), however, no significant difference was seen in either the relatively curative resection or noncurative resection groups. TF seems to inhibit postoperative recurrence and appears to be an effective postoperative adjuvant immunotherapeutic for primary resected adenocarcinoma of the lung, especially at the relatively early stages.


Adjuvant immunotherapy of primary resected lung cancer with transfer factor.
Author
Fujisawa T; Yamaguchi Y; Kimura H; Arita M; Baba M; Shiba M
Address
Source
Cancer, 1984 Aug, 54:4, 663-9
Abstract
One hundred seventy-one patients were studied in order to evaluate the clinical efficacy of the transfer factor (TF) for primary resected lung cancers under a randomized controlled trial. Eligible cases for evaluation were randomly chosen at 75 and 74 patients in TF and control groups, respectively. The same long-term intermittent adjuvant chemotherapy was administered to two groups as a standard therapy. The distribution of clinical features in both groups was very similar. The overall survival rates of the TF group at 2 and 4 years postoperatively were 69% and 53%, respectively, which was about 15% better than the control group, but this difference could not yet be considered statistically significant. The survival of the TF group was significantly better than that of the control group in patients with Stages I + II or curative resection (P less than 0.05 by Cox-Mantel test); however, there was no significant difference in patients with Stages III + IV, or noncurative resection. The recurrence rate of pulmonary and mediastinal regions was less in the TF group. In conclusion, TF seems to suppress postoperative recurrence and appears to be beneficial for primary resected lung cancer patients, especially at early stages, as postoperative adjuvant immunotherapy.

TF for Viral Infections

Guidelines for immunotherapy of antigen-specific defects with transfer factor.
Author
Wilson GB; Fudenberg HH; Keller RH
Address
Source
J Clin Lab Immunol, 1984 Feb, 13:2, 51-8
Abstract
Dialyzable leukocyte extracts (DLE) containing transfer factor (TF) with documented specificity for one or more microbial antigens have shown previously variable clinical effectiveness in treating many infectious diseases caused by viruses, fungi, protozoa and mycobacteria. The efficacy has sometimes been strong, and at other times dubious, in treating patients with inherited or presumably "acquired" immunodeficiency diseases refractory to standard therapy. The recent development of assays for screening leukocyte donors of DLE, for monitoring recipients, and especially for determining the potency of various DLE preparations containing antigen-specific TF and for predicting the clinical course of disease have, in our hands, greatly improved the likelihood of successful immunotherapy with TF. Two representative cases are reported, one involving a patient with an antigen selective defect to Candida, and another involving a patient with an antigen selective defect to Mycobacterium fortuitum. Both patients responded as judged by laboratory tests and clinical improvement when treated with certain DLE preparations but not with others. Finally, certain DLE preparations appeared to suppress cell-mediated immunity in vivo and this suppression could be predicted by in vitro tests. Based on these results, guidelines for optimal therapy with DLE are proffered.

Treatment of varicella-zoster pneumonia with transfer factor.
Author
Winkelmann RK; DeRemee RA; Ritts RE Jr
Address
Source
Cutis, 1984 Sep, 34:3, 278-81
Abstract
A 29-year-old woman with a long history of immunoreactive disease--thrombocytopenic purpura, bullous pemphigoid, nephropathy, and hemolytic anemia--contracted generalized herpes zoster and varicella pneumonia. Respiratory failure requiring assisted respiration accompanied progressive chest findings. She recovered rapidly simultaneous with the administration of transfer factor from a healing herpes zoster patient. We believe that this therapy should be attempted in similar desperate circumstances.

Title
Symposium on infectious complications of neoplastic disease (Part II).

Immunoprophylaxis of varicella-zoster infections.
Author
Gershon AA
Address
Source
Am J Med, 1984 Apr, 76:4, 672-7
Abstract
Because it is possible to identify groups of persons with a high risk of varicella development and also because it is possible to anticipate when an attack may occur, immunoprophylaxis for varicella has met with great success. In contrast, the nature of zoster--its unpredictability and low attack rate--makes immunoprophylaxis much more difficult to implement. Varicella may be modified by administration of varicella-zoster immune globulin within three days of a known exposure to the virus. Although interferon has not yet been used in an attempt to prevent or modify varicella in humans, it has been used successfully to abort an outbreak of simian varicella in a monkey colony. Thus it might be clinically useful, particularly for those who cannot be given varicella-zoster immune globulin within three days of exposure. Transfer factor has also been shown to induce at least partial immunity to varicella in children with leukemia. The duration of this protection is unknown, and further study of the efficacy of transfer factor against both varicella and possibly even against zoster seems warranted. Live attenuated varicella vaccine, although still experimental, seems now to be the most practical way to prevent severe varicella in high-risk persons. The vaccine is safe and immunogenic, even in children with underlying leukemia who are still receiving chemotherapy. Studies in Japan, Europe, and the United States have shown that most vaccinated leukemic children who are exposed are protected against severe disease, although mild breakthrough cases have been reported. Varicella vaccine's potential to cause zoster remains under study.

TF for Bacterial Infections

Dialyzable leukocyte extract (transfer factor) in the treatment of superinfected fistulating tuberculosis of the bone.
Author
Zielinski CC; Savoini E; Ciotti M; Orani R; Königswieser H; Eibl MM
Address
Source
Cell Immunol, 1984 Mar, 84:1, 200-5
Abstract
The effect of the addition of dialyzable leukocyte extract (DLE)(transfer factor) to tuberculostatic drugs in the treatment of superinfected fistulating tuberculosis of bones and joints was evaluated in a controlled study. Eleven patients whose disease had persisted for a mean of 20 +/- 4.8 years and had proved to be resistant to antibiotics and tuberculostatic drugs were treated with an additional combined tuberculostatic drug regimen consisting of isoniazide, ethambutol, and rifampin for a control period of 2 years; after this therapy had failed as judged by the persistence of the superinfected fistulae and of the symptoms, DLE was added to the regimen. The result of this therapeutic approach was evaluated after another 2 years. Through this therapy, a closure of the fistulae was achieved in 9 out of the 11 patients (P less than 0.001) with a concomitant decrease of symptoms. DLE may prove beneficial in the treatment of patients with superinfected fistulating tuberculous osteomyelitis.

Transfer factor and repeated otitis media.
Author
Kaminkova J; Lange CF
Address
Source
Cell Immunol, 1984 Nov, 89:1, 259-64
Abstract
The effect of transfer factor (TF) was investigated in 12 children with repeated otitis media. These patients were immunologically compared to a control group of 23 age-matched healthy children. Levels of immunoglobulins, total and "active" T-cells, and phagocytic activity of granulocytes and monocytes were evaluated in the 12 children prior to, during, and after TF therapy. Percentages of "active" T cells and absolute numbers of "active" T and total T cells, which were initially low in the patient group, increased significantly after TF therapy to statistically match those of the healthy control group. The percentage of phagocytic monocytes in patients after therapy did not differ from healthy children; however, the percentage of phagocytic granulocytes remained depressed significantly. The levels of IgG, IgA, and IgM were unaffected by the therapy although the IgA and IgM were higher in the patient population throughout the study. After therapy, one-half of the patient population remained asymptomatic for a 1-year period and the others had markedly reduced attack rates.

Separate transfer of mouse protection and delayed-type hypersensitivity with Salmonella typhimurium transfer factor.
Author
Kita E; Matsuda Y; Matsuda K; Kashiba S
Address
Source
Cell Immunol, 1984 Sep, 87:2, 528-37
Abstract
Delayed-type hypersensitivity (DTH) induced with Salmonella typhimurium transfer factor (TF) contributed to an increase in mean survival days of mice challenged with homologous organisms and afforded only a low level of host protection as determined by survival rate, compared with that obtained by active immunization. TF of other enteric bacteria could transfer DTH which is cross-reactive to salmonella antigen but did not afford host protection. Although TF of Listeria monocytogenes did not transfer the cross-reactive DTH, it could confer the significant increase in mean survival days against the lethal challenge with S. typhimurium. Listerial ribosomal vaccine conferred the high level of mouse protection without inducing DTH to salmonella antigen. The resistance generated upon active immunization with listerial ribosomal vaccine could be enhanced by the injection of S. typhimurium TF to the same level as that obtained after immunization with homologous ribosomal vaccine. Among salmonella TF, there could be no cross-reactive immunity between S. typhimurium and S. choleraesuis, although the cross-reactive DTH was observed. The DTH transfer ability of TF was sensitive to Pronase which could not affect the ability to transfer host immunity, but RNase could abolish the ability to transfer host immunity without impairing DTH transfer activity. These results suggest that in mouse typhoid infection, DTH is not associated with host protection as determined by survival rate.

A case report of the successful treatment of recurrent aphthous stomatitis with some preparations of orally administered transfer factor.
Author
Schulkind ML; Heim LR; South MA; Jeter WS; Small PA Jr
Address
Source
Cell Immunol, 1984 Apr, 84:2, 415-21
Abstract
A patient with severe disabling recurrent aphthous stomatitis (RAS) was treated with four different preparations of oral human transfer factor (TF), as well as placebo, following a double-blind protocol. Two of the TF preparations had a significant effect upon the course of the patient's illness by prolonging the interval between attacks and decreasing the severity of attacks. No side effects attributable to any of the preparations were noted by the patient. Thus, some but not all preparations of human transfer factor given orally are an effective therapy for RAS.

References

Review
1. 1. Bock K Transfer Factor: Immune System Modulators Autism/Asperger's Digest-2004.
2. Moss RW Cancer and complementary and alternative medicine in Italy: personal observations and historical considerations. Integr Cancer Ther-2004. 3(2);173-88
3. Singh VK Autoimmunity as Basis of Therapy for Autism In: Center for Autistic Spectrum Disorders Conference. Dallas, TX. -2003.
4. Kidd PM Autism, an extreme challenge to integrative medicine. Part 2: medical management. Altern Med Rev-2002. 7(6);472-99
5. Molife R, Hancock BW Adjuvant therapy of malignant melanoma. Crit Rev Oncol Hematol-2002. 44(1);81-102
6. [No Author(s)] Jarrow formulas: "colostrum specific" for cryptospordium. Posit Health News-2001.
7. [No Author(s)] Transfer factor. Posit Health News-2001.
8. Sosa Vazquez M, et al. [New concepts about atopic dermatitis] Rev Alerg Mex-2001. 48(1);15-24
9. Bock SJ Transfer Factor and its Clinical Applications Rhinebeck Health Center-2000.
10. Liubchenko TA, et al. [The biological activity of the transfer factor induced by bacterial antigens] Mikrobiol Z-1998. 59(5);83-100
11. Salazar Villa RM, Mejia Ortega J [Use of transfer++factor in allergic bronchial asthma] Rev Alerg-1997. 40(2);42-5
12. Bang D Treatment of Behcet's disease. Yonsei Med J-1997. 38(6);401-10
13. Dwyer JM Transfer factor in the age of molecular biology: a review. Biotherapy-1996. 9(1-3);7-11
14. Kirkpatrick CH Activities and characteristics of transfer factors. Biotherapy-1996. 9(1-3);13-6
15. Levine PH The use of transfer factors in chronic fatigue syndrome: prospects and problems. Biotherapy-1996. 9(1-3);77-9
16. Viza D AIDS and transfer factor: myths, certainties and realities. Biotherapy-1996. 9(1-3);17-26
17. Katoch K Immunotherapy of leprosy. Indian J Lepr-1996. 68(4);349-61
18. Hicks P, et al. Azithromycin therapy for Cryptosporidium parvum infection in four children infected with human immunodeficiency virus. J Pediatr-1996. 129(2);297-300
19. Ritchie DJ, Becker ES Update on the management of intestinal cryptosporidiosis in AIDS. Ann Pharmacother-1994. 28(6);767-78
20. Kirkpatrick CH Structural nature and functions of transfer factors. Ann N Y Acad Sci-1993. 685(0);362-8
21. Berthon P, Salmon H Immunological Factors in Mammary Secretions. Biologie de la Lactation. Institut National de la Recherche Agronomique. Versailles, France-1993.
22. Hassner A, Adelman DC Biologic response modifiers in primary immunodeficiency disorders. Ann Intern Med-1991. 115(4);294-307
23. Dwyer JM The rise and fall and rise again of transfer factor. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
24. Pekarek J, et al. The clinical use of specific transfer factors. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
25. Woodfield DG, et al. Transfer factor - Preparation, quality control and clinical use in New Zealand. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
26. Crusinberry R, Williams RD Immunotherapy of renal cell cancer. Semin Surg Oncol-1991. 7(4);221-9
27. Hadden JW Immunotherapy of human immunodeficiency virus infection. Trends Pharmacol Sci-1991. 12(3);107-11.
28. Gottlieb AA, Gottlieb MS Development of immunomodulators for treatment of HIV infection. Lymphology-1990. 23(2);98-101
29. Smogorzewska E [Transfer of delayed type hypersensitivity in guinea pigs] Probl Med Wieku Rozwoj-1990. 16(0);167-88
30. Kirkpatrick CH Biological response modifiers. Interferons, interleukins, and transfer factor. Ann Allergy-1989. 62(3);170-6
31. Fudenberg HH, Fudenberg HH Transfer factor: Past, Present and Future. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
32. Soave R Clinical Cryptosporidiosis in Man. Proc 1st Int work. Edinburgh Animal Diseases Research Assoc.-1989.
33. Kirkpatrick CH Transfer factor. J Allergy Clin Immunol-1988. 81(5 Pt 1);803-13
34. Steele RW, Charlton RK Immune modulators as antiviral agents. Clin Lab Med-1987. 7(4);911-24
35. Purdy BD, Plaisance KI Current concepts in clinical therapeutics: immunologic treatment of human immunodeficiency virus infections. Clin Pharm-1987. 6(11);851-65
36. Fudenberg HH Transfer Factor: Past, present, and future. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987.
37. Morescat Laboratory assays for TF. A critical overview. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987.
38. Kirkpatrick CH Transfer factor: perspectives in human and veterinary medicine. J Exp Pathol-1987. 3(4);383-98
39. Spitler LE, Miller L Clinical trials of transfer factor in malignancy. J Exp Pathol-1987. 3(4);549-64
40. Solinger AM Indications for immunotherapy. Pharmacotherapy-1987. 7(2);S12-20
41. Pekarek J, Cech K [Transfer factor SEVAC - Perspectives of its medical application.] Zpravy SEVAC-1986. 1;3-36
42. Fan ZQ The immunity-regulating agent: Transfer factor. Conferernce for Appraisal of Transfer Factor-1985.
43. Drews J The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections. Infection-1985. 13 Suppl 2(0);S241-50
44. Fudenberg HH "Transfer factor": an update. Proc Soc Exp Biol Med-1985. 178(3);327-32
45. Gershon AA Symposium on infectious complications of neoplastic disease (Part II). Immunoprophylaxis of varicella-zoster infections. Am J Med-1984. 76(4);672-7
46. Kirkpatrick CH Host factors in defense against fungal infections. Am J Med-1984. 77(4D);1-12
47. Drews J The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections. Infection-1984. 12(2);157-66
48. Wilson GB, Fudenberg HH Is controversy about "transfer factor therapy" nearing an end? Immunol Today-1983. 4(6);157
49. Chase MW The immunological enigma of transfer factor. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
50. Klesius PH Dialyzable leukocyte extract containing transfer factor--Its future in veterinary medicine. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
51. Wilson GB, et al. Mechanism(s) of action of human transfer factor: Insights obtained from studying "Antigen-liberated transfer factor" specific for tuberculin. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
52. Hughes RA Immunological treatment of multiple sclerosis. J Neurol-1983. 230(2);73-80
53. Massicot JG, Goldstein RA Transfer factor. Ann Allergy-1982. 49(6);326-9
54. Salaman MR The state of transfer factor. Immunology Today-1982. 3(1);4
55. Khan A, Hill NO [Unknown] In: Human Lymphokines, The Biological Immune Response Modifiers. Khan AK, Hill NO, Eds. Academic Press, NY-1982.
56. Svoboda J, et al. [Our experience with the therapeutic use of transfer factor] Vnitr Lek-1982. 28(10);1003-8
57. Casado de Frìas E, et al. [Treatment of juvenile rheumatoid arthritis (author's transl)] An Esp Pediatr-1981. 15(1);48-62.
58. Pasternak G The present status of immunodiagnosis and immunotherapy of cancer. Arch Geschwulstforsch-1981. 51(4);284-93
59. Dienstag JL, Isselbacher KJ Therapy for acute and chronic hepatitis. Arch Intern Med-1981. 141(11);1419-23
60. Lawrence HS, Borkowsky W Transfer factor: recent developments in the pursuit of an idea. Cell Immunol-1981. 62(2);301-8
61. Lugwig S Indications and limitation of TF therapy Clin Immunol Allergy. North Holland Biochemical Press.-1981.
62. Arnold W, Meyer zum Buschenfelde KH [Therapy of chronic hepatitis (author's transl)] Leber Magen Darm-1981. 11(2);73-80
63. Krakowka S Developments in immunotherapy. Mod Vet Pract-1981. 62(6);447-51
64. Sobczyk W, Kulczycki J [Antiviral treatment of subacute sclerosing panencephalitis] Neurol Neurochir Pol-1981. 15(2);143-8
65. Sherlock S Treatment of chronic hepatitis. Ann Acad Med Singapore-1980. 9(2);185-7
66. Klesius PH, et al. Comparative studies on dialyzable leukocyte extracts containing transfer factor--a review. Comp Immunol Microbiol Infect Dis-1980. 3(3);247-60
67. Kirkpatrick CH Transfer factor. CRC Crit Rev Clin Lab Sci-1980. 12(2);87-122
68. Pizza G, et al. Transitional cell carcinoma of the bladder. Differences between primary tumour and following relapses. Eur Urol-1980.6(1);45-7
69. Auer IO [Therapy of chronic hepatitis (author's transl)] Leber Magen Darm-1980. 10(5);251-8
70. Kirkpatrick CH Therapeutic potential of transfer factor. N Engl J Med-1980. 303(7);390-1
71. Zdunczyk A [Transfer factor (its use in immunotherapy of neoplasms and other diseases)] Wiad Lek-1980. 33(11);877-81
72. Schroder I [Therapy with transfer factor in diseases with disorders of the cellular immune reaction] Z Gesamte Inn Med-1980. 35(2);86-91
73. Khan A The syndrome of asthma, recurrent viral infections and T-cell immunodeficiency: investigations and management. Ann Allergy-1979. 43(2);69-72
74. Burger DR, et al. A structural model for human transfer factor. Ann N Y Acad Sci-1979. 332(0);236-40
75. Petersen EA, Kirkpatrick CH Nature and activities of transfer factor. Ann N Y Acad Sci-1979. 332(0);216-27
76. Spitler LE Transfer factor in immunodeficiency diseases. Ann N Y Acad Sci-1979. 332(0);228-35
77. Sutcliffe SB, et al. Transfer factor and immunity: an introduction. Ann N Y Acad Sci-1979. 332(0);184-6
78. Ballow M, et al. Transfer factor, autoimmunity and T-cell immune deficiencies. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
79. Marescot MR, et al. Quantification and biological assays of transfer factor. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
80. Moulias R, et al. Transfer factor therapy in viral diseases: Results, adverse effects, indications. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
81. Di Padova F [A new approach to immunotherapy: the transfer factor] Minerva Med-1979. 70(25);1773-85
82. Edelman L, Reviron J [Technics and applications of transfer factor (author's transl)] Pathol Biol (Paris)-1979. 27(10);647-8
83. Rosman N Chronic mucocutaneous candidiasis. Postgrad Med J-1979. 55(647);611-4
84. Smogorzewska E [Levamisole as an immunostimulating factor] Probl Med Wieku Rozwoj-1979. 8(0);56-62
85. 85. Uotila A Transfer factor and other immunological activities of human leucocyte dialysate and other dialysates of mammalian tissues University of Tampere, Tampere-1979.
86. Schroder I [The current position of the transfer factor investigation (author's transl)] Allerg Immunol (Leipz)-1978. 24(4);243-53
87. Freedman RS, et al. Transfer factor and possible applications in gynecology. Am J Obstet Gynecol-1978. 130(5);572-84
88. Arala-Chaves MP, et al. Biological and clinical aspects of transfer factor. In: Immunological Engineering. Jirsch DW, Ed. MTP Press, London-1978.
89. Basten A, Croft S. Transfer factor: Clinical uasage and experimental studies. In: Immunological Engineering. Jirsch DW, Ed. MTP Press, London-1978.
90. Grob PJ Transfer factor. General aspects. Acta Neurol Scand Suppl-1977. 63(0);217-26
91. Warren SL Transfer factor for the practicing allergist-immunologist. Ann Allergy-1977. 39(2);130-2
92. Graziano FM, Dwyer JM Transfer factor--clinical enigma. History, preparation, properties and immunology of transfer factor. Conn Med-1977. 41(12);751-4
93. Mazaheri MR, et al. Immunotherapy of viral infections with transfer factor. J Med Virol-1977. 1(3);209-17
94. Rocha H ["Transfer factor" in ophthalmology (author's transl)] Klin Monatsbl Augenheilkd-1977. 171(1);63-70
95. Medunitsyn NV ["Transfer factor". Experimental findings and prospects for its clinical use] Patol Fiziol Eksp Ter-1977.
96. Kuhn HA [Therapy of hepatitis B. Practical implications] Schweiz Med Wochenschr-1977. 107(15);514-20
97. Fudenberg HH Dialyzable transfer factor in the treatment of human osteosarcoma: an analytic review. Ann N Y Acad Sci-1976. 277(00);545-57
98. Fudenberg HH, et al. Dialyzable transfer factor. An analytical review Folia Allerg Immunol-1976. 23;1
99. Erhan S On the nature of transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
100. Lawrence HS Summation In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
101. Novelli GD A biochemist's view of the mediators of cellular immunit, with special reference to transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
102. LoBuglio AF, Neidhart JA Transfer factor: a potential agent for cancer therapy. Med Clin North Am-1976. 60(3);585-90
103. Gröhn P Biological and chemical characterisation of human transfer factor Tampereen yliopisto, Tampere -1976.
104. Neidhart JA, LoBuglio AF Transfer factor: Potential for therapy of malignant diseases. Arch Otolaryngol-1975. 101(11);664-6
105. Hong R Thymus transplants: a look to the future. Birth Defects Orig Artic Ser-1975. 11(1);357-60
106. Levin AS, et al. Transfer factor I: methods of therapy. Birth Defects Orig Artic Ser-1975. 11(1);445-8
107. Spitler LE, et al. Transfer factor II: results of therapy. Birth Defects Orig Artic Ser-1975. 11(1);449-56
108. Scalise G "Transfer factor" therapy in infectious diseases. Boll Ist Sieroter Milan-1975. 54(6);502-5
109. Grob PJ Therapeutic use of transfer factor. Eur J Clin Invest-1975. 5(1);33-43
110. Kirkpatrick CH Properties and activities of transfer factor. J Allergy Clin Immunol-1975. 55(6);411-21
111. Florman AL, Holzman RS Nonspecific enhancers of resistance in man. J Pediatr-1975. 87(6 PT 2);1094-1102
112. Grob PJ, et al. [Transfer factor. Properties and possible therapeutic applications (author's transl)] MMW Munch Med Wochenschr-1975. 117(13);517-24
113. Shifrine M, Scibienski R Transfer factor - hypotheses for its structure and function. Oncology-1975. 32(5-6);269-74
114. Frey-Wettstein M, Grob PJ [Proceedings: Transfer factor--a preliminary report] Schweiz Med Wochenschr-1975. 105(51);1794-6
115. Maddison SE Dialyzable transfer factor. South Med J-1975. 68(12);1545-51
116. Basten A, et al. Uses of transfer factor. Vox Sang-1975. 28(4);257-77
117. Reymond JF, Grob PJ Transfer factor preparations: some physico-chemical and biological properties. Vox Sang-1975. 29(5);338-51
118. Schroder I, et al. [The preparation and characterization of transfer factor (author's transl)] Z Immunitatsforsch Exp Klin
119. Immunol-1975. 149(5);365-71
120. LoBuglio AF, Neidhart JA A review of transfer factor immunotherapy in cancer. Cancer-1974. 34(4 Suppl);suppl:1563-70
121. Lawrence HS Transfer factor in cellular immunity. Harvey Lect-1974. 68(0);239-350
122. Burnet FM Transfer factor--a theoretical discussion. J Allergy Clin Immunol-1974. 54(1);1-13
123. Dressler D, Rosenfeld S On the chemical nature of transfer factor. Proc Natl Acad Sci U S A-1974. 71(11);4429-34
124. Zanelli JM Transfer factor--fact or fiction? Clin Sci Mol Med-1973. 45(3);19P
125. Grob PJ, et al. [Immune function and transfer factor] Dtsch Med Wochenschr-1973. 98(9);446-51
126. Gottlieb AA, et al. What is transfer factor? Lancet-1973. 2(7833);822-3
127. Bloom BR Editorial: Does transfer factor act specifically or as an immunologic adjuvant? N Engl J Med-1973. 288(17);908-9
128. Gottlieb AA Nature of "transfer factor". N Engl J Med-1973. 289(5);272
129. Hitzig WH, et al. [Transfer factor. Immunologic basis and therapeutic experience] Schweiz Med Wochenschr-1972. 102(35);1237-44
130. Lawrence HS, Valentine FT Transfer factor and other mediators of cellular immunity. Am J Pathol-1970. 60(3);437-52
131. Lawrence HS Transfer factor and autoimmune disease. Ann N Y Acad Sci-1965. 124(1);56-60
Human
1. Morfin Maciel BM [Demodicidosis in a female patient treated as allergic blepharoconjunctivitis. A case report] Rev Alerg Mex-2004. 50(6);232-6
2. Orozco TT, et al. [Inflammatory mediators in patients with atopic dermatitis after treatment with transfer factor] Rev Alerg Mex-2004. 51(4);151-4
3. Beltran de Paz C, et al. [Psychological, immunological, and endocrinological implications of atopic dermatitis] Rev Alerg Mex-2003. 50(2);54-9
4. Garcia Angeles J, et al. [Lymphocyte apoptosis in atopic dermatitis treated with transfer factor] Rev Alerg Mex-2003. 50(1);3-7
5. See D, et al. Increased tumor necrosis factor alpha (TNF-alpha) and natural killer cell (NK) function using an integrative approach in late stage cancers. Immunol Invest-2002. 31(2);137-53
6. Sosa M, et al. [Comparative treatment between thalidomide and transfer factor in severe atopic dermatitis] Rev Alerg Mex-2001. 48(2);56-64
7. Jia WC, et al. [Immune functional changes in patients of acute Henoch-Schonlein purpura and regulatory effect of integrated Traditional Chinese and Western medicine on it] Zhongguo Zhong Xi Yi Jie He Za Zhi-2001. 21(8);585-7
8. Cordero Miranda MA, et al. [Safety and efficacy of treatment for severe atopic dermatitis with cyclosporin A and transfer factor] Rev Alerg Mex-1999. 46(2);49-57
9. Estrada-Parra S, et al. Comparative study of transfer factor and acyclovir in the treatment of herpes zoster. Int J Immunopharmacol-1998. 20(10);521-35
10. Simko M, et al. [Immunomodulatory therapy of epilepsy with transfer factor] Bratisl Lek Listy-1997. 98(4);234-7
11. Chen N, et al. [Oral candidiasis in Sjogren's syndrome: prevalence, clinical features and treatment] Hua Xi Kou Qiang Yi Xue Za Zhi-1997. 15(3);239-41
12. Valdes Senchez AF, et al. [Treatment of extrinsic bronchial asthma with transfer factor] Rev Alerg Mex-1997. 40(5);124-31
13. Ablashi DV, et al. Use of anti HHV-6 transfer factor for the treatment of two patients with chronic fatigue syndrome (CFS). Two case reports. Biotherapy-1996. 9(1-3);81-6
14. Byston J, et al. Effect of anti-herpes specific transfer factor. Biotherapy-1996. 9(1-3);73-5
15. De Vinci C, et al. Lessons from a pilot study of transfer factor in chronic fatigue syndrome. Biotherapy-1996. 9(1-3);87-90
16. De Vinci C, et al. Use of transfer factor for the treatment of recurrent non-bacterial female cystitis (NBRC): a preliminary report. Biotherapy-1996. 9(1-3);133-8
17. Fudenberg HH Dialysable lymphocyte extract (DLyE) in infantile onset autism: a pilot study. Biotherapy-1996. 9(1-3);143-7
18. Gottlieb AA, et al. Rationale and clinical results of using leucocyte-derived immunosupportive therapies in HIV disease. Biotherapy-1996. 9(1-3);27-31
19. Hana I, et al. The influence of age on transfer factor treatment of cellular immunodeficiency, chronic fatigue syndrome and/or chronic viral infections. Biotherapy-1996. 9(1-3);91-5
20. Masi M, et al. Transfer factor in chronic mucocutaneous candidiasis. Biotherapy-1996. 9(1-3);97-103
21. Meduri R, et al. Efficacy of transfer factor in treating patients with recurrent ocular herpes infections. Biotherapy-1996. 9(1-3);61-6
22. Nevsimal O, et al. An attempt to inhibit the course of amyotrophic lateral sclerosis (ALS) by suppressor factor. Biotherapy-1996. 9(1-3);139-41
23. Ojeda Ojeda M, et al. Dialysable leucocyte extract (DLE) reduces lipopolysaccharide-induced tumour necrosis factor secretion in human leucocytes. Biotherapy-1996. 9(1-3);163-70
24. Pilotti V, et al. Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC) therapy. Biotherapy-1996. 9(1-3);117-21
25. Pizza G, et al. Preliminary observations using HIV-specific transfer factor in AIDS. Biotherapy-1996. 9(1-3);41-7
26. Pizza G, et al. In vitro studies during long-term oral administration of specific transfer factor. Biotherapy-1996. 9(1-3);175-85
27. Pizza G, et al. A preliminary report on the use of transfer factor for treating stage D3 hormone-unresponsive metastatic prostate cancer. Biotherapy-1996. 9(1-3);123-32
28. Pizza G, et al. Orally administered HSV-specific transfer factor (TF) prevents genital or labial herpes relapses. Biotherapy-1996. 9(1-3);67-72
29. Prasad U, et al. Transfer factor with anti-EBV activity as an adjuvant therapy for nasopharyngeal carcinoma: a pilot study. Biotherapy-1996. 9(1-3);109-15
30. Raise E, et al. Preliminary results in HIV-1-infected patients treated with transfer factor (TF) and zidovudine (ZDV). Biotherapy-1996.9(1-3);49-54
31. Fujisawa T, Yamaguchi Y Postoperative immunostimulation after complete resection improves survival of patients with stage I nonsmall cell lung carcinoma. Cancer-1996. 78(9);1892-8
32. Colagiuri S, et al. Intravenous immunoglobulin therapy for autoimmune diabetes mellitus. Clin Exp Rheumatol-1996. 14 Suppl 15(0);S93-7
33. Navarro Cruz D, et al. [Transference factor in moderate and severe atopic dermatitis] Rev Alerg Mex-1996. 43(5);116-23
34. Estrada-Parra S, et al. Immunotherapy with transfer factor of recurrent herpes simplex type I. Arch Med Res-1995. 26 Spec No(0);S87-92
35. Pizza G, et al. Transfer factor prevent relapse in herpes keratitis patients: A pilot study. Biotherapy-1995. 8;1-6
36. Sizemore RC, et al. A novel methodology for quantitating the enhancement of cutaneous delayed-type hypersensitivity by IMREG-1: a measure of the immunopotentiation of cell-mediated immunity. Clin Immunol Immunopathol-1995. 76(3 Pt 1);308-13
37. Ji T, et al. [Hepatic artery chemotherapy-embolization and biological response modifiers for late hepatic carcinoma] Zhonghua Zhong Liu Za Zhi-1995. 17(2);129-31
38. Pizza G, et al. Transfer factor prevents relapses in herpes keratitis patients: a pilot study. Biotherapy-1994. 8(1);63-8
39. Ferrer-Argote VE, et al. Successful treatment of severe complicated measles with non-specific transfer factor. In Vivo-1994. 8(4);555-7
40. Lloyd AR, et al. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. Am J Med-1993. 94(2);197-203
41. Fernandez O, et al. Effect of transfer factor on myelosuppression and related morbidity induced by chemotherapy in acute leukaemias. Br J Haematol-1993. 84(3);423-7
42. Orosi P, Nugent K Studies of phagocytic and killing activities of alveolar macrophages in patients with sarcoidosis. Lung-1993. 171(4);225-33
43. Fazio M, et al. Transfer in vivo of tuberculin hypersensitivity by sensitised lymphocytes. Panminerva Med-1993. 35(3);149-53
44. Fazio M, et al. Transfer in vitro of tubercolin hypersensitivity by sensitised lymphocytes. Panminerva Med-1993. 35(2);96-100
45. Li JF, Zou ZW [Effects of the jianpi yiqi prescription in treating infantile repetitive respiratory infection] Zhongguo Zhong Xi Yi Jie He Za Zhi-1993. 13(10);594-6, 579-80
46. Whyte RI, et al. Adjuvant treatment using transfer factor for bronchogenic carcinoma: long-term follow-up. Ann Thorac Surg-1992. 53(3);391-6
47. Prucha M, Limberk B [Secondary post-traumatic immunodeficiency syndrome in patients in the anesthesiology-resuscitation department. Possibilities of immunomodulation therapy] Cesk Epidemiol Mikrobiol Imunol-1992. 42(3);116-20
48. Xiuxin X. Observation of curative effect curing scleroderma with transfer factor of health person. In: [Unknown]-1992.
49. Fujisawa T, et al. [Recent advances of surgical treatment in elderly lung cancer patients] Nihon Kyobu Shikkan Gakkai Zasshi-1992. 30(2);224-9
50. Wu S, Zhong X [Observation of the effect of PSTF oral liquor on the positive tuberculin test reaction] Zhongguo Yi Xue Ke Xue Yuan Xue Bao-1992. 14(4);314-6
51. Sumiyama K, et al. Combination therapy with transfer factor and high dose stronger neo-minophagen C in chronic hepatitis B in children (HBe Ag positive). Acta Paediatr Jpn-1991. 33(3);327-34
52. Gottlieb MS, et al. Response to treatment with the leukocyte-derived immunomodulator IMREG-1 in immunocompromised patients with AIDS-related complex. A multicenter, double-blind, placebo-controlled trial. Ann Intern Med-1991. 115(2);84-91
53. Tan ST, et al. Recurrent orf in an immunocompromised host. Br J Plast Surg-1991. 44(6);465-7
54. Veselská A, et al. [Mucosal candidiasis] Cas Lek Cesk-1991. 130(18-19);561-2
55. Nevsimal O, et al. [Low-molecular transfer factor and its use in the treatment of amyotrophic lateral sclerosis] Cesk Neurol Neurochir-1991. 54(4);220-2
56. Mydlil J [Treatment of Hodgkin's malignant lymphoma in children and adolescents by immunomodulation with a dialysate of human leukocytes] Cesk Pediatr-1991. 46(5);266-9
57. Akasawa A, et al. Clinical and immunological evaluations of oral transfer factor treatment on patients with atopic dermatitis and aphthous stomatitis. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
58. Baba M, et al. Postsurgical adjuvant immunotherapy for non-smallcell lung carcinomas. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
59. Baolai H, Jingxin W Clinical observation on the effects of dialyzable leukocyte extracts. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
60. Baoqun L, et al. Transfer factor and thymosin in the treatment Guillan-Barre's syndrome. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
61. Dwyer JM, et al. A controlled trial of dialysable leucocyte extracts (DLE) in the management of newly diagnosed insulin dependent diabetes mellitus. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
62. Fucikova T, et al. DLE in immunosuppresed patients. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
63. Gottlieb AA, Gottlieb MS Clinical and biological effects of IMREG-1 and IMREG-2, two immunologically active components of leukocytedialysates. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, KomatsuF, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
64. Guang-Shu Z, et al. Evaluation of the effects of acute hepatitis B treated with specific placenta transfer factor. In: Recent Advancesin Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
65. Haiyan Q, et al. HSV-1 specific transfer factor for the treatment of herpes simplex keratitis. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
66. Jaji Z, et al. Therapeutic effects of acupoint injection of transfer factor on bronshial asthma In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
67. Jian-nan P, et al. Effect of transfer factor on oral mucous ulcer. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
68. Jing-Xin W, Ju-Xiang L Treatment on hepatitis B with bovine spleen transfer factor. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
69. Karl M, et al. Immunotherapy of women with recurrent spontaneous abortions by human large pool dialyzable leukocyte extract (DLE) In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
70. Li-Yi P, et al. Efficiency and immunological function observation on 100 cases malignant tumour with dialyzable placenta extracts. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
71. Matsumoto S, et al. Treatment of chronic persistent hepatitis B with high dose of specific dialyzable leukocyte extracts. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
72. Mayer V, et al. Marked therapeutic effect of human leukocyte ultrafiltrate in herpes zoster: Association with cell-mediated immune response induction. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
73. Metzner G, et al. Effect of DLE in patients suffered from chronic active and chronic persistent HBs-antigen-positive hepatitis. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
74. Pekarek J, et al. The use of DLE-TF fraction with the suppressive effect in some autoaggressive disease. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co.,LTD., Tokyo-1991.
75. Rovensky J, et al. DLE in the therapy of juvenile chronic arthritis. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
76. Rovensky J, et al. Wegner's granulomatosis: Some comments on the diagnosis and therapy. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
77. Shi-Liang L, et al. The experimental study on the immune-activity of oral pig's spleen transfer factor (PS-TF) in human body. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
78. Sumiyama K, et al. Combined therapy with transfer factor and large dose SNMC in juvenile chronic hepatitis type B (Hbe Ag positive) In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
79. Takenouchi K, Sasakawa S Effects of dialyzable leukocyte extracts (DLE) on survival curves of subacute sclerosing panencephalitis (SSPE) patients. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, SasakawaS, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
80. Tatsuzawa O, et al. Clinical application of a transfer factor suppository. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
81. Wei-zhong W, et al. The effects of swine spleen transfer factor on the subset of T lymphocyte and cell factor in the patients with cancer of large intestine. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
82. Xiaolan L, et al. Treatment of recurrent acute tonsillitis with bovine spleen dialyzable leucocyte extract In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co.,LTD., Tokyo-1991.
83. Ya-ge L, et al. Study of immune action for transfer factor and interferon. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
84. Yizhen F, et al. Evaluation of the clinical and immunological effects of transfer factor (TF), thymosin (TH) and placonta factor (PF) onasthma in children. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
85. Yizhen F, et al. Effects and immunological analysis of transfer factor (TF) and placent facter (PF) on Guillain-Barre's syndrome (GBS) in children. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
86. Yuexing L, et al. Study of transfering delayed type hypersensitivity by dialyzable human placenta extract. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co.,LTD., Tokyo-1991.
87. Zhenqing F, et al. Comparison of the effectiveness between porcine and human spleen transfer factors in the treatment of bronchialasthma. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
88. Fiala M, et al. Clinical benefits and recovery of delayed-type hypersensitivity in patients with AIDS-related complex treated with IMREG-1 or placebo. Int J Immunopharmacol-1991. 13(7);999-1004
89. Gottlieb AA Clinical and immunologic observations in patients with AIDS-related complex treated with IMREG-1. Int J Immunopharmacol-1991. 13 Suppl 1(0);29-32
90. Yang BZ, et al. Spleen cell dialyzable extracts (SCDE) mediated immunotherapy for patients with myasthenia gravis. Int J Immunopharmacol-1991. 13(7);825-9
91. Shizawa Y, et al. [An autopsied case of chronic active Epstein-Barr virus (EBV) infection with various symptom] Kansenshogaku Zasshi-1991. 65(4);481-7
92. Valdes Senchez AF, et al. [Atopic dermatitis. Treatment with transfer factor. A controlled clinical trial] Rev Alerg-1991. 38(6);158-62
93. Zackin RA, et al. Intention to treat analysis demonstrates IMREG-1 delays progression to AIDS in ARC patients in a six month trial. 6th Internation Conference on AIDS, San Francisco, CA-1990.
94. Neequaye J, et al. Specific transfer factor with activity against Epstein-Barr virus reduces late relapse in endemic Burkitt's lymphoma. Anticancer Res-1990. 10(5A);1183-7
95. Cabezas R, et al. Inmuterapia con Factor de Transferencia en pacientes con herpes zoster. Biotecnologia Aplicada-1990. 7;52-7
96. Stedry V, et al. [Manifestations of epidermolysis bullosa in the deglutition tract] Cesk Otolaryngol-1990. 39(4);199-203
97. Klein S, et al. [Alternatives to steroid therapy in chronic uveitis] Fortschr Ophthalmol-1990. 87(4);355-8
98. Gottlieb AA, Gottlieb MS Experience with IMREG-1, a leukocyte derived immunomodulator on candidiasis and progression of disease in patients with AIDS-related complex. In: Immunotherapeutic Prospects of Infectious Disease. Masihi KN, Lange W, Eds. Springer, NY-1990.
99. Guang-Shu Z, et al. Survey on the T-lymphocyte subsets transformation of hepatitis B patients treated with specific placenta transfer factor. In: Proceedings of the 4th Chinese Workshop on Transfer Factor. Science and Technology Press. Beijing-1990.
100. Guang-Shu Z, et al. Effects of specific placenta transfer factor on erythrocyte rosette formation and lymphocyte transformation tests of the hepatitis B patients. In: Proceedings of the 4th Chinese Workshop on Transfer Factor. Science and Technology Press. Beijing-1990.
101. Janout V, et al. An outbreak of viral hepatitis B associated with transfer factor administration. J Hyg Epidemiol Microbiol Immunol-1990. 34(1);31-6
102. McMeeking A, et al. A controlled trial of bovine dialyzable leukocyte extract for cryptosporidiosis in patients with AIDS. J Infect Dis-1990. 161(1);108-12
103. Guang-Shu Z, et al. Survey on the treatment of 200 cases of chornic hepatitis B with specific transfer factor extracted from HBVM positive placenta. Med J Chin People's Liberation Army-1990. 15(1);21
104. Lackovicova M, et al. Increased migration inhibition factor production by leukocytes of patients with herpes zoster given the leukocyte ultrafiltrate. Acta Virol-1989. 33(5);428-34
105. Vezendi S, Schroder I Transfer factor therapy of thoracic sarcoidosis. Allergol Immunopathol (Madr)-1989. 17(1);35-7
106. Perrick D, et al. Use of transfer factor in a pediatric AIDS patient with disseminated Mycobacterium avium intracellulare. Ann Allergy-1989. 62(5);437-40
107. Corrado F, et al. [Immunotherapy with transfer factor in hormone-resistant metastasized carcinoma of the prostate] Arch Esp Urol-1989. 42 Suppl 2(0);191-6
108. Sibl O, et al. [Non-differentiated carcinoma of the nasopharynx in children] Cesk Otolaryngol-1989. 38(2);121-7
109. Chng HH, et al. Inability of oral bovine transfer factor to eradicate cryptosporidial infection in a patient with congenital dysgammaglobulinemia. Clin Immunol Immunopathol-1989. 50(3);402-6
110. Cabeza-Quiroga R, et al. Effects of DLE in patients with herpes. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
111. Han Y, et al. A control study of transfer factor and chlorpromazine in the treatment of schizophrenics. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
112. Sonkoly I, et al. Treatment of SLE with transfer factor. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z,Eds. Xue Yuan Press, Beijing-1989.
113. Su CZ, Wan ZF Antigen-dependent activities and physio-chemical characterization of specific goat's transfer factor to human gastric adenocarcinoma. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
114. Xie D, et al. Clinical observation of 37 cases of schizophrenia treated with transfer factor from bovine spleen. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
115. Yan D, et al. The effect of DLE induced by psoriasis scale on psoriasis patients and their immunological function. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
116. Zhan Y, et al. Transfer of Taekypleus Triclententus Hemocyanin and DNP-BSA dermal reactivity to human with goose derived transfer factor. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
117. Zhang G, et al. Survey on the treatment of 200 CAH cases with specific transfer factor extracted from HBVM positive placenta. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
118. [No Author(s)] Interferon-alpha and transfer factor in the treatment of multiple sclerosis: a double-blind, placebo-controlled trial. AUSTIMS Research Group. J Neurol Neurosurg Psychiatry-1989. 52(5);566-74
119. Iseki M, et al. [Effects of transfer factor on chronic hepatitis B in childhood] Kansenshogaku Zasshi-1989. 63(12);1329-32
120. Zachar V, et al. Varicella-zoster virus IgG antibodies during primoinfection in competent and transfer factor modulated immunocompromised host: comparison of three indirect assays. Acta Virol-1988. 32(3);243-51
121. Miller LL, et al. A randomized, double-blind, placebo-controlled trial of transfer factor as adjuvant therapy for malignant melanoma. Cancer-1988. 61(8);1543-9
122. Hancock BW, et al. Transfer factor in Hodgkin's disease: a randomized clinical and immunological study. Eur J Cancer Clin Oncol-1988. 24(5);929-33
123. Yizhen F. Effects of transfer factor on 50 children with asthma. Practical and Clin J Pediatrics-1988. 3(3);146
124. Yonghua Han Liu Jiancheng, et al. A control study of transfer factor (TF) and chlopromazine in the treatment of schizophrenics. Reasearch and Application of Transfer Factor and DLE. Proceeding of the Sixth International Workshop on Transfer Factor Beijing Science Hall-1988.
125. Karl M, et al. [Clinical and immunologic results of immunotherapy with pooled buffy coat transfusions in females with habitual abortion] Z Geburtshilfe Perinatol-1988. 192(4);147-54
126. Zachariae H, Thestrup-Pedersen K Combination chemotherapy with bleomycin, cyclophosphamide, prednisone and etretinate (BCPE) in advanced mycosis fungoides: a six-year experience. Acta Derm Venereol-1987. 67(5);433-7
127. Mastromatteo V, et al. [Effects of transfer factor on the number of circulating lymphocytes in patients with spinocellular carcinoma of the cervicofacial area] Boll Soc Ital Biol Sper-1987. 63(11);1043-50
128. Negri L, et al. [Changes in circulating lymphocytes and "E" rosettes in patients with colonic neoplasms treated with transfer factor] Boll Soc Ital Biol Sper-1987. 63(11);1051-8
129. Jackson WB, et al. Laser therapy of conjunctival papillomas. Can J Ophthalmol-1987. 22(1);45-7
130. Wagner G, et al. Transfer factor for adjuvant immunotherapy in cervical cancer. Cancer Detect Prev Suppl-1987. 1(0);373-6
131. Louie E, et al. Treatment of cryptosporidiosis with oral bovine transfer factor. Clin Immunol Immunopathol-1987. 44(3);329-34
132. Iikura Y, et al. Clinical trial of human leukocyte extracts in allergic diseases and the study of their transfer factor content. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987.
133. Mayer V, et al. Gel-Filtered ehtanol-precipitated material from human leukocyte ultrafiltrate in patients with herpes zoster. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987.
134. Prochazkova J, et al. Clinical and immunological improvement in infants with HCMV infection treated with dialyzable leukocyte extract. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987.
135. Waisbren BA Observations on the combined systemic administration of mixed bacterial vaccine, bacillus Calmette-Guerin, transfer factor, and lymphoblastoid lymphocytes to patients with cancer, 1974-1985. J Biol Response Mod-1987. 6(1);1-19
136. Nkrumah FK, et al. Transfer factor in prevention of Burkitt's lymphoma relapses. J Exp Pathol-1987. 3(4);463-9
137. Viza D, et al. Use of specific transfer factor for the prevention or the treatment of herpes infections in mice and in man. J Exp Pathol-1987. 3(4);407-20
138. Viza D, et al. A preliminary report on three AIDS Patients treated with anti-HIV specific transfer factor. J Exp Pathol-1987. 3(4);653-9
139. Carey JT, et al. Augmentation of skin test reactivity and lymphocyte blastogenesis in patients with AIDS treated with transfer factor. JAMA-1987. 257(5);651-5
140. Wiersbitzky S, et al. Clinical results of transfer factor (BBZ Plauen) therapy in immunodeficient children. Padiatr Grenzgeb-1987. 26(6);439-41
141. Briese V, Richter C [Choriocarcinoma: neutropenia--acute emergency] Zentralbl Gynakol-1987. 109(7);450-8
142. Frith JA, et al. Transfer factor as a therapy for multiple sclerosis: a follow-up study. Clin Exp Neurol-1986. 22(0);149-54
143. Van Haver H, et al. Transfer factor therapy in multiple sclerosis: a three-year prospective double-blind clinical trial. Neurology-1986. 36(10);1399-402
144. Ashorn RG, et al. Dialysable leukocyte extracts (transfer factor) augment nonspecifically keyhole limpet haemocyanin and horseshoe crab haemocyanin skin reactivity in unimmunized human recipients. Scand J Immunol-1986. 23(2);161-7
145. Rytter M, et al. [Chronic mucocutaneous candida mycosis (CMCC) caused by a T-cell defect] Z Gesamte Inn Med-1986. 41(7);214-6
146. Ashorn R, et al. Cellular immunity in acne vulgaris during transfer factor treatment. Ann Clin Res-1985. 17(4);152-5
147. Goldenberg GJ, et al. Cooperative trial of immunotherapy for nasopharyngeal carcinoma with transfer factor from donors with Epstein-Barr virus antibody activity. Cancer Treat Rep-1985. 69(7-8);761-7
148. Misarova Z, et al. [Transfer factor in the treatment of children with disorders of cellular immunity] Cesk Pediatr-1985. 40(6);346-9
149. Gouyon JB, et al. Outbreak of respiratory syncytial virus in France. Eur J Clin Microbiol-1985. 4(4);415-6
150. Mowbray JF, et al. Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet-1985. 1(8435);941-3
151. Nkrumah F, et al. Regression of progressive lymphadenopathy in a young child with acute cytomegalovirus (CMV) infection following the administration of transfer factor with specific anti-CMV activity. Lymphokine Res-1985. 4(3);237-41
152. Viza D, et al. Orally administered specific transfer factor for the treatment of herpes infections. Lymphokine Res-1985. 4(1);27-30
153. Georgescu C Effect of long-term therapy with transfer factor in rheumatoid arthritis. Med Interne-1985. 23(2);135-40
154. Rosenberg SA, et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med-1985. 313(23);1485-92
155. Fujisawa T [The results of immunotherapy as an adjunct to the surgical treatment of primary lung cancers] Nippon Geka Gakkai Zasshi-1985. 86(9);1055-8
156. Hong R, et al. Omenn disease: termination in lymphoma. Pediatr Pathol-1985. 3(2-4);143-54
157. Roda E, et al. Transfer factor for the treatment of HBsAg-positive chronic active hepatitis. Proc Soc Exp Biol Med-1985. 178(3);468-75
158. Borkowsky W, et al. Juvenile laryngeal papillomatosis with pulmonary spread. Regression following transfer factor therapy. Am J Dis Child-1984. 138(7);667-9
290. Kirsh MM, et al. Transfer factor in the treatment of carcinoma of the lung. Ann Thorac Surg-1984. 38(2);140-5
159. Wiedemann HP, et al. Progressive immune failure in dyskeratosis congenita. Report of an adult in whom Pneumocystis carinii and fatal disseminated candidiasis developed. Arch Intern Med-1984. 144(2);397-9
160. Aziz S, et al. Mucormycosis in patients with multiple-organ failure. Arch Surg-1984. 119(10);1189-91
161. Borkowsky W, Karpatkin S Leukocyte migration inhibition of buffy coats from patients with autoimmune thrombocytopenic purpura when exposed to normal platelets: modulation by transfer factor. Blood-1984. 63(1);83-7
162. Fujisawa T, et al. Adjuvant immunotherapy of primary resected lung cancer with transfer factor. Cancer-1984. 54(4);663-9
163. Strejcek J, Jìra M [The effect of transfer factor on phagocytosis and humoral immunity in children with recurrent otitis media] Cas Lek Cesk-1984. 123(32);1003
164. Kaminkova J, Lange CF Transfer factor and repeated otitis media. Cell Immunol-1984. 89(1);259-64
165. Schulkind ML, et al. A case report of the successful treatment of recurrent aphthous stomatitis with some preparations of orally administered transfer factor. Cell Immunol-1984. 84(2);415-21
166. Zielinski CC, et al. Dialyzable leukocyte extract (transfer factor) in the treatment of superinfected fistulating tuberculosis of the bone.Cell Immunol-1984. 84(1);200-5
167. Winkelmann RK, et al. Treatment of varicella-zoster pneumonia with transfer factor. Cutis-1984. 34(3);278-81
168. Corbeel L, et al. Immunological observations before and after successful treatment of chronic mucocutaneous candidiasis with
169. ketoconazole and transfer factor. Eur J Pediatr-1984. 143(1);45-8
170. Martinez MI, Sanchez JL Treatment of leprosy with weekly intravenous infusion of leukocytes. Int J Dermatol-1984. 23(5);341-7
171. Franzoni E, et al. Behcet syndrome: report of two early-onset cases treated with transfer factor. Ital J Neurol Sci-1984. 5(1);93-6
172. Vasily DB, et al. Epidermodysplasia verruciformis: response to therapy with dialyzable leukocyte extract (transfer factor) derived from household contacts. J Clin Lab Immunol-1984. 14(1);49-57
173. Wilson GB, et al. Guidelines for immunotherapy of antigen-specific defects with transfer factor. J Clin Lab Immunol-1984. 13(2);51-8
174. Zhenqing F Observation of the skin delayed hypersensitivity response of transfer factor to patients with cancer. Jiangsu Med-1984.7;186
175. Fujisawa T, et al. Randomized controlled trial of transfer factor immunochemotherapy as an adjunct to surgical treatment for primary adenocarcinoma of the lung. Jpn J Surg-1984. 14(6);452-8
176. Rosenfeld F, et al. [Treatment of herpes infections with transfer factor] Presse Med-1984. 13(9);537-40
177. Dwyer JM, et al. Clinical and immunologic response to antigen-specific transfer factor in drug-resistant infection with Mycobacterium xenopi. Am J Med-1983. 74(1);161-8
178. Bukowski RM, et al. Randomized controlled trial of transfer factor in Stage II malignant melanoma. Cancer-1983. 51(2);269-72
179. Kamikova J, et al. [Te effect of transfer factor on phagocytosis and humoral immunity in children with recurrent middle ear inflammations] Cas Lek Cesk-1983. 122(51);1577-9
180. Kamikova J, et al. [The effect of the transfer factor on T lymphocytes in children with recurrent otitis media] Cas Lek Cesk-1983. 122(25);779-82
181. Tanphaichitra D Cellular immunity in typhoid fever, Legionnaires' disease, amebiasis: role of transfer factor and Levamisole in typhoid fever. Dev Biol Stand-1983. 53(0);35-40
182. Burton RC, et al. Effects of age, gender, and cigarette smoking on human immunoregulatory T-cell subsets: establishment of normal ranges and comparison with patients with colorectal cancer and multiple sclerosis. Diagn Immunol-1983. 1(3);216-23
183. Metzner G, et al. [Human transfer factor. II. Clinical results with the large pool transfer factor] Folia Haematol Int Mag Klin Morphol Blutforsch-1983. 110(4);526-39
184. Schutt C, et al. [Discrepancy between the clinical and immunologic picture of in vitro diagnosis during transfer factor therapy in a patient with Wiscott-Aldrich syndrome] Folia Haematol Int Mag Klin Morphol Blutforsch-1983. 110(5);677-84
185. Fujisawa T, Yamaguchi Y [Transfer factor immunochemotherapy for primary lung cancer--evaluation of histologic types] Gan No Rinsho-1983. 29(12);1409-16
186. Yamaguchi Y [Recurrence of lung cancer--its treatment and prevention] Gan No Rinsho-1983. 29(10);1063-71
187. Yamaguchi Y [Strategy and treatment of postoperative recurrence of primary lung cancer] Gan To Kagaku Ryoho-1983. 10(11);2258-67
188. Akashi K, et al. Clinical use of leukocyte dialysate (transfer factor) in Osaka area of Japan. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
189. Ashorn RGI, et al. The effects of immune and nonimmune dialyzable leucocoyte extracts on KLH and HCH reactivity in unprimed human recipients: A double blind study. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
190. Burger DR, et al. Human transfer factor: Specificity and structural models. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
191. Fudenberg HH, et al. Clinical applications of the leukocyte migration inhibition assay: New methods for determining transfer factor potency and for predicting clinical response. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
192. Hainaut J, et al. Dialyzable leukocyte extracts in pulmonary diseases (lung cancer and recurrent bronchitis) In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
193. Jones JF, et al. Oral bovine transfer factor (OTF) use in the hyper IgE syndrome In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
194. Viza D, et al. Specific bovine transfer factor for the treatment of herpes infections. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
195. Fudenberg HH, et al. Evaluation of potency and predictability of clinical response to DLE containing transfer factor. In: Immunomodulation and Thermotherapy. Fudenberg HH, Pontiggia P, Eds. Acta Medica; Rome-1983.
196. Chen WB, et al. Boosting effects of drugs benefiting vital energy and activating blood and transfer factor on the immunity of patients with chronic cor pulmonale. J Tradit Chin Med-1983. 3(1);63-6
197. Fujisawa T, et al. Transfer factor in restoration of cell mediated immunity in lung cancer patients. Jpn J Surg-1983. 13(4);304-11
198. Williamson MM, Gordon RD Severe chronic mucocutaneous candidiasis. Favourable response to oral therapy with ketoconazole. Med J Aust-1983. 1(6);276-8
199. Lang I, et al. [Enhancing decreased natural lymphocytotoxicity in tumor patients by transfer factor therapy] Orv Hetil-1983. 124(14);807-10
200. Jones JM, Craig WA Cryptococcal meningitis: resolution eight months after antifungal therapy. South Med J-1983. 76(12);1567-9
201. Wagner G, et al. [Transfer factor as adjuvant immunotherapy in invasive cervix cancer. Report of a double-blind study] Wien Klin Wochenschr-1983. 95(20);738-42
202. Jin A, et al. [Transfer factor therapy of viral hepatitis--report of 22 cases] Zhongguo Yi Xue Ke Xue Yuan Xue Bao-1983. 5(6);396-7
203. Bjerring P, et al. Treatment of Kaposi's varicelliform eruption wit adenine arabinoside (Vira-A) and transfer factor. Acta Derm Venereol-1982. 62(1);85-7
204. Thestrup-Pedersen K, et al. Transfer factor therapy in mycosis fungoides: a double-blind study. Acta Derm Venereol-1982.
205. 62(1);47-53
206. Zachariae H, et al. Oral retinoid in combination with bleomycin, cyclophosphamide, prednisone and transfer factor in mycosis
207. fungoides. Acta Derm Venereol-1982. 62(2);162-4
208. Allen R, et al. Disseminated cryptococcosis after transurethral resection of the prostate. Aust N Z J Med-1982. 12(4);296-9
209. Hersey P, et al. Deficient natural killer cell activity in a patient with Fanconi's anaemia and squamous cell carcinoma. Association withdefect in interferon release. Clin Exp Immunol-1982. 48(1);205-12
210. Lang I, et al. Effect in vivo and in vitro treatment with dialyzable leukocyte extracts on human natural killer cell activity. Clin Immunol Immunopathol-1982. 25(1);139-44
211. Cameron J, et al. Severe tubulo-interstitial disease in a renal allograft due to cytomegalovirus infection. Clin Nephrol-1982. 18(6);321-5
212. Buck BE, et al. Measles virus panniculitis subsequent to vaccine administration. J Pediatr-1982. 101(3);366-73
213. Montie JE, et al. A critical review of immunotherapy of disseminated renal adenocarcinoma. J Surg Oncol-1982. 21(1);5-8
214. Georgescu C, Chirulescu Z Study of trace elements in patients with rheumatoid arthritis stage I-II, before and after treatment. Med Interne-1982. 20(4);271-5
215. Novitzky N, Jacobs P Acyclovir therapy in cutaneous herpes simplex following bone marrow transplantation. A case report. S Afr Med J-1982. 62(8);251-2
216. Jarisch R, et al. Influence of dialysable transfer factor on IgE concentrations in patients with atopic dermatitis. Allergy-1981. 36(2);99-105
217. Ortiz A, et al. [Transfer factor in the treatment of laryngeal papillomatosis. Apropos of 2 cases treated at the Caracas University Hospital] An Otorrinolaringol Ibero Am-1981. 8(4);289-94
218. Schwartz RA, Jeter WS Oral administration of human dialyzable transfer factor in a patient with psoriasis. Arch Dermatol-1981 117(1);3-4
219. Catanzaro A, et al. Transfer factor therapy for histoplasmosis in a patient with Hodgkin's disease. Arch Intern Med-1981. 141(4);533-7
220. Kauffman CA, et al. Invasive fungal infections in patients with chronic mucocutaneous candidiasis. Arch Intern Med-1981. 141(8);1076-9
221. Tamari H, et al. An acute variant of subacute sclerosing panencephalitis: an autopsy case report. Brain Dev-1981. 3(1);87-91
222. Blume MR, et al. Adjuvant immunotherapy of high risk stage I melanoma with transfer factor. Cancer-1981. 47(5);882-8
223. Lamoureux G, et al. A clinical and immunological study of the effects of transfer factor on multiple sclerosis patients. Clin Exp Immunol-1981. 43(3);557-64
224. Delgado O, et al. Dialyzable leukocyte extract therapy in immunodepressed patients with cutaneous leishmaniasis. Clin Immunol Immunopathol-1981. 19(3);351-9
225. Khan A, et al. Transfer factor in the treatment of herpes simplex types 1 and 2. Dermatologica-1981. 163(2);177-85
226. Goring HD [IgA deficiency in the dermatologic clinic. Frequency, clinical relevance, diagnosis and therapy] Hautarzt-1981. 32(10);505-11
360. Pizza G, et al. The possible use of specific transfer factor in the treatment of patients with nasopharyngeal carcinoma. In: Nasopharyngeal Carcinoma. Grundman E, Krueger GRF, Ablashi DV, Eds. Fisher-Verlag Editor, Stuttgart-1981.
227. Moulias R, et al. Human dialysable leucocyte extracts (transfer factor) in interstitial pneumonia. A retrospective trial in immunodeficient patients. J Clin Lab Immunol-1981. 6(1);13-6
228. Jones JF, et al. Treatment of childhood combined Epstein-Barr virus/cytomegalovirus infection with oral bovine transfer factor. Lancet-1981. 2(8238);122-4
229. Gilchrist GS, et al. Management of osteogenic sarcoma: a perspective based on the Mayo Clinic experience. Natl Cancer Inst Monogr-1981.
230. Yamaguchi Y [Effect of transfer factor on surgical treatment of primary lung cancer] Rinsho Kyobu Geka-1981. 1(3);397-405
231. Berezhnaia NM, et al. [Transfer factor immunotherapy of oncological patients] Vopr Onkol-1981. 27(2);89-91
232. Jensen JR, Thestrup-Pedersen K Subpopulations of T lymphocytes in a patient with fulminant mycosis fungoides. Acta Derm Venereol-1980. 60(2);159-61
233. Mobacken H, et al. Transfer factor in the treatment of chronic mucocutaneous candidiasis: a controlled study. Acta Derm Venereol-1980. 60(1);51-5
234. Kyong CU, et al. Chorioretinitis with a combined defect in T and B lymphocytes and granulocytes. A new syndrome successfully treated with dialyzable leukocyte extracts (transfer factor). Am J Med-1980. 68(6);955-61
235. De Bruyere M, et al. HLA haplotypes and long survival in childhood acute lymphoblastic leukaemia treated with transfer factor. Br J Haematol-1980. 44(2);243-51
236. Abramson A, et al. Immunocompetence and transfer factor therapy in uveitis. Br J Ophthalmol-1980. 64(5);332-8
237. Gonzalez RL, et al. Adjuvant immunotherapy with transfer factor in patients with melanoma metastatic to lung. Cancer-1980. 45(1);57-63
238. Schwarz MA, et al. Chemoimmunotherapy of disseminated malignant melanoma with DTIC-BCG, transfer factor + melphalan. Cancer-1980. 45(10);2506-15
239. Steele RW Transfer factor and cellular reactivity to varicella-zoster antigen in childhood leukemia. Cell Immunol-1980. 50(2);282-9
240. Spitler LE Transfer factor: failure to transfer reactivity in normal human subjects. Clin Exp Immunol-1980. 39(3);708-16
241. Khan A, et al. Transfer factor treatment in bullous pemphigoid. Impaired T cell function. Dermatologica-1980. 161(4);243-9
242. Zachariae H, et al. Transfer factor in mycosis fungoides: three years experience. Dermatologica-1980. 160(1);1-6
243. Leser PG, et al. Cell mediated immunity in patients with Virchowian hanseniasis before and after treatment with transfer factor. Hansenol Int-1980. 5(1);3-27
244. Stubbs EG, et al. Transfer factor immunotherapy of an autistic child with congenital cytomegalovirus. J Autism Dev Disord-1980. 10(4);451-8
245. Landwehr DM, et al. Rapidly progressive glomerulonephritis in Behcet's syndrome. JAMA-1980. 244(15);1709-11
246. Fujisawa T, et al. Effect of transfer factor in the primary resected, lung cancer patients with secondary immunodeficiency due to chemotherapy. Jpn J Cancer Chemother-1980. 7(11);2004-11
247. Basten A, et al. Transfer factor in treatment of multiple sclerosis. Lancet-1980. 2(8201);931-4
248. Thestrup-Pedersen K, et al. Epstein-Barr-virus-induced lymphoproliferative disorder converting to fatal Burkitt-like lymphoma in a boy with interferon-inducible chromosomal defect. Lancet-1980. 2(8202);997-1002
249. Kornblut AD An evolution of therapy for mucocutaneous candidiasis. Laryngoscope-1980. 90(7 Pt 2 Suppl 22);1-30
250. Simo-Camps E, et al. [Cell immunity responses in patients with widespread neoplasias following administration of transfer factor (author's transl)] Med Clin (Barc)-1980. 74(10);403-7
251. dos Reis VL, et al. [Transfer factor in diffuse cutaneous leishmaniasis. Experience with one case] Med Cutan Ibero Lat Am-1980. 8(4-6);95-100
252. Keith CG, La Nauze J Cytomegalovirus retinitis. Med J Aust-1980. 1(1);24-6
253. Franchi F, et al. [Clinico-immunological studies of 32 cases of bone tumors] Minerva Med-1980. 71(25);1815-22
388. Steele RW, et al. Transfer factor for the prevention of varicella-zoster infection in childhood leukemia. N Engl J Med-1980. 303(7);355-9
254. Spitler LE, et al. Nephropathy in the Wiskott-Aldrich syndrome. Pediatrics-1980. 66(3);391-8
255. Olding-Stenkvist E, et al. Fatal progressive vaccinia in two immunodeficient infants. Scand J Infect Dis Suppl-1980. Suppl 24(0);63-7
256. Han SH, et al. Conversion of reactions to leprolin and lepromin in patients with lepromatous leprosy by the transfer factor. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi-1980. 13(1);1-8
257. Zachariae H, et al. Transfer factor in mycosis fungoides: a case report on a patient "cured". Acta Derm Venereol-1979. 59(4);375-8
258. Spitler LE Transfer factor therapy in the Wiskott-Aldrich syndrome. Results of long-term follow-up in 32 patients. Am J Med-1979. 67(1);59-66
259. Hainaut J, et al. [Effect of transfer factor on the immunity state of patients with bronchopulmonary cancer. A report on 12 cases (author's transl)] Ann Med Interne (Paris)-1979. 130(11);517-21
260. Olarte MR, et al. Transfer factor is ineffective in amyotrophic lateral sclerosis. Ann Neurol-1979. 5(4);385-8
261. Horsmanheimo M, et al. Immunologic features of chronic granulomatous mucocutaneous candidiasis before and after treatment with transfer factor. Arch Dermatol-1979. 115(2);180-4
262. Manz HJ, et al. Delayed radiation necrosis of brainstem related to fast neutron beam irradiation: case report and literature review. Cancer-1979. 44(2);473-9
263. Burger DR, et al. Transfer of keyhole limpet hemocyanin dermal reactivity to man with bovine transfer factor. Cell Immunol-1979. 43(1);192-6
264. Shulman ST, et al. A double-blind evaluation of transfer factor therapy of HBsAg-positive chronic aggressive hepatitis: preliminary report of efficacy. Cell Immunol-1979. 43(2);352-61
265. Ellis-Pegler R, et al. Transfer factor and hepatitis B: a double blind study. Clin Exp Immunol-1979. 36(2);221-6
266. Faber WR, et al. A placebo controlled clinical trial of transfer factor in lepromatous leprosy. Clin Exp Immunol-1979. 35(1);45-52
267. Kesarwala HH, et al. Transfer factor therapy in hyperimmunoglobulinaemia E syndrome. Clin Exp Immunol-1979. 36(3);465-72
268. Nekam K, et al. Effects of therapy with dialyzable leukocyte extracts containing transfer factor activity on antibody-dependent
269. cytotoxic activity in humans. Clin Immunol Immunopathol-1979. 13(4);407-12
270. Sharma MK, et al. Preliminary results of transfer factor therapy of persistant cutaneous leishmania infection. Clin Immunol Immunopathol-1979. 12(2);183-90
271. Vicary FR, et al. Double-blind trial of the use of transfer factor in the treatment of Crohn's disease. Gut-1979. 20(5);408-13
272. Schut BJ, et al. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study. Immunology-1979. 36(1);1-12
273. Berkel AI, et al. Transfer factor therapy in ataxia-telangiectasia: A 3 year follow-up. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
274. Bukowski RM, et al. Immunotherapy of stage II malignant melanoma and renal cell carcinoma with transfer factor in clinical results. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
275. Freedman RS, et al. Experiences with TFd in advanced gynecological cancer and two non-gynecological sarcomas. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
276. Grob PJ, et al. Clinical trials with transfer factor preparations Zurich (TFz) -7 series of patients. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
277. Heim LR Atopic dermatitis, specific virus infections, and Behcet's syndrome: Transfer factor therapy. In: Immune Regulators in: Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
278. Jeter WS, et al. Oral administration of bovine and human dialyzable transfer factor to human volunteers. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
279. Khan A, et al. Management of viral infections with transfer factor. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
280. Kirkpatrick CH, Greenberg LE Treatment of chronic mucocutaneous candidiasis with transfer factor. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
281. Nekam K, et al. Effect of transfer factor therapy on antibody-dependent cytotoxic activity in humans. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
282. Peetoom F, Florey MJ. Transfer factor in the treatment of disseminated herpes zoster (Hz) infection in immune-suppressed patients. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
283. Phillips TM, et al. Variation of antitumor antibodies in patients treated with transfer factor. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
284. Rodriguez GE, et al. Treatment of Behcet's disease with transfer factor. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
285. Rovensky J, et al. Transfer factor treatment in patients with psoriasis. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
286. Sharma M, et al. Transfer factor therapy in human cutaneous leishmania infection (CLI). In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
287. Silverman M, et al. Transfer factor in the treatment of B-cell disorders: Effects and potential risks. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
288. South MA, Caleb M Intravenous long term transfer factor therapy. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
289. Steele RW Passive transfer of reactivity to varicella-zoster in the compromised host. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
290. Vich JM, et al. Transfer to man of sensitisation to keyhole limpet haemocyanin by mouse transfer factor. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
291. Zachariae H, et al. Transfer factor as an additional therapeutic agent in mycosis fumgoides. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
292. Epstein WL, Byers VS Transfer of contact sensitivity to beryllium using dialyzable leukocyte extracts (transfer factor). J Allergy Clin Immunol-1979. 63(2);111-5
293. Kirsh MM, et al. Clinical presentation and management of patients with carcinoma of the lung: a 14-year experience. J Fam Pract-1979. 8(6);1127-31
294. Plouffe JF, et al. Cell-mediated immune responses in sporotrichosis. J Infect Dis-1979. 139(2);152-7
295. Lankford J, et al. A case of varicella pneumonia treated with transfer factor. JAMA-1979. 241(24);2598
296. Sodomann CP, et al. [Transfer factor (TF) treatment of patients with HBs-Ag-positive chronic active hepatitis. A prospective, controlled study (author's transl)] Klin Wochenschr-1979. 57(17);893-903
297. Ketchel SJ, et al. A study of transfer factor for opportunistic infections in cancer patients. Med Pediatr Oncol-1979. 6(4);295-301
298. Endre L, et al. [Successful treatment of Wiscott-Aldrich syndrome with transfer factor] Orv Hetil-1979. 120(39);2361-6
299. [No Author(s)] [Prevention of infection in patients with chronic obstructive pulmonary disease by normal human tonsillar transfer factor (author's transl)] Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi-1979. 2(1);25-7
300. Romano EL, et al. [Treatment of patients with multiple sclerosis with transfer factor (author's transl)] Acta Cient Venez-1978. 29(1);49-52
Grohn P, et al. The effect of transfer factor on cystic acne. Acta Derm Venereol-1978. 58(2);153-5
301. Hovmark A, Ekre HP Failure of transfer factor therapy in atopic dermatitis. Acta Derm Venereol-1978. 58(6);497-500
302. Hastings RC, Job CK Reversal reactions in lepromatous leprosy following transfer factor therapy. Am J Trop Med Hyg-1978. 27(5);995-1004
303. Khan A, et al. The usefulness of transfer factor in asthma associated with frequent infections. Ann Allergy-1978. 40(4);229-32
304. Hoyeraal HM, et al. No effect of transfer factor in juvenile rheumatoid arthritis by double-blind trial. Ann Rheum Dis-1978. 37(2);175-9
305. Spitler LE, et al. Combined immunotherapy of malignant melanoma. Unusual survival following cerebral metastasis. Arch Dermatol-1978. 114(10);1501-4
306. Mackie RM, et al. Wiskott-Aldrich syndrome with partial response to transfer factor. Br J Dermatol-1978. 98(5);567-71
307. Phillips J, et al. Effect of in vitro produced transfer factor on Hodgkin patients. Br J Haematol-1978. 38(3);430-1
308. Danoff D, et al. Disseminated coccidioidomycosis: clinical, immunologic and therapeutic aspects. Can Med Assoc J-1978. 118(4);390-2
309. FitzSimons RB, Ferguson AC Cellular immunity and nutrition in refractory disseminated blastomycosis. Can Med Assoc J-1978. 119(4);343-6
310. Gilchrist GS, et al. Adjuvant therapy for nonmetastatic osteogenic sarcoma: an evaluation of transfer factor versus combination chemotherapy. Cancer Treat Rep-1978. 62(2);289-94
311. Collins RC, et al. A double-blind trial of transfer factor vs placebo in multiple sclerosis patients. Clin Exp Immunol-1978. 33(1);1-11
312. Sharma MK, et al. Progressive BCG infection in an immunodeficient child treated with transfer factor. Clin Immunol Immunopathol-1978. 10(4);369-80
313. Wolf RE, et al. Transfer factor therapy in a case of pemphigus vegetans associated with chronic mucocutaneous candidiasis. Clin Immunol Immunopathol-1978. 10(3);292-7
314. Ritts RE, et al. Comparison of transfer factor and combination chemotherapy as post surgical adjuvants in osteogenic sarcoma: Results at 3 years. In: Immunotherapy of Malignant Disease. Rainer H, Borberg H, Mishler JM, Schafer U, Eds. FK Schattauer Verlag, NY-1978.
315. Timar L, et al. Progressive vaccinia: immunological aspects and transfer factor therapy. Infection-1978. 6(4);149-53
316. Krown SE, et al. Effects of transfer factor in patients with advanced cancer. Isr J Med Sci-1978. 14(10);1026-38
317. Neidhart JA, et al. Skin test conversion following transfer factor. A double-blinded study of normal individuals. J Allergy Clin
318. Immunol-1978. 61(2);115-8
319. Virelizier JL, et al. Impaired defense against vaccinia in a child with T-lymphocyte deficiency associated with inosine phosphorylase defect. J Pediatr-1978. 92(3);358-62
320. Gross PA, et al. Disseminated Cryptococcus treated with transfer factor. JAMA-1978. 240(22);2460-2
321. Fog T, et al. Long-term transfer-factor treatment for multiple sclerosis. Lancet-1978. 1(8069);851-3
322. Vich JM, et al. Transfer to man of sensitisation to keyhole limpet haemocyanin by mouse transfer factor. Lancet-1978. 1(8058);265-6
323. Vetto RM, Burger DR Transference of cell mediated immunity in patients with head and neck cancer. Laryngoscope-1978. 88(1 Pt 2 Suppl 8);79-82
324. Maida E, et al. [Transfer-factor therapy in a case of chronic herpes simplex myelitis (author's transl)] Nervenarzt-1978. 49(11);671-3
325. Horn GV, et al. Progressive multifocal leukoencephalopathy: failure of response to transfer factor and cytarabine. Neurology-1978. 28(8);794-7
326. Nekam K, et al. [Therapeutic experience with transfer factor in 18 cases] Orv Hetil-1978. 119(29);1787-91
327. Kyong CU, et al. X-linked immunodeficiency with increased IgM: clinical, ethnic, and immunologic heterogeneity. Pediatr Res-1978. 12(10);1024-6
328. Winsnes R, et al. Effect of transfer factor and zoster immunoglobulin in patients with varicella-zoster infection and malignancy.
329. Scand J Infect Dis-1978. 10(1);21-7
330. Rainer H, et al. [Randomized study: chemotherapy versus chemotherapy plus transfer factor in metastasized breast neoplasm] Verh Dtsch Ges Inn Med-1978.
331. Thulin H, et al. Long-term transfer factor treatment in severe atopic dermatitis. Acta Allergol-1977. 32(4);236-7
332. Mobacken H, et al. Deficient neutrophil function in a patient with chronic mucocutaneous candidiasis, thymoma and myasthenia gravis. Acta Derm Venereol-1977. 57(4);335-9
333. Offner H, et al. Lymphocyte stimulation in multiple sclerosis patients untreated and treated with transfer factor. Long-term studies on the effect of different stimulants on myo-(2-3H)inositol incorporation into phosphatidylinositol of lymphocytes. Acta Neurol Scand-1977. 56(6);465-74
334. Espinoza LR, et al. Cell-mediated immunity in multiple sclerosis. Acta Neurol Scand Suppl-1977. 63(0);123-31
335. Jersild C, et al. Transfer factor treatment of multiple sclerosis. A pilot study. Acta Neurol Scand Suppl-1977. 63(0);253-64
336. Spitler LE, Dau PC Immunotherapy in infectious disease, autoimmunity and cancer. Acta Neurol Scand Suppl-1977. 63(0);227-37
337. Anttila R, et al. Transfer factor and cellular immune response in urinary tract infections in children. Acta Paediatr Scand-1977.66(2);219-24
338. Grohn P Transfer factor in chronic and recurrent respiratory tract infections in children. Acta Paediatr Scand-1977. 66(2);211-7
339. Pedersen FK, et al. Indication of primary immune deficiency in Fanconi's anemia. Acta Paediatr Scand-1977. 66(6);745-51
340. Benz CC, et al. Acquired chronic candidiasis treated with transfer factor. Br J Dermatol-1977. 97(1);87-91
341. Berkel AI, et al. Transfer factor therapy in ataxia--telangiectasia. Clin Exp Immunol-1977. 29(3);376-84
342. Jain S, et al. Transfer factor in the attempted treatment of patients with HBsAg-positive chronic liver disease. Clin Exp Immunol-1977.30(1);10-5
343. Rubinstein A, et al. Transfer factor treatment in a patient with progressive tuberculosis. Clin Immunol Immunopathol-1977. 8(1);39-50
344. Espanol T, et al. Neuroblastoma and transfer factor. Dev Biol Stand-1977. 38(0);331-3
345. Pizza G, et al. Effect of in vitro produced transfer factor on the immune response of cancer patients. Eur J Cancer-1977. 13(9);917-23
346. Lawton JW, et al. Human transfer factor prepared by dialysis, ultrafiltration and gel chromatography: biological activity in local transfer of skin sensitivity. J Immunol Methods-1977. 16(2);119-29
347. Horsmanheimo M, et al. Clinical study of a patient with lupus vulgaris before and after injection of dialyzable transfer factor. J Invest Dermatol-1977. 68(1);10-5
348. Sieber OF, et al. Coccidioides immitis osteomyelitis of the mandible in an infant. J Oral Surg-1977. 35(9);721-5
349. Jeter WS, et al. Oral administration of dialyzable transfer factor to tuberculin to human volunteers. J Reticulo Endothel Soc-1977. 22;46a
350. Montie JE, et al. Immunotherapy of disseminated renal cell carcinoma with transfer factor. J Urol-1977. 117(5);553-6
351. Wolf RE, et al. Treatment of Behcet's syndrome with transfer factor. JAMA-1977. 238(8);869-71
352. Boucheix C, et al. Activity of animal transfer factor in man. Lancet-1977. 1(8004);198-9
353. Thomas IT, et al. Transfer-factor treatment in congenital cytomegalovirus infection. Lancet-1977. 2(8047);1056-7
354. Garcia-Calderon PA, et al. [Therapy with transfer factor in a case of recidivating herpes with polymorphous erythema] Med Cutan Ibero Lat Am-1977. 5(5);361-6
355. Balsamo V, et al. [Preliminary experience with the treatment of a case of Wiskott-Aldrich syndrome with transfer factor] Minerva Pediatr-1977. 29(10);651-5
356. Sutherland DC, et al. Transfer factor therapy: clinical experience and the role of the E rosette assay. N Z Med J-1977. 85(579);3-6
357. Fukawa O, et al. [Cytotoxic activity of lymphocyte in patients with brain tumor and its augmentation effect by transfer factor (author's transl)] Neurol Med Chir (Tokyo)-1977. 17(2 pt. 2);115-22
358. Dammacco F, et al. Immune function in patients with multiple myeloma (delayed cutaneous reactivity and lymphocytes bearing receptors for sheep, human and mouse erythrocytes). Ric Clin Lab-1977. 7(4);343-53
359. Ng RP Disseminated varicella infection: treatment with transfer factor in a patient with Hodgkin's disease. Scand J Infect Dis-1977. 9(2);139-40
360. Kind CH, et al. [Transfer factor therapy in a patient with anergic pulmonary tuberculosis] Schweiz Med Wochenschr-1977. 107(48);1742-3
361. Platz P, et al. Transfer factor, sarcoidosis and cellular immunity. Acta Pathol Microbiol Scand [C]-1976. 84(1);68-70
362. Businco L, et al. Clinical and immunological improvement in a patient with chronic mucocutaneous candidiasis treated with transfer factor. Allergol Immunopathol (Madr)-1976. 4(5);345-50
363. Steele RW, et al. Therapy for disseminated coccidioidomycosis with transfer factor from a related donor. Am J Med-1976. 61(2);283-6
364. Khan A, et al. Increase in E-rosettes after transfer factor (TF) treatment: fractionation of TF. Ann Allergy-1976. 36(5);330-6
365. Ivins JC, et al. Transfer factor versus combination chemotherapy: a preliminary report of a randomized postsurgical adjuvant treatment study in osteogenic sarcoma. Ann N Y Acad Sci-1976. 277(00);558-74
366. Pasino M, et al. Aspecific transfer factor in children with Hodgkin's disease. Boll Ist Sieroter Milan-1976. 55(2);168-73
367. Sousa MD, et al. Chronic mucocutaneous candidiasis treated with transfer factor. Br J Dermatol-1976. 94(1);79-83
368. Lawton JW, et al. The effect of transfer factor on neutrophil function in chronic mucocutaneous candidiasis. Br J Haematol-1976. 33(1);137-42
369. Small P, Levitt P Disseminated histoplasmosis and necrotizing vasculitis. Can Med Assoc J-1976. 114(2);140-1
370. Goldenberg GJ, Brandes LJ In vivo and in vitro studies of immunotherapy of nasopharyngeal carcinoma with transfer factor. Cancer Res-1976. 36(2 pt 2);720-3
371. Spitler LE, et al. Combined immunotherapy in malignant melanoma. Regression of metastatic lesions in two patients concordant in timing with systemic administration of transfer factor and Bacillus Calmette-Guerin. Cell Immunol-1976. 21(1);1-19
372. Angers JW, et al. Clinical evaluation of the effects of transfer factor on multiple sclerosis. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
373. Ballow M, Good RA Transfer factor therapy in a patient with an isolated T-cell deficiency. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
374. Ballow M, Hyman L. Immunological reconstitution of chronic mucocutaneous candidiasis with transfer factor and fetal thymic tissue. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
375. Bearden JD, et al. Adjunctive transfer factor in osteogenic sarcoma. I. clinical implications of chemotherapy and immunotherapy. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
376. Bukowski RM, et al. Immunotherapy of human neoplasms with transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
377. Catanzero A, Spitler LE Clinical and immunologic results of transfer factor therapy in coccidiomycosis. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
378. Cozine WS, et al. Transfer factor immunotherapy of rheumatoid arthritis. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
379. Frenkel LD, et al. Treatment of a child with Behcet's Syndrome with transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
380. Graybill JR, et al. Transfer factor therapy of disseminated histoplasmosis. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976
381. Grob PJ, et al. Some physio-chemical and biological properties of a transfer factor preparation and its clinical application. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
382. Grohn P, et al. The effect of a chromatographically purified transfer factor component on Juvenile Rheumatoid Arthritis. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
383. Hastings RC, et al. Preliminary results in the safety and efficacy of transfer factor in leprosy. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
384. Heim LR, et al. Transfer factor treatment of viral disease in Milwaukee. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
385. Khan A, et al. Clinical trials with transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
386. Khan A, et al. The role of transfer factor in the treatment of lymphoma cutis in Wiskott-Aldrich syndrome. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
387. Levin AS, et al. An unusual metastatic lesion in a patient with osteosarcoma receiving tumour specific transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
388. Littman BH, et al. Combination transfer factor-amphotericin B therapy in a case of chronic mucocutaneous candidiasis. A controlled study. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
389. Maini RN, et al. Is the clinical benefit from transfer factor in rheumatoid arthritis a placebo effect? In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
390. Platz P, et al. Transfer factor treatment of patients with multiple sclerosis. II. Immunological parameters in a long-term clinical trial. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
391. Shulman ST, et al. Transfer factor therapy of chronic aggressive hepatitis. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
392. Silva J, et al. Transfer factor therapy in disseminated neoplasms. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
393. Silverman MA, et al. Effects of transfer factor in Waldenstrom's Macroglobulinemia and Multiple Myeloma. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
394. South MA, et al. Transfer factor and skin grafts. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
395. Thor DE, et al. Adjunctive transfer factor in osteogenic sarcoma. II. Methodology and results of the immunological studies. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
396. Vetto RM, et al. Transfer factor immunotherapy in cancer. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
397. Waldman SR, Pilch YH Leukapheresis of cancer patients for adoptive immunotherapy. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
398. Livni E, et al. Cell-mediated immunity in subacute sclerosing panencephalitis. Isr J Med Sci-1976. 12(10);1183-8
399. Mittal MM, et al. Passive transfer of immunity in lepromatous leprosy patients by Lawrence's transfer factor. J Indian Med Assoc-1976. 66(9);197-9
400. Groshong T, et al. Chronic cytomegalovirus infection, immunodeficiency, and monoclonal gammopathy-antigen-driven malignancy? J Pediatr-1976. 88(2);217-23
401. Anttila R, et al. Letter: Transfer factor and cell-mediated immunity in urinary-tract infections in children. Lancet-1976. 1(7954);315
402. Behan PO, et al. Transfer-factor therapy in multiple sclerosis. Lancet-1976. 1(7967);988-90
403. Jose DG, Ford GW Therapy with parent's lymphocyte transfer factor in children with infection and malnutrition. Lancet-1976. 1(7954);263-6
404. D'Amelio R, et al. [Personal experiences of immunotherapy using the transfer factor] Minerva Med-1976. 67(24);1613-6
405. Sacks N, et al. The use of transfer factors in the treatment of multiple sclerosis: a case report. S Afr Med J-1976. 50(40);1556-8
406. Haneberg B, et al. Fetal thymus transplantations in severe combined immunodeficiency. Scand J Immunol-1976. 5(8);917-24
407. Jersild C, et al. Transfer factor treatment of patients with multuple sclerosis. I. Preliminary report of changes in immunological parameters. Scand J Immunol-1976. 5(1-2);141-8
408. Grohn P, et al. The effect of non-specifically acting transfer factor component on cellular immunity in juvenile rheumatoid arthritis. Scand J Rheumatol-1976. 5(3);151-7
409. Morison WL Phytohaemagglutinin and transfer factor in the leucocyte migration inhibition test in patients with sarcoidosis. Thorax-1976. 31(1);87-90
410. Keller E [Clinical picture of a generalized BCG vaccination tuberculosis as an expression of a progressive septic granulomatosis (author's transl)] Z Erkr Atmungsorgane-1976. 146(2);134-9
411. Dahl B, et al. Lymphocyte transformation, IgE and T-cells in eczema vaccinatum treated with transfer factor. A case report. Acta Derm Venereol-1975. 55(3);187-90
412. Sellars WA, South MA Wiskott-Aldrich syndrome with 18-year survival. Treatment with transfer factor. Am J Dis Child-1975. 129(5);622-7
413. Gerbeaux J, et al. [Partial deficiency of cell-mediated immunity in a child with chronic mucocutaneous candidiasis. Intercurrent meningeal and pulmonary cryptococcosis] Ann Med Interne (Paris)-1975. 126(8-9);623-4
414. Quick CA, et al. Treatment of papillomatosis of the larynx with transfer factor. Ann Otol Rhinol Laryngol-1975. 84(5 Pt 1);607-13
415. Ter Meulen V, et al. Transfer factor therapy in patients with SSPE Arch Neurol-1975. 32;501A
416. Jose DG Treatment of chronic muco-cutaneous candidiasis by lymphocyte transfer factor. Aust N Z J Med-1975. 5(4);318-23
417. Ballow M, et al. Transfer factor therapy: Evidence for nonspecificity. Birth Defects Orig Artic Ser-1975. 11(1);457-61
418. Buckley RH Bone marrow and thymus transplantation in ataxia-telangiectasia. Birth Defects Orig Artic Ser-1975. 11(1);421-4
419. Kirkpatrick CH Restoration of cell-mediated immune responses with transfer factor. Birth Defects Orig Artic Ser-1975. 11(1);441-4
420. Rocklin RE Use of transfer factor in patients with depressed cellular immunity and chronic infection. Birth Defects Orig Artic Ser-1975. 11(1);431-5
421. Schulkind ML, Ayoub EM Transfer factor as an approach to the treatment of immune deficiency disease. Birth Defects Orig Artic Ser-1975. 11(1);436-40
422. Santana Mondragon R, et al. [Severe mixed immunodeficiency. Report of a case] Bol Med Hosp Infant Mex-1975. 32(6);1033-45
423. Claudy A, Thivolet J Multiple keratoacanthomas: association with deficient cell mediated immunity. Br J Dermatol-1975. 93(5);593-5
424. Khan A, et al. Improvement in delayed hypersensitivity in Hodgkin's disease with transfer factor: lymphapheresis and cellular immune reactions or normal donors. Cancer-1975. 36(1);86-9
425. Ballow M, Good RA Report of a patient with T-cell deficiency and normal B-cell function: a new immunodeficiency disease with response to transfer factor. Cell Immunol-1975. 19(2);219-29
426. Kirkpatrick CH, Gallin JI Suppression of cellular immune responses following transfer factor: report of a case. Cell Immunol-1975. 15(2);470-4
427. Walker AM Transfer factor in the immune deficiency of protein-calories malnutrition: a controlled study with 32 cases. Cell Immunol-1975. 15(2);372-81
428. Stevens DA, et al. Randomized trial of transfer factor treatment of human warts. Clin Exp Immunol-1975. 21(3);520-4
429. Criswell BS, et al. Fine structure of lymphocytes from an immune deficient child before and after administration of transfer factor. Exp Hematol-1975. 3(5);327-35
430. Maini RN, et al. Preliminary experience of transfer factor in rheumatoid arthritis: Clinical and immunological studies. In: Infection and Immunology in the Rheumatic Diseases. Dumonde DC, Ed. Blackwell Synergy Publications. London-1975.
431. Levin AS, et al. Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor.J Clin Invest-1975. 55(3);487-9
432. Saha K, et al. Passive transfer of immunity into leprosy patients by transfusion of lymphocytes and by transfusion of Lawrence's transfer factor. J Clin Microbiol-1975. 1(3);279-88
433. Kackell YM, et al. Transfer factor therapy in patients with subacute sclerosing panencephalitis. J Neurol-1975. 211(1);39-49
434. Ng RP, et al. Transfer factor in Hodgkin's disease. Lancet-1975. 2(7941);901-3
435. Zabriskie JB, et al. Proceedings: Immunologic studies with transfer factor in multiple sclerosis patients. Neurology-1975. 25(5);490
436. Zaldivar NM, et al. The use of transfer factor in a patient with agammaglobulinemia. Pediatr Res-1975. 9(6);541-7
437. Rachelefsky GS, et al. T-cell reconstitution by thymus transplantation and transfer factor in severe combined immunodeficiency. Pediatrics-1975. 55(1);114-8
438. Maldyk E [Transfer factor in the treatment of rheumatoid arthritis in children] Reumatologia-1975. 13(2);147-9
439. Ammann AJ, et al. Thymus transplantation in patients with thymic hypoplasia and abnormal immunoglobulin synthesis. Transplantation-1975. 20(6);457-66
440. Ammann AJ, et al. Transfer factor: therapy in patients with deficient cell-mediated immunity and deficient antibody-mediated immunity. Cell Immunol-1974. 12(1);94-101
441. Arala-Chaves M, et al. Short communications. Evidence for prompt and intense reconstitution of cell-mediated immunity by means of transfer factor in a case of complex immune deficiency. Cell Immunol-1974. 12(1);160-3
442. Arala-Chaves MP, et al. Transfer factor therapy in a case of complex immunodeficiency. Cell Immunol-1974. 10(3);371-9
443. Price FB, et al. The therapy of malignant melanoma with transfer factor. A preliminary report. Cleve Clin Q-1974. 41(1);1-4
444. Grob PJ, Withrich B Transfer factor therapy in a patient with chronic vaginal candidiasis. J Obstet Gynaecol Br Commonw-1974. 81(10);812-7
445. Oettgen HF, et al. Effects of dialyzable transfer factor in patients with breast cancer. Proc Natl Acad Sci U S A-1974. 71(6);2319-23
446. Kirkpatrick CH, et al. Immunological and clinical effects of transfer factor in anergic subjects. Adv Exp Med Biol-1973. 29(0);343-50
447. Khan A, et al. Management of Chediak-Higashi syndrome with transfer factor. Am J Dis Child-1973. 126(6);797-9
448. Whitcomb ME, Rocklin RE Transfer factor therapy in a patient with progressive primary tuberculosis. Ann Intern Med-1973. 79(2);161-6
449. Graybill JR, et al. Immunologic and clinical improvement of progressive coccidioidomycosis following administration of transfer factor.Cell Immunol-1973. 8(1);120-35
450. Morse PA, et al. Transfer factor therapy of human cancer. Clin Res-1973. 21;71
451. Moulias R, et al. [Transfer factor of cellular immunity. Preliminary therapeutic trials during specific immunologic deficiencies of an antigen in human clinical practice] Nouv Presse Med-1973. 2(20);1341-4
588. Touraine JL, et al. [Chronic mucocutaneous moniliasis. Immunological clinical study of a case and trial treatment with the transfer factor] Pediatrie-1973. 28(3);271-81
452. Vandvik B, et al. Immunological features in a case of subacute sclerosing panencephalitis treated with transfer factor. Scand J Immunol-1973. 2(4);367-74
453. Wong VG, Kirkpatrick CH Immunologic reconstitution in a patient with keratoconjunctivitis, superficial candidiasis and hypoparathyroidism: the role of immunocompetent lymphocyte transfusion and transfer factor. Trans Am Ophthalmol Soc-1973. 71(0);254-67; discussion 267-71
454. Schulkind ML, et al. Transfer factor in the treatment of a case of chronic mucocutaneous candidiasis. Cell Immunol-1972. 3(4);606-15
455. Goldenberg GJ, Brandes LJ Immunotherapy of nasopharyngeal carcinoma with transfer factor from donors with previous infectious mononucleosis. Clin Res-1972. 20;947
456. Oettgen H, et al. Effects of transfer factor in cancer patients. Clin Res-1972. 20;47
457. Kirkpatrick CH, et al. Effect of transfer factor on lymphocyte function in anergic patients. J Clin Invest-1972. 51(11);2948-58
458. Bullock WE, et al. An evaluation of transfer factor as immunotherapy for patients with lepromatous leprosy. N Engl J Med-1972. 287(21);1053-9
459. Oettgen HF, et al. Effects of transfer factor in cancer patients. J Clin Invest-1971. 50;71a
460. Lawrence HS Transfer factor, homograft rejection and the effects of antilymphocyte serum in man. Fed Proc-1970. 29(1);183-5
461. Levin AS, et al. Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factor. Proc Natl Acad Sci U S A-1970. 67(2);821-8
462. Paque RE, et al. In vitro studies with "transfer factor": transfer of the cell-migration inhibition correlate of delayed hypersensitivity in humans with cell lysates from humans sensitized to histoplasmin, coccidioidin, or PPD. J Immunol-1969. 103(5);1014-21
463. Montgomery M The nature of transfer factor. J Am Med Womens Assoc-1968. 23(10);903-7
464. Brandriss MW Attempt to transfer contact hypersensitivity in man with dialysate of peripheral leukocytes. J Clin Invest-1968. 47;2152
465. Gudkova RG [Characteristics of the "transfer factor" in blood leukocytes in patients with bronchial asthma] Arkh Patol-1967. 29(7);24-8
466. Baram P, Mosko MM A dialysable fraction from tuberculin-sensitive human white blood cells capable of inducing tuberculin-delayed hypersensitivity in nagative recipients. Immunology-1965. 8(5);461-74
467. Lawrence HS, et al. Transfer of immunologic information in humans with dailysates of leukocytes extracts. Trans Assoc Amer Physicians-1963. 76;84
468. JENSEN K, et al. Multiple passive transfer of the delayed type of hypersensitivity in humans. Annu Rev Respir Dis-1962. 85(0);373-7
469. LAWRENCE HS, et al. Transfer of delayed hypersensitivity to skin homografts with leukocyte extracts in man. J Clin Invest-1960. 39(0);185-98
470. Lawrence HS, et al. Transfer of delayed hypersensitivity to skin homografts with leukocyte extracts in man. J Clin Invest-1960.39;185
471. LAWRENCE HS, PAPPENHEIMER AM Transfer of delayed hypersensitivity to diphtheria toxin in man. J Exp Med-1956. 104(3);321-35
472. Lawrence HS The transfer in humans of delayed hypersensitivity to streptococcal M substance and to tuberculin with disrupted leukocytes. J Clin Invest-1955. 34;219-32
473. Lawrence HS The transfer of generalized cutaneous hypersensitivity of the delayed tuberculin type in man by means of the constituents of disrupted leucocytes. J Clin Invest-1954. 33;951
474. Lawrence HS The cellular transfer of cutaneous hypersensitivity to tuberculin in man. Proc Soc Exp Biol Med-1949. 71;516
475. Fan ZQ Observation of the skin delayed hypersensitive response of transfer factor to patients with cancer. Jiangsu Med-0. 2(1978);46
Animal
613. Fabre RA, et al. Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis. Clin Exp Immunol-2004. 136(2);215-23
614. Chivinda Eduardo AB, Kalynovs'ka IH [Immunomorphological changes in the lymph nodes and spleen of rats sensitized with the transfer factor] Fiziol Zh-2000. 46(4);66-70
615. Li SX [Influence of several immunoenhancers on sleep and their mechanism] Sheng Li Ke Xue Jin Zhan-1997. 28(2);129-31
616. Alvarez-Thull L, Kirkpatrick CH Profiles of cytokine production in recipients of transfer factors. Biotherapy-1996. 9(1-3);55-9
617. Arnaudov A, Tziporkov N Some properties and protective activity of specific DLE against Salmonella cholerae suis infection. Biotherapy-1996. 9(1-3);105-8
618. Borkowsky W, et al. Dialyzable lymphoid extract (DLE) from mice resistant to STZ-induced diabetogenesis can interrupt the progress of diabetes in STZ-treated CD-1 mice. Biotherapy-1996. 9(1-3);149-57
619. Rosso di San Secondo VE, et al. Influence of a DLE-extracted lymphocytic suppressor factor on CsA-induced immunosuppression. Biotherapy-1996. 9(1-3);159-62
620. Kirkpatrick CH, et al. Murine transfer factors: dose-response relationships and routes of administration. Cell Immunol-1995. 164(2);203-6
621. Stevens MG, Pugh GW Effect of Brucella abortus transfer factor in preventing murine brucellosis. FEMS Immunol Med Microbiol-1995. 11(4);279-84
622. Stancikova M, et al. Influence of various forms of dialyzable leukocyte extracts on rat adjuvant arthritis. Arch Immunol Ther Exp (Warsz)-1994. 42(4);295-9
623. Kreeger JM, et al. Effects of dialyzable lymph node extracts on lymphoblast proliferative capacity of blood mononuclear cells in cattle with chronic paratuberculosis. Am J Vet Res-1992. 53(7);1225-30
624. Micula I, et al. Dialyzable leucocyte extract used in the prevention of Salmonella infection in calves. Vet Immunol-1992. 32;113-24
625. Benkova M, et al. [Immunostimulatory effects of certain substances in experimental ascaridiasis in pigs] Vet Med (Praha)-1992. 36(12);717-24
626. Kondoh Y, et al. Transfer Delayed Cutaneous Hypersensitivity to Guinea-Pigs by Transfer Factor of Colostrum from Cow Immunized with Marek's Disease Virus. Abstr Gen Meet Am Soc Microbiol-1991. 91;1-128
627. Chong-Bi L, et al. Initial research of brucella specific transfer factor. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
628. Guang-Shu Z, et al. Survey on the function of mice treated with placenta transfer factor and specific placenta transfer factor. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
629. Kofranek V, et al. The radioprotective effect of DLE-TF on BM cells in mice. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
630. Matz AN, et al. Amplification of the transfer factor activity of lymphocytic untrafiltrate incorporated into liposomes. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
631. Zhaofen Z, et al. The effects of dialyzable leukocyte extract (DLE) and interferon (IFN) on mitotic index of bone marrow cells in mouse. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
632. Micula I, Pistl J Salmonella-specific DLE: Its influence upon bacteremia in mice. Folia Veterinaria-1990. 34;155-62
633. Micula I, Pistl J The use of mouse model for the determination of protective activity in Salmonela-specific leucocyte dialyzate. Act Vet B-1989. 58;281-96
634. Guo X, et al. Study of production and character of transfer factor of normal swine. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
635. Cerhova M, et al. The use of DLE for the protection of weaning calves. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing.-1989.
636. Guo B, et al. The effect of transfer factor curing mastitis in 159 cows. In: Research and Applications of TF and DLE. Baolai H, Ruzhang W, Zhoafen Z, Eds. Xue Yuan Press, Beijing.-1989.
637. Ballarini G Colostral Immunity in Calves. Obiettivi e Documenti Veterinari-1989. 10(12);13-17
638. Pogodina VV, et al. [The effect of preparations of specific and nonspecific transfer-factor on the course of experimental tick-borne encephalitis] Vopr Virusol-1989. 34(6);689-94
639. Mats AN, et al. [Delayed hypersensitivity to the antigens of the herpes simplex virus and herpetic resistance induced in mice by the administration of xenogeneic lymphocytic ultrafiltrates] Zh Mikrobiol Epidemiol Immunobiol-1989.
640. Wilson GB, et al. De novo initiation of specific cell-mediated immune responsiveness in chickens by transfer factor (specific immunity inducer) obtained from bovine colostrum and milk. Acta Virol-1988. 32(1);6-18
641. Rozzo SJ, et al. Murine transfer factor. IV. Studies with genetically regulated immune responses. Cell Immunol-1988. 115(1);130-45
642. Karhumaki E, et al. Chromatographic and enzymatic effects on transfer factor-like activity from human leukocytes and porcine spleen dialysate. Int J Biochem-1988. 20(10);1067-72
643. Viza D, et al. Soluble extracts from a lymphoblastoid cell line modulate simian immunodeficiency syndrome (SAIDS) evolution. J Virol Methods-1988. 21(1-4);241-53
644. Karhumäki E Modulation of infection resistance of mice with dialysates containing transfer factor-like activity derived from leukocytes of man and other mammalia Tampere : University of Tampere-1988.
645. Boroskova Z, et al. [The immunostimulatory effect of nonspecific transfer factor on T- and B-dependent lymphocytes in guinea pigs during its protective action in ascariasis] Vet Med (Praha)-1988. 33(4);233-40
646. Huang LL, et al. Nature and antigen-specific activities of transfer factor against herpes simplex virus type 1. Acta Virol-1987. 31(6);449-57
647. Bogdanov OV, et al. [Afferent determination of transfer factor formation in the rat spinal cord] Biull Eksp Biol Med-1987. 104(10);396-8
648. Dwyer JM, et al. The prevention of diabetes in BB rats by the administration of transfer factor. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987.
649. Dwyer JM, et al. The prevention of diabetes in BB rats by the administration of transfer factor. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987.
650. Fayer R, et al. Efficacy of bovine transfer factor to protect neonatal calves against experimentally induced clinical cryptosporidiosis. J Parasitol-1987. 73(5);1061-2
651. Dundas SA, Clark A The effect of transfer factor on lymph node morphology in murine toxoplasmosis. Br J Exp Pathol-1986. 67(2);181-90
652. Viza D, et al. Specific transfer factor protects mice against lethal challenge with herpes simplex virus. Cell Immunol-1986. 100(2);555-62
653. Donovan GA, et al. Factors influencing passive transfer in dairy calves. J Dairy Sci-1986. 69(3);754-9
654. Grimova J, et al. The effects of transfer factor in adjuvant diseases in rats. Allergol Immunopathol (Madr)-1985. 13(1);17-21
655. Radosevich JK, et al. Delayed-type hypersensitivity responses induced by bovine colostral components. Am J Vet Res-1985. 46(4);875-8
656. Tsang KY, et al. Transfer of osteosarcoma-specific cell-mediated immunity in hamsters by rabbit dialyzable leukocyte extracts. Cell Immunol-1985. 90(2);295-302
657. Kirkpatrick CH, et al. Murine transfer factor. II. Transfer of delayed hypersensitivity to synthetic antigens. J Immunol-1985. 134(3);1723-7
658. Pizza G, et al. Transfer of reactivity with in vitro produced transfer factor in rhesus and owl monkeys. Lymphokine Res-1985. 4(4);351-7
659. Buchwald S, et al. [The local specific immune response to Staphylococcus aureus protein A in human tonsillar lymphoid tissue] Zh Mikrobiol Epidemiol Immunobiol-1985.
660. Kita E, et al. Separate transfer of mouse protection and delayed-type hypersensitivity with Salmonella typhimurium transfer factor. Cell Immunol-1984. 87(2);528-37
661. Liu JJ, et al. Effects of long-term treatment of mice with anti-I-J monoclonal antibody and dialyzable leukocyte extract on immune function and lifespan. Mech Ageing Dev-1984. 27(3);359-72
662. Levieux D Transmission of Passive Immunity via Colostrum: Current Knowledge Physiologie et Pathologie Perinatales chez les Animaux de Ferme-1984.
663. Klesius PH, Giambrone JJ Adoptive transfer of delayed hypersensitivity and protective immunity to Eimeria tenella with chicken-derived transfer factor. Poult Sci-1984. 63(7);1333-7
664. Gay CC The Role of Colostrum in Managing Calf Health. Proc Am Assoc Bovine Pract-1984. 16;79-84
665. MacKenzie G, et al. The effect of transfer factor treatment on two challenge infections of Haemonchus contortus in immuno-competent 7-month-old lambs. Vet Res Commun-1984. 8(4);283-92
666. Mazaheri R, et al. Cell-mediated immunity: correlation of mixed-leucocyte-macrophage migration inhibition with delayed-type hypersensitivity after immunization and donor-specific transfer of cell migration inhibition by dialyzable leucocyte extract. Cell Immunol-1983. 82(1);147-62
667. Ashorn R, et al. Porcine spleen cell dialysate increases the phagocytic capacity and decreases prosaglandin levels of peritoneal macrophages in mouse. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
668. Borkowsky W, Lawrence HS Antigen-specific suppressor factor in human leukocyte dialysates suppresses in vivo footpad reactivity in immunized BALB/C mice. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
669. Karhumaki E, Krohn KJE Effect of dialyzable leukocyte extract and other tissue dialysates on listeria resistance. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
670. Kwong Y, et al. Osteosarcoma-specific dialyzable extracts: Prophylaxis post-surgery in an animal model of human osteosarcoma. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
671. Lesourd B, et al. Kinetics of immune response and production of transfer factor in bovine. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
672. Mayer V, et al. Antigen-specific transfer factor induced in mice by an attenuated virus from the tick-borne encephalitis complex: Biological, histological and concentrations studies. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
673. Petersen EA Selective removal of transfer factor activity with antigen In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
674. Vich JM, Viza D Specific suppressor dialysates from mice In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
675. Giambrone JJ, et al. Adoptive transfer of delayed wattle reactivity in chickens with a dialyzable leukocyte extract containing transfer factor. Poult Sci-1983. 62(5);767-71
676. Richter H, et al. Dam Vaccination as Basic Principle for Passive Oral Immunization of Newborn and Young Animals. Tierzucht-1983. 37(5);232-234
677. Hunter AR, et al. The effects of transfer factor, parasitic antigen and precipitated immunoglobulin treatments in lambs infected with Haemonchus contortus. Vet Parasitol-1983. 13(1);45-53
678. Hunter AR, et al. A comparison of the effects of dialysed and non-dialysed transfer factor preparations on Haemonchus contortus infections in young lambs. Vet Res Commun-1983. 6(3);227-34
679. Wang FZ, Huang ZX [Studies on effect of a specific transfer factor on Japanese encephalitis virus infection in mice] Zhongguo Yi Xue Ke Xue Yuan Xue Bao-1983. 5(2);102-6
680. Ashorn R Immunomodulation in guinea pigs by porcine spleen cell dialysate. Acta Pathol Microbiol Immunol Scand [C]-1982. 90(6);339-45
681. Ashorn RG, et al. Augmentation of delayed-type hypersensitivity in antigen-primed guinea pigs by human dialyzable leukocyte extract. Chromatographic and enzymatic characterization of the active principle. Acta Pathol Microbiol Immunol Scand [C]-1982. 90(6);331-7
682. Mayer V, et al. Dialysable specific transfer factor in mice immunized with attenuated Langat virus from the tick-borne encephalitis complex: generation, action and quantitative assay. Acta Virol-1982. 26(6);453-65
683. Lin MS, et al. Partial reversal of radiation-induced immunosuppression by T-lymphocyte lysate. Immunology-1982. 47(3);489-96
684. Smith RA, et al. Transfer of Salmonella resistance and delayed hypersensitivity with murine-derived transfer factor. Infect Immun-1982. 36(1);271-6
685. Mackenzie G, et al. The effects of treatment with transfer factor, parasitic antigen and precipitated immunoglobulin on the parasitological and histopathological responses in Haemonchus contortus infection in lambs under six months of age. J Helminthol-1982. 56(4);305-13
686. Ross JG, Halliday WG Investigations of transfer factor activity in resistance to Trichostrongylus colubriformis infections in guinea-pigs. J Helminthol-1982. 56(1);27-35
687. Sen P, et al. Modification of an experimental mouse Candida infection by human dialyzable leukocyte extract. Sabouraudia-1982. 20(2);85-93
688. Sogandares-Bernal F, et al. Secretory/excretory antigens produced by tetrathyridia of Mesocestoides corti defined by SDS--PAGE and HPLC. Vet Parasitol-1982. 10(2-3);221-8
689. Petersen EA, et al. Murine transfer factor. I. Description of the model and evidence for specificity. J Immunol-1981. 126(6);2480-4
690. Mitchell GB, et al. Successful passive transfer of resistance to Fasciola hepatica infection in rats by immune serum and transfer factor. Res Vet Sci-1981. 30(2);246-7
691. Ross JG, Halliday WG Passive transfer of immunity to trichostrongyle species infections in sheep. Investigations of specificity and limitations of 'transfer factor' activity with Trichostrongylus axei infections. Vet Res Commun-1981. 4(4);287-90
692. Mayer V, et al. Transfer with dialysable transfer factor of T-lymphocyte cytolytic response to tick-bone encephalitis virus antigen in naive mice. Acta Virol-1980. 24(6);459-63
693. Metzger M, et al. Development of immunological responsiveness and resistance to infection with Treponema pallidum in rabbits given immune lymphocyte preparations. Arch Immunol Ther Exp (Warsz)-1980. 28(2);329-36
694. Lie TS, et al. [A humoral transfer factor preventing rejection of allotransplanted rat liver? (author's transl)] Chir Forum Exp Klin Forsch-1980.
695. Williams ME, Kauffman CA Transfer factor: a murine model. Infect Immun-1980. 27(1);187-91
696. Jones RL, et al. Low molecular weight iron-binding factor from mammalian tissue that potentiates bacterial growth. J Exp Med-1980. 151(2);418-28
697. Sasaki K, et al. Transfer factor from BCG-sensitized mice. Tohoku J Exp Med-1980. 131(3);271-83
698. Klesius PH, et al. Resistance to coccidiosis (Eimeria ferrisi) in C57BL/6 mice: effects of immunization and transfer factor. Clin Immunol Immunopathol-1979. 12(2);143-9
699. Arala-Chaves MP, et al. Evidence for specific and nonspecific effects of dialyzable leukocyte extracts (containing transfer factor activity) in mice. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
700. Arrenbrecht S, et al. Human transfer factor in rats. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
701. Bhardwaj N, et al. Transfer of DTH to SK-SK and tetanus toxoid in BALB/C mice by TFd prepared from purified subpopulations of murine lymphocytes. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
702. Brummer E, et al. A murine model for studying the transfer of DTH with dialyzable human transfer factor. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
703. Eichberg JW, et al. Experiments to prevent herpesvirus saimiri induced lymphoma in marmosets with nonhuman primate transfer factor and immune RNA. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
704. Finkelstein MS, et al. Production of rabbit antibodies to human leukocyte dialysates containing transfer factor (TFd). In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
705. Foster LG, et al. Transfer of cutaneous DTH with human TFd to BALB/C mice: Partial purification of active components. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
706. Huard TK, Baram P Effects of the injection of human dialyzable leukocyte lysate (HDLL) fractions into mice on subsequent responses to mitogens. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
707. Klesius PH Bovine dialyzable transfer factor: Stimulation of antigen-specific leukocyte reactivity in C57/BL/6 mice. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
708. Krohn K, et al. Augmentation of skin reactivities in antigen primed guinea pigs by transfer factor and other cellular dialysates. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
709. Lesourd B, et al. Guinea-pig as an experimental model for testing activity and spcificity of human and bovine transfer factor. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
710. Lewis DE, et al. Detection of a new protein component in canine plasma after transfer factor administration: Correlation with delayed-type skin reactivity. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
711. Lewis DE, Stafford ME. Appearance of new components in guinea pig T-cell extracts after sensitization. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
712. Mazaheri MR, et al. Specificity determinants of dialyzable transfer factor (DTF) in the rhesus monkey model. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
713. Mischak RP and Spitler LE Modulation of suppressor activity by treatment with dialyzable leucocyte extract. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
714. Salaman MR, et al. Transfer factor as an adjuvant for antibody production in the mouse. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
715. Thilsted JP Studies on the transfer of tuberculin specific CMI in the dog. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
716. Waxman F, et al. Nonspecificity of the transfer of KLH hypersensitivity to marmoset monkeys with TFd prepared from the leucocytes of KLH-sensitive rehsus monkeys. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
717. Maddison SE, et al. Immunization against Schistosoma mansoni in rhesus monkeys and the requirement of activation of both cell-mediated and humoral mechanisms. Infect Immun-1979. 25(1);237-48
718. Ross JG, Halliday WG Investigations of 'transfer factor' activity in immunity to Ostertagia circumcincta and Trichostrongylus colubriformis infections in sheep. Int J Parasitol-1979. 9(4);281-4
719. Ross JG, et al. Investigation of Haemonchus contortus infections in sheep. Comparison of irradiated larvae and transfer factor treatment. Res Vet Sci-1979. 27(2);258-9
720. Ross JG, Halliday WG Investigations of 'transfer factor' activity in the transfer of immunity to Trichostrongylus axei infections in sheep. Res Vet Sci-1979. 26(1);41-6
721. Lehner T, et al. Passive immunization with antisera to Streptococcus mutans in the prevention of caries in rhesus monkeys. Adv Exp Med Biol-1978. 107(0);303-15
722. Klesius PH, et al. Effects of bovine transfer factor (TFd) in mouse coccidiosis (Eimeria ferrisi). Clin Immunol Immunopathol-1978. 10(2);214-21
723. Mittler RS, Everhart DL Reciprocal transfer of delayed hypersensitivity in hamsters and guinea pigs employing xenogenic transfer factor. Fed Proc-1978. 37;2106
724. Olson GB, Drube CG Modulation of influenza in mice by transfer factor therapy. J Reticuloendothel Soc-1978. 24(5);589-99
725. Roda A, et al. Human transfer factor produced in vitro increases antibody titers in rabbits. N Engl J Med-1978. 298(11);629
726. Eichberg JW, et al. Transfer factor and its protective effect against herpesvirus infections of marmosets. Primates Med-1978. 10(0);271-6
727. Ross JG, Halliday WG Investigation of the transfer of immunity to gastrointestinal nematode infections in sheep by leucocyte lysates. Vet Rec-1978. 102(11);240-1
728. Likholetov SM, et al. [Transfer of cellular immunity to the causative agent of coccidioidosis using the transfer factor in mice] Zh Mikrobiol Epidemiol Immunobiol-1978.
729. Klesius PH, Fudenberg HH Bovine transfer factor: in vivo transfer of cell-mediated immunity to cattle with alcohol precipitates. Clin Immunol Immunopathol-1977. 8(2);238-46
730. Klesius PH, Kristensen F Bovine transfer factor: effect on bovine and rabbit coccidiosis. Clin Immunol Immunopathol-1977. 7(2);240-52
731. Vandenbark AA, et al. Human transfer factor activity in the guinea pig: absence of antigen specificity. Clin Immunol Immunopathol-1977. 8(1);7-16
732. Wilson GB, et al. Tx: a component in human dialyzable transfer factor that induces cutaneous delayed hypersensitivity in guinea pigs. Clin Immunol Immunopathol-1977. 7(2);187-202
733. Rifkind D, et al. Transfer of delayed hypersensitivity in mice to microbial antigens with dialyzable transfer factor. Infect Immun-1977. 16(1);258-62
734. Simon MR, et al. Tuberculin-specific transfer factor in dogs. Infect Immun-1977. 18(1);73-7
735. Green JA, et al. Specific restoration of delayed hypersensitivity by lymphoid tissue extracts. J Immunol-1977. 118(6);1936-43
736. Tomar RH, Terzian J Reactions in canine skin with human leukocyte lysates. Proc Soc Exp Biol Med-1977. 156(2);242-50
737. Smolin G, Okumoto M Human transfer factor in the treatment of guinea pig keratitis. Ann Ophthalmol-1976. 8(4);427-32
738. Eichberg JW, et al. Cellular immunity in gnotobiotic primates induced by transfer factor. Cell Immunol-1976. 26(1);114-9
739. Welch TM, et al. Preliminary studies on human "transfer factor" activity in guinea pigs. Systemic transfer of cutaneous delayed-type hypersensitivity to PPD and SKSD. Clin Immunol Immunopathol-1976. 5(3);407-15
740. Maddison SE, et al. Schistosoma mansoni: reduction in clinical manifestations and in worm burdens conferred by serum and transfer factor from immune or normal rhesus monkeys. Exp Parasitol-1976. 39(1);29-39
741. Clinton BA, Magoc TY Leshmania enrietti infections in guinea-pigs and transfer factor obtained from convalescent yet immune animals. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
742. Dumonde DC, et al. Acquisition of mixed cell migration reactivity by actively sensitised and transfer-factor treated rhesus monkeys. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
743. Jeter WS, et al. Correlation of in vivo and in vitro activity of guinea pig transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
744. Klesius PH, et al. Bovine transfer factor: Isolation and characteristics. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
745. Petersen EA, et al. Transfer of delayed hypersensitivity to mice with human immune cell extracts. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
746. Schroder I, et al. Investigations on the transfer of cellular immunity in animal model system by the transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
747. Shifrine M, et al. Canine transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
748. Steele RW, et al. Prevention of herpes simplex virus type 1 fatal dissemination in primates with human transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
749. Steele RW, et al. Transfer of cellular reactivity to 3 non-human primate species with human and baboon transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
750. Tomar RH. Local transfer of delayed hypersensitivity to dogs by human transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
751. Trepo CG, Prince AM Attempted immunotherapy with dialyzable transfer factor in hepetitis B carrier chimpanzees: Induction of delayed hypersensitivity to hepatitis B surface antigen (HBsAg). In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
752. Triglia R, Spitler LE Human 'transfer factor' activity in quinea pigs: Further studies. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
753. Vandenbark AA, et al. Human transfer factor: Trial with an assay in guinea-pigs. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
754. Welch TM, et al. Human transfer factor in guinea-pigs: Further Studies. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
755. Wilson GB, et al. Human transfer factor in guinea pigs: Partial purification of the active component. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
756. Friedman H Transfer of protective immunity to friend leukemia virus by cell free extracts of immune lymphoid cells. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH. Eds. Academic Press, NY-1976.
757. Halliday R. Some Factors Influencing Immunoglobulin Transfer in Sheep. Maternofoetal Transmission of Immunoglobulins. Cambridge Univ Press. London-1976.
758. Zanelli JM, Adler WH Transfer factor--transfer of tuberculin cutaneous sensitivity in an allogeneic and xenogeneic monkey model. Cell Immunol-1975. 15(2);475-8
759. Miller JF, et al. A radioisotopic method to measure delayed type hypersensitivity in the mouse. II. Cell transfer studies. Int Arch Allergy Appl Immunol-1975. 49(5);693-708.
760. Greco RS, Storer EH The effect of intact and lysed leukocytes on murine tumor growth and host survival. J Surg Oncol-1975. 7(1);67-76
761. Klesius PH, et al. Passive transfer of coccidian oocyst antigen and diphtheria toxoid hypersensitivity in calves across species barriers. Transplant Proc-1975. 7(3);449-52
762. Baram P, Condoulis W Studies on rhesus-monkey nondialyzable and dialyzable transfer factors. Transplant Proc-1974. 6(2);209-15
763. Liburd EM, et al. Transfer factor in rat coccidiosis. Cell Immunol-1972. 5(3);487-9
764. Burger DR, et al. Transfer factor from guinea pigs sensitive to dinitrochlorobenzene: absence of superantigen properties. Science-1972. 175(29);1471-5
765. Maddison SE, et al. Transfer factor: delayed hypersensitivity to Schistosoma mansoni and tuberculin in Macaca mulatta. Science-1972. 178(62);757-9
766. Bray RS, Wilson VC Lack of transfer factor in guinea-pig leishmaniasis. Trans R Soc Trop Med Hyg-1972. 66(6);955-6
767. Burger DR, Jeter WS Cell-free passive transfer of delayed hypersensitivity to chemicals in guinea pigs. Infect Immun-1971. 4(5);575-80
768. Powell AE, et al. Time of development and duration of the effect of a guinea pig transfer factor. J Surg Res-1968. 8(3);109-14
769. Bloom BR, Chase MW Transfer of delayed-type hypersensitivity. A critical review and experimental study in the guinea pig. Prog Allergy-1967. 10(0);151-255
770. POWELL AE, et al. THE INDUCED REJECTION OF GUINEA PIG SKIN HOMOGRAFTS BY A PARTIALLY PURIFIED TRANSFER FACTOR. J Immunol-1964. 92(0);73-81
771. Tsugi S, et al. Studies on the "transfer factor" of tuberculin sensitivity in animals. J Immunol-1964. 93;838-49
772. GILLISSEN G [CELL-FREE PREPARATION OF THE SO-CALLED TRANSFER FACTOR IN TUBERCULIN ALLERGY IN ANIMALS] Zentralbl Bakteriol [Orig]-1963. 191(0);260-4
773. JETER WS, et al. Passive transfer of delayed hypersensitivity to 2,4-dinitrochlorobenzene in guinea pigs with leucocytic extracts. Proc Soc Exp Biol Med-1954. 86(2);251-3
In vitro
774. Davydovs'ka TL, et al. [Transfer factor modulates inhibitory action of neurotransmitters on intestinal smooth muscles] Fiziol Zh-2002. 48(5);9-16
775. Ojeda MO, et al. Dialyzable leukocyte extract suppresses the activity of essential transcription factors for HIV-1 gene expression in unstimulated MT-4 cells. Biochem Biophys Res Commun-2000. 273(3);1099-103
776. Holeva OH, et al. [The immune reactivity transfer factor as a modulator of lymphocyte functional activity in rats] Fiziol Zh-2000. 46(4);58-65
777. Vacek A, et al. Positive effects of dialyzable leukocyte extract (DLE) on recovery of mouse haemopoiesis suppressed by ionizing radiation and on proliferation of haemopoietic progenitor cells in vitro. Int J Immunopharmacol-2000. 22(8);623-34
778. Kirkpatrick CH Transfer factors: identification of conserved sequences in transfer factor molecules. Mol Med-2000. 6(4);332-41
779. Borysov VA, et al. [The adjuvant and specific activity of transfer factors to Candida albicans antigens] Fiziol Zh-1998. 44(4);3-9
780. Iushkova TA, Iushkov VV [The immunomodulating activity of a transfer-factor preparation transflavin, specific to tick-borne encephalitis virus] Zh Mikrobiol Epidemiol Immunobiol-1998.
781. Liubchenko TA, et al. [Human specific transfer factor to Staphylococcus aureus antigens] Fiziol Zh-1997. 43(3-4);25-32
782. Barnet K, et al. The effect of DLE fractions on GM-progenitors of haematopoietic stem cells in vitro. Biotherapy-1996. 9(1-3);171-4
783. Fernandez-Ortega C, et al. Inhibition of in vitro HIV infection by dialyzable leukocyte extracts. Biotherapy-1996. 9(1-3);33-40
784. Lawrence HS, Borkowsky W Transfer factor--current status and future prospects. Biotherapy-1996. 9(1-3);1-5
785. Holieva OH, et al. [The isolation of a transfer factor of the delayed-hypersensitivity type to the antigenic substances of Staphylococcus aureus in guinea pigs] Fiziol Zh-1996. 42(5-6);58-65
786. Fazio M, et al. Serial in vitro transfer of hypersensitivity to cancer antigens by sensitised lymphocytes. Panminerva Med-1995. 37(4);186-9
787. Moore KG, Dannenberg AM Immediate and delayed (late-phase) dermal contact sensitivity reactions in guinea pigs. Passive transfer by IgG1 antibodies, initiation by mast cell degranulation, and suppression by soybean proteinase inhibitor. Int Arch Allergy Immunol-1993. 101(1);72-81
788. Mrazova A, Mraz J Transfer factor and its signification for practice. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove-1993. 36(3);117-37
789. Pen GY [Effect of hepatocellular carcinoma-specific transfer factor (HCC-S-TF) on IL-2 activity and IL-2R expression] Zhonghua Zhong Liu Za Zhi-1993. 15(6);435-7
790. Qi HY, et al. Chemical characterization of the purified component of specific transfer factor in the leukocyte dialysates from HSV-1 immunized goats. Acta Virol-1992. 36(3);239-44
791. Qi HY, et al. Isolation and purification of HSV-1 specific transfer factor produced by HSV-1 immunized goat leukocyte dialysate. Acta Virol-1992. 36(3);231-8
792. Rozzo SJ, Kirkpatrick CH Purification of transfer factors. Mol Immunol-1992. 29(2);167-82
793. Xu WM [Determination of antigen-dependent activity of human lung cancer transfer factor by H3-leucine leucine leukocyte adherence inhibition assay] Zhonghua Zhong Liu Za Zhi-1992. 14(2);116-8
794. Barnet K, et al. The costimulating activity of DLE-TF and PHA, RESP. Con A, on thymocytes. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
795. Borvak J, Schmidtmayerova H Inhibition of HIV-1 reverse transcriptase activity by HPLC fractions of lysed leukocyte ultrafiltrate. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
796. Cech K, et al. The histamine content in different DLE preparations. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
797. De-Yuan C, et al. The development of specific transfer factor to EB-virus In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
798. Franke W, et al. Improvements in the preparation of human large pool DLE with special reference to viral safety. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
799. Haiyan Q, et al. HSV-1 specific transfer factor in goat leukocyte dialysates: Purification and biochemical characterization. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
800. Komatsu F Effects of DLE, inosine and isoprinosine on adult T-cell leukemia cells. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
801. Kui L, Wen L Clinical application of transfer factor on tun duck blood. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
802. Matsumoto C, et al. The effects of dialyzable leukocyte extracts on monocyte procoaguran activity and TNF secretion. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
803. Matz AN, et al. Amplification of the transfer factor activity of lymphocytic untrafiltrate incorporated into liposomes. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
804. Rebulla P, et al. Inhibitory effect of fractions of the dialyzable leukocyte extract on in vitro phagocytosis of polymorphonuclear leukocytes. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
805. Rosso di San Secondo V, et al. Purification of an immunosuppressive factor from dialyzable leukocyte extracts. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
806. Rozzo SJ, et al. Purification and composition of transfer factors. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
807. Saito S, et al. Inhibitory effects of dialyzable leukocyte extracts (DLE) on cell functions of lymphocyte and other cell lines. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
808. Schroder I, et al. On the characterization of the biological activity of DLE fractions. Comparison of transfer factor preparations of different origin. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
809. ShuQin S, et al. Study of effect of transfer factor of pig's spleen (TFP) upon the T lymphocyte subsets in human peripheral blood. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
810. Vu-Trieu A, Nguyen KM Contribution to the study of transfer factor activity in vitro on E rosette formuing cells of some tropical diseases. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
811. Xu WM, et al. Antigen-specific transfer factor antagonizes the inhibitory effect of human a-fetoprotein on RNA and protein synthesis in mouse lymphocytes. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
812. Xu WM, et al. Antigen-specific transfer factor antagonizes the promotive effect of human-a-fetoprotein RNA synthesis in mouse hepatoma-22 ascites cells. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
813. Xu WM, et al. Antigen-specific transfer factor antagonizes the promotive effect of human a-feto-protein DNA and protein synthesis in mouse hepatoma-22 ascites cell. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
814. Zoungdong W, et al. Study on inhibition mechanism of transfer factor on tumour cell growth In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
815. Zunyi Z, et al. A new method for measurement of activity of transfer factor by chemiluminescence. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
816. Rebulla P, et al. Inhibition of in vitro adherence of antibody-coated red cells to monocytes by the dialyzable leukocyte extract. Transfusion-1991. 31(3);218-21
817. Borvak J, et al. Amino acid analysis of selected reversed-phase high performance liquid chromatographic peaks of crude and partially purified lysed human leukocyte ultrafiltrate. Acta Virol-1990. 34(1);11-8
818. Schmidtmayerova H, et al. Human immunodeficiency virus inhibition by lysed leukocyte ultrafiltrate. Acta Virol-1990. 34(3);263-71
819. Friedrich A, et al. [Modulation of granulocyte phagocytosis] Allerg Immunol (Leipz)-1990. 36(1);17-24
820. Benes E, et al. Effect of IMREG-1 on intracellular calcium levels of human peripheral blood mononuclear cells. FASEB J-1990. 4;A1858
821. Montecucchi PC, et al. Purification of immunomodulatory factors in human peripheral blood leukocytes. J Chromatogr-1990. 512(0);139-47
822. Fazio M, et al. A new method for the in vitro transfer of delayed hypersensitivity by dialysed transfer factor. J Nucl Med Allied Sci-1990. 34(4 Suppl);271-4
823. Saito S, et al. Effect of freeze and thawing and treatment of Dnase on production of DLE (dialyzable leukocyte extracts) Jpn Blood Program-1990. 13;3-11
824. Rosso di San Secondo VE, et al. Purification of leukocyte factor inhibiting PHA-induced lymphocyte transformation. Minerva Biotec-1990. 2;454
825. Borvak J, et al. Semipurified human leukocyte ultrafiltrate in herpes zoster. I. Large-scale preparation and biochemical analysis. Acta Virol-1989. 33(5);417-27
826. Wilson GB, Paddock G Process for obtaining transfer factor from colostrum, transfer factor so obtained and use thereof. Biotechnol Adv-1989. 7(3);445
827. Komatsu F Effects of dialyzable leukocyte extracts (DLE) and inosine on stimulated lymphocytes. Bull Tokyo Med Dent Univ-1989. 36(3);35-40
828. Westphal HJ, Schroder I [Re-expression of the sheep red blood cell receptor--a diagnostic marker of cutaneous T-cell lymphomas?] Dermatol Monatsschr-1989. 175(2);87-94
829. Barnet K, et al. The effect of DLE and isoprinosine on guinea pig thymocytes in comitogenic test. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
830. Fomatsu F. Effects of DLE and inosine fraction of DLE on lymphocytes. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
831. Jiang X, Zhu W In vitro experimental study on the activating effect of sheep spleen transfer factor on E receptor of human T lymphocytes. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
832. Kobayashi M, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med-1989. 170(3);827-45
833. Wilson GB, Paddock GV Process for obtaining transfer factor from colostrum, transfer factor so obtained and use thereof. US Patent 4,816,563-1989.
834. Matshumoto C, et al. The effects of Dnase treatment of dialyzable leukocyte extracts (DLE) on lymphocytes reactions. Jpn J Clin Immunol-1988. 11;176-82
835. Sipka S, et al. Effect of different fractions of dialyzable leukocyte extract--transfer factor--on the chemiluminescence of human phagocytes. Allergol Immunopathol (Madr)-1987. 15(3);143-4
836. Rosso di San Secondo VE, et al. Inhibitory effects of dialyzed leukocyte extract on DNA and RNA synthesis. Basic Appl Histochem-1987. 31(3);325-30
837. Gordienko SM, et al. [In vitro and in vivo modulation of cellular immunity using human transfer factor] Gematol Transfuziol-1987. 32(1);39-43
838. Gottlieb AA, et al. Augmentation of antigen-induced interleukin-2 receptor expression and gamma-interferon production by IMREG-1, a leukocyte derived immunomodulator. In: Clinical Immunology. Pruzanski W, Seligmann M, Eds. Elsevier, NY-1987.
839. Drofling P, Schroder I Effect of the dialysable leukocyte extract and its different fractions on the production of H2O2 and IL-1 by macrophages. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987.
840. Nekam K, et al. Effects of dialyzable leukocyte extracts on lectin dependent cell mediated cytotoxicity in vitro. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987.
841. Paddock GV Comparative structural analysis of transfer factor from different species and sources: Relationships with other immunopotentiators. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987.
842. Schmidtmayerova H, et al. The effect of lysed leukocyte ultrafiltrate on the HIV: in vitro study. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987.
843. Rosso di San Secondo VE, et al. Dialyzable leukocyte extract: partial purification of low-molecular-weight factors suppressing and enhancing lymphocyte transformation. J Exp Pathol-1987. 3(4);425-7
844. Lawrence HS Characterization of inducer factor and suppressor factor in T cells dialysates. 8th Congress on Immunology, Canada-1986.
845. Machado RZ, et al. Dialyzable transfer factor in experimental Chagas' disease: in vitro studies. Trop Med Parasitol-1986. 37(4);399-402
846. Perepechkina NP, et al. [Ultrafiltration characteristics of immunobiological preparations] Zh Mikrobiol Epidemiol Immunobiol-1986.
847. Borvak J, Mayer V UV-absorbance profile of human leukocytic ultrafiltrate after affinity chromatography on immobilized m-aminophenyl boronic acid: implication for transfer factor purification. Acta Virol-1985. 29(2);119-28
848. Mayer V, et al. Antigen-specific transfer factor from mice immunized with an attenuated flavivirus: augmentation of inducing activity in semipurified splenocytic dialyzates. Acta Virol-1985. 29(1);25-34
849. Shaw MW, et al. Effect of transfer factor on tumor-associated immunity and tumor growth of the Dunning R-3327G rat prostate adenocarcinoma. Am J Reprod Immunol Microbiol-1985. 8(3);80-3
850. Lukacs K, et al. Effect of dialysable leukocyte extract on the mononuclear leukocytes in Hodgkin's disease. Haematologia (Budap)-1985. 18(2);105-13
851. Kirkpatrick CH, et al. Murine transfer factor. III. Specific interactions between transfer factor and antigen. J Immunol-1985. 135(6);4027-33
852. Li ZL The study of human transfer factor. Sci Sin [B]-1985. 28(4);394-401
853. Schroder I, Luneburg S Transfer factor--a lymphocyte cell surface component. Allergol Immunopathol (Madr)-1984. 12(1);1-5
854. Ohno T, et al. Antigen-independent leukocyte random locomotion inhibitory activity in human ultrafiltrated leukocyte extracts. Cell Immunol-1984. 84(2);217-27
855. Tsuneta H [The role of cultured thymic epithelium and dialyzable leukocyte extracts on the maturation process of T cell. Study of their effects on cyclic nucleotides levels in thymocytes] Hokkaido Igaku Zasshi-1984. 59(2);128-39
856. Chinchilla M, Frenkel JK Specific mediation of cellular immunity to Toxoplasma gondii in somatic cells of mice. Infect Immun-1984. 46(3);862-6
857. Farmer JL, et al. Counter inhibitor: a low molecular weight cytokine derived from human leukocyte dialysates reverses antigen dependent PMN and macrophage migration inhibition. Int Arch Allergy Appl Immunol-1984. 73(2);146-50
858. Gottlieb AA, et al. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates. J Immunol-1984. 132(1);256-60
859. Mayer V, et al. Concentration of murine antigen-specific transfer factor of defined potency. Acta Virol-1983. 27(3);228-37
860. Valaskova M, et al. Thermal inactivation of the partially purified murine transfer factor. Acta Virol-1983. 27(1);92
861. Lawrence HS, Borkowsky W A new basis for the immunoregulatory activities of transfer factor--an arcane dialect in the language of cells. Cell Immunol-1983. 82(1);102-16
862. Karl M, et al. [Human transfer factor. I. Production by the great pool technic and the biochemical and immunological characteristics of the preparation] Folia Haematol Int Mag Klin Morphol Blutforsch-1983. 110(1);9-23
863. Uotila A, et al. Mechanism of the in vitro augmentation of lymphocyte transformation by transfer factor and by other cellular dialysates. In: [Unknown]-1983.
864. Borkowsky W, et al. Antigen-specific suppressor factor in human leukocyte dialysates: A product of Ts cells which binds to anti-V region and anti-Ia region antibodies. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
865. Borkowsky W, Lawrence HS Antigen-specific inducer factor in human leukocyte dialysates: A product of Th cells which binds to anti-V region and anti-Ia region antibodies. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
866. Fudenberg HH, et al. Clinical applications of the leukocyte migration inhibition assay: New methods for determining transfer factor potency and for predicting clinical response. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
867. Hainaut J, et al. Dialyzable leukocyte extracts (DLE) and theophylline treated lymphocytes. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
868. Holzman RS, et al. Isolation and purification of antigen-specific inducer and suppressor factors from pooled leukocyte dialysates of unselected donors by affinity adsorption. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
869. Jensen J, et al. Dialyzable leucocytes extract stimulates cAMP in Tgamma lymphocytes: Lack of Fc-receptor induction or NK-cell activation. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
870. Kirkpatrick CH, et al. Thymosin alpha1-like material in dialysates of leukocyte extracts. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
871. Paddock GV, et al. Human transfer factor: Exogenous labelling, purification, and role of ribonucleic acid segment. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
872. Schindler TE, et al. Initial characterization of an ampliative nucleoside isolated from human dialyzable leukocyte lysate. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
873. Viza D, et al. Transfer factor and immune RNA In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
874. Wilson GB, et al. Transfer of cell-mediated immunity in vitro to human lymphocytes using dialyzable leukocyte extracts from immune burros. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
875. Wilson GB, et al. Immunochemical and phsical-chemical evidence for the presence of thymosin alpha1-peptide in dialyzable leukocyte extracts. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.
876. Wang FZ, Huang ZX [Effect of Japanese encephalitis virus-specific transfer factor on adherent inhibitory activity of peritoneal exudate cells] Zhongguo Yi Xue Ke Xue Yuan Xue Bao-1983. 5(1);47-50
877. Schroder I, Rovensky J In vitro determination of effects of dialyzable leukocyte extracts containing transfer factor activity. Allergol Immunopathol (Madr)-1982. 10(3);171-6
878. Wybran J, Dupont E The active T rosette: an early marker for T-cell activation. Ann Immunol (Paris)-1982. 133D(2);211-8
879. Komatsu F, et al. [Enhancement of BHK cell proliferation in culture by transfer factor] Arerugi-1982. 31(4);252-9
880. Okada M [Augmentation of lymphocyte transformation by human dializable transfer factor and its target cell (author's transl)] Arerugi-1982. 31(2);69-80
881. Viza D, et al. Characterization of a human lymphoblastoid cell line, LDV/7, used to replicate transfer factor and immune RNA. Biol Cell-1982. 46;1-10
882. Tsakalos ND, et al. Dialyzable leukocyte extract induces mast cell secretion. Cell Immunol-1982. 66(2);383-93
883. Lang I, et al. Effect in vivo and in vitro treatment with dialyzable leukocyte extracts on human natural killer cell activity. Clin Immunol Immunopathol-1982. 25(1);139-44
884. Smith RA, Esa A In vitro effect of murine-derived transfer factor on Salmonella-specific rosette formation. Infect Immun-1982. 38(2);588-91
885. Paige CJ, et al. Mediators from cloned T helper cell lines affect immunoglobulin expression by B cells. Proc Natl Acad Sci U S A-1982.79(15);4756-60
886. Wilson GB, et al. Bovine 'transfer factor': an oligoribonucleopeptide which initiates antigen-specific lymphocytes responsiveness. Thymus-1982. 4(6);335-50
887. Klesius PH Modulation of cell-mediated responses with dialyzable leukocyte extract containing transfer factor. Adv Exp Med Biol-1981. 137(0);293-323
888. Person JM, et al. [Production of dialysable leukocytes extracts in cattle (author's transl)] Comp Immunol Microbiol Infect Dis-1981. 4(1);47-57
889. Nekam K, et al. Resynthesis of trypsinized sheep red blood cell receptors on human lymphocytes: comparison of the effects of immunopotentiators of biological and synthetic origin in vitro. Immunopharmacology-1981. 3(1);31-9
890. Borkowsky W, et al. Antigen-specific activity of murine leukocyte dialysates containing transfer factor on human leukocytes in the leukocyte migration inhibition (LMI) assay. J Immunol-1981. 126(1);80-2
891. Borkowsky W, Lawrence HS Deletion of antigen-specific activity from leukocyte dialysates containing transfer factor by antigen-coated polystyrene. J Immunol-1981. 126(2);486-9
892. Philp JR, et al. A lymphokine resembling transfer factor that stimulates MIF production by nonsensitive lymphocytes. J Immunol-1981. 126(4);1469-72
893. Wilson GB, Fudenberg HH Leukocyte migration inhibition as a method for assaying transfer factor activities. Lymphokines-1981. 4;107-73
894. Markowicz S, et al. Transfer factor (TFd). Part III. In vitro effects on the leucocyte migration inhibition. Mater Med Pol-1981. 13(2);104-7
895. Wilson GB, et al. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. V. Antigen-specific lymphocyte responsiveness can be initiated by two structurally distinct polyribonucleopeptides. Thymus-1981. 2(4-5);257-6
896. Xie LX [The erythrocyte-rosette forming cell (E-RFC) count and results of treatment with transfer factor in herpes simplex keratitis (author's transl)] Zhonghua Yan Ke Za Zhi-1981. 17(4);204-7
897. Nekam K, et al. The effect of transfer factor on spontaneous shedding of sheep red blood cell binding receptors of T lymphocytes in vitro. Acta Med Acad Sci Hung-1980. 37(1);83-8
898. Ablin RJ Transfer factor: specific and nonspecific effects and chemical characteristics of dialyzable leukocyte lysates (DLL). Part III. Biochemical characterization. (third of three parts). Allergol Immunopathol (Madr)-1980. 8(3);203-12
899. Ablin RJ Transfer factor: specific and nonspecific effects and chemical characteristics of dialyzable leukocyte lysates (DLL). Part I. Introduction. (first of three parts). Allergol Immunopathol (Madr)-1980. 8(1);53-60
900. Hainaut J, Devismes D [Increase by the total dialysate leukocyte extract of E rosette formation in human theophylline treated lymphocytes] C R Seances Acad Sci D-1980. 290(1);33-5
901. Basten A, et al. Transfer of cell-mediated immunity with cell-free leukocyte extracts. III. Demonstration of Ia antigens in the specific component. Cell Immunol-1980. 56(2);440-51
902. Croft S, et al. Transfer of cell-mediated immunity with cell-free leukocyte extracts. I. Comparison of in vitro and in vivo assays of cell-mediated immune function. Cell Immunol-1980. 56(2);415-26
903. Khan A, et al. Isolation and characterization of immunopeptide from dialyzable leukocyte extract. Cell Immunol-1980. 55(2);420-7
904. Schindler TE, Baram P In vivo effects of human dialyzable leukocyte lysates. II. Augmentation of the spleen cell proliferative response to antigen in KLH-sensitive mice. Cell Immunol-1980. 56(1);120-31
905. Wilson GB, et al. Effects of dialyzable leukocyte extracts (DLE) with transfer factor activity on leukocyte migration in vitro. IV. Two distinct effects of DLE on leukocyte migration can be produced by prostaglandins. Clin Immunol Immunopathol-1980. 16(1);90-102
906. Uotila A Studies on the chemical nature of dialysable transfer factor. Comparison of human leukocyte dialysate and dialysates derived from human serum and from mammalian lymphoid and non-lymphoid organs. Immunobiology-1980. 156(4-5);353-63
907. Sargent IL, Salaman MR Effects of human transfer factor on the migration of guinea-pig macrophages: is there an antigen-specific activity? Immunology-1980. 41(1);227-35
908. Hainaut J, et al. Restoration by DLE of E rosette of human theophilline treated lymphocytes. Workshop on "Leukocytes dialysates" Intern congress Immunol, Paris-1980.
909. Tomar RH, John PA Human T lymphcytes are enriched for transfer factor. J Immunol-1980. 124(3);1054-7
910. Shohat B, Trainin N The local xenogeneic graft-versus-host reaction as a clinical test for immunocompetence of human T lymphocytes. Thymus-1980. 2(2);93-105
911. Ahmed A, et al. T-lymphocyte maturation: cell surface markers and immune function induced by T-lymphocyte cell-free products and thymosin polypeptides. Ann N Y Acad Sci-1979. 332(0);81-94
912. Wilson GB, et al. Detection of "dialyzable transfer factor" in vitro: structural and chemical characterization of the activity specific for tuberculin. Ann N Y Acad Sci-1979. 332(0);579-90
913. Togawa A, et al. Ability of dialysates containing transfer factor to induce lymphocyte activating factor by human mononuclear cells. Cell Immunol-1979. 45(1);133-41
914. Wilson GB, et al. Bovine dialyzable lymph node extracts have antigen-dependent and antigen-independent effects on human cell-mediated immunity in vitro. Cell Immunol-1979. 47(1);1-18
915. Ashorn RG, et al. Human transfer factor in vitro. II. Augmentation of the secretion of leucocyte migration inhibitory factor (LIF) by leucocyte dialysate and by its components L-serine and glycine. Clin Exp Immunol-1979. 37(1);50-7
916. Ascher MS, Andron LA Transfer factor in vitro: nonspecificity of components that enhance lymphocyte proliferation to antigen. Clin Immunol Immunopathol-1979. 12(1);72-81
917. Whitacre CC, Paterson PY Guinea pig transfer factor: restriction of macrophage migration inhibitory activity to extraordinary dilution confirmed with demonstration of diminished potency of stored preparations. Clin Immunol Immunopathol-1979. 13(3);287-95
918. Arrenbrecht S, et al. TF activity in vitro. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
919. Ashorn R, et al. In vitro augmentation of LIF synthesis by transfer factor and by its components L-serine and glycine. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
920. Ballow M Modulation of immunoglobulin synthesis in vitro by dialyzable transfer factor. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
921. Borkowsky W, Lawrence HS Effects of human dialyzable leukocyte extract on the leukocyte migration inhibition assay. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
922. Burger DR, et al. A structural model for human transfer factor suggested by enzymatic susceptibilities. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
923. Gottlieb AA, et al. Modification of intradermal delayed hypersensitivity by components of leukocyte dialysates. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
924. Hamblin A, et al. Augmentation of lymphocyte transformation: An assay for transfer factor? In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
925. Khan A, et al. Induction of cortisone resistance and increased mitogen responsiveness in thymocytes by transfer factor. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
926. Krohn K, et al. The relationship of L-serine, O-phospho-L-serine and glycine to the in vitro activity of human transfer factor. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
927. Nekam K, et al. Effect of transfer factor therapy on antibody-dependent cytotoxic activity in humans. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
928. Newell RT, et al. In vitro effects of bovine dialyzable lymph node extracts hon human cell-mediated immunity. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
929. Paddock GV, et al. Purification and structural analysis of the transfer factor-like activity detected in vitro by leukocyte migration inhibition. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
930. Pizza G, et al. In vitro produced transfer factor: Clinical observations and antiviral activity. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
931. Pyle JM, Baram P. Effects of in vivo dialyzable leukocyte lysate treatment on the development of allogeneic cell-mediated cytotoxicity. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
932. Sargent IL, et al. Effect of transfer factor (TF) and thymosin on the recovery of E-rosetting capacity in trypsinised lymphocytes. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
933. Sargent IL, Salaman MR Specificity of transfer factor action on macrophage migration. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
934. Schindler T, Baram P The in vitro augmentation of antigen-induced proliferation of spleen cells obtained from human dialyzable leukocyte lysate (HDLL)-recipient mice sensitized to KLH. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
935. Uotila A, et al. Mechanism of the in vitro augmentation of lympocyte transformation by transfer factor and by other cellular dialysates. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
936. Wilson GB, et al. Possible identification of an antigen-independent leukocyte migration inhibitory activity in human dialyzable leukocyte extracts as neutrophil immobilizing factor. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
937. Wilson GB, et al. Contribution of prostaglandins to the biological activity of dialyzable leukocyte extracts containing transfer factor activity. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.
938. Misra DS, et al. Antibiotic resistance and transfer factor (R+) in E. coli isolated from raw sewage. Indian J Med Res-1979. 70(0);559-62
939. Wilson GB, et al. Effects of dialyzable leukocyte extracts (DLEs) with transfer factor activity on leukocyte migration in vitro. III. Characterization of the antigen-independent migration inhibition factor in DLEs as a neutrophil immobilizing factor. J Allergy Clin Immunol-1979. 64(1);56-66
940. Borkowsky W, Lawrence HS Effects of human leukocyte dialysates containing transfer factor in the direct leukocyte migration inhibition (LMI) assay. J Immunol-1979. 123(4);1741-8
941. Burger DR, et al. Human transfer factors: structural properties suggested by HPRP chromatography and enzymatic sensitivities. J Immunol-1979. 122(3);1091-8
942. Tomar RH, John PA Mononuclear cells contain human transfer factor as assayed locally on the skin of dogs. J Immunol-1979. 123(2);590-3
943. Wilson GB, et al. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. 1. Antigen-dependent inhibition and antigen-independent inhibition and enhancement of migration. J Lab Clin Med-1979. 93(5);800-18
944. Wilson GB, Fudenberg HH Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. II. Separation and partial characterization of the components in DLE producing antigen-dependent and antigen-independent effects. J Lab Clin Med-1979. 93(5);819-37
945. Grubek-Jaworska H, et al. Transfer factor (TFd). Part II. In vitro effect on lymphocyte transformation. Mater Med Pol-1979. 11(4);320-3
946. Komorowska-Rycerz A, et al. Transfer factor (TFd). Part I. Some physicochemical data. Mater Med Pol-1979. 11(4);317-9
947. Wilson GB, et al. The chemical nature of the antigen-specific moiety of transfer factor. Trans Assoc Am Physicians-1979.
948. 92(0);239-56
949. Schroder I, et al. [Adjuvant properties of transfer factor preparations from human tonsillar lymphocytes] Zh Mikrobiol Epidemiol Immunobiol-1979.
950. Kalmar L, et al. In vitro effect of transfer factor on the cyclic nucleotide level of human lymphocytes in chronic lymphocytic leukaemia and of mouse lymphocytes. Acta Med Acad Sci Hung-1978. 35(1);43-6
951. Nekam K, et al. Effect of dialysable leukocytes extracts on antibody-dependent cellular cytotoxicity and lymphocyte Fc receptors. Acta Microbiol Acad Sci Hung-1978. 25(3);191-7
952. Nekam K, et al. Separation of beta2-microglobulin from transfer factor in dialyzable leukocyte extracts. Allerg Immunol (Leipz)-1978. 24(4);254-8
953. Andron LA, Ascher MS Transfer factor in vitro: chromatography of components that enhance antigen-induced lymphocyte proliferation. Clin Immunol Immunopathol-1978. 9(2);157-65
954. Huard TK, et al. In vivo effects of dialyzable leukocyte lysates (DLL): changes in the responses of murine spleen cells to T-and B-cell mitogens, spleen weight, and morphology of splenic tissue. Clin Immunol Immunopathol-1978. 11(2);229-44
955. Salaman MR An investigation into the antigen-specificity of transfer factor in its stimulatory action on lymphocyte transformation. Immunology-1978. 35(2);247-56
956. Uotila A, et al. The effect of transfer factor on lymphocyte transformation. Comparison of augmentation by dialysates of leucocytes and lymphoid and non-lymphoid organs. Int Arch Allergy Appl Immunol-1978. 57(3);210-20
957. Burger DR, et al. Properties of human transfer factor from KLH-immunized donors: dissociation of dermal transfer and proliferation augmenting activities. J Reticuloendothel Soc-1978. 24(4);385-402
958. Fan ZQ The isolation of transfer factor and its nature. Jiangsu Med-1978. 5;41
959. Miyagawa Y, et al. In vitro assay for responsiveness of lymphocytes to transfer factor by a new leukocyte migration inhibitory test. Microbiol Immunol-1978. 22(11);701-10
960. Uotila A, et al. Human transfer factor in vitro: identification of L-serine and glycine as components with augmenting effect in lymphocyte transformation assay. Scand J Immunol-1978. 7(6);495-502
961. Wilson GB, et al. Distinct components in dialyzable leukocyte extracts (DLE) have specific and nonspecific effects on cellular immunity as shown by leukocyte migration inhibition. Trans Assoc Am Physicians-1978. 91(0);295-332
962. Rainer H, et al. [In vitro studies on human transfer factor] Verh Dtsch Ges Inn Med-1978.
963. Rainer H, Moser K [In-vitro studies with human transfer factor] Blut-1977. 34(6);471-8
964. Littman BH, et al. Augmentation of 3H-thymidine incorporation by human lymphocytes in the presence of antigen and fractions of dialyzable transfer factor: a nonspecific phenomenon. Cell Immunol-1977. 28(1);158-66
965. Nekam K, et al. In vitro effect of transfer factor on active rosettes and leucocyte migration of patients with cancer. Clin Exp Immunol-1977. 27(3);416-20
966. Valdimarsson H, McGuire RL Crude transfer-factor preparations stimulate trypsinized human lymphocytes to form rosettes with sheep red cells. Clin Exp Immunol-1977. 29(2);261-5
967. Arala-Chaves MP, et al. In vitro and in vivo studies of the target cell for dialyzable leukocyte extracts. Evidence for recipient specificity. Clin Immunol Immunopathol-1977. 8(3);430-47
968. Wilson GB, et al. Characterization of Tx, an active subfraction of human dialyzable transfer factor. I. Identification of the major component in TFg, a precursor of Tx, as hypoxanthine. Clin Immunol Immunopathol-1977. 8(3);551-68
969. Rifkind D, et al. Susceptibility of murine transfer factor to dimerized ribonuclease A. Infect Immun-1977. 16(3);920-2
970. Muller MR, et al. Biologic activity of transfer factor tested in vitro with cord blood lymphocytes. Int Arch Allergy Appl Immunol-1977. 54(3);269-80
971. Dunnick WA, Bach FH Specificity and structural analysis of a guinea pig transfer factor-like activity. J Immunol-1977. 118(6);1944-50
972. Holzman RS, Lawrence HS In vitro augmentation of lymphocyte sheep cell rosette formation by leukocyte dialysates. J Immunol-1977. 118(5);1672-6
973. Vandenbark AA, et al. Human transfer factor: fractionation by electrofocusing and high pressure, reverse phase chromatography. J Immunol-1977. 118(2);636-41
974. Gottlieb AA, et al. Biochemical analysis of dialyzable leukocyte extracts. J Reticuloendothel Soc-1977. 21(6);403-16
975. Fumarola D, et al. [Possible contamination of preparations of transfer factor with bacterial endotoxins] Minerva Pediatr-1977. 29(26);1625-8
976. Sharma MK, et al. Specificity of transfer factor. In vitro lymphoblast transformation of peripheral lymphocytes to Leishmania major antigen in the presence of transfer factor. Scand J Immunol-1977. 6(11);1101-6
977. Krohn K, et al. Studies on the chemical composition and biological properties of transfer factor. Z Immunitatsforsch Immunobiol-1977.153(5);395-411
978. Goust JM, et al. Characterization of human dialyzable transfer factor from normal and chronic lymphoid leukemia sources. Biomedicine-1976. 24(1);39-44
979. Mueller-Eckhardt C, Ritts RE Inhibitory activity of medium-dialyzed transfer factor on lymphocyte blastogenesis. Blut-1976. 32(5);353-60
980. Pizza G, et al. In vitro production of a transfer factor specific for transitional-cell carcinoma of the bladder. Br J Cancer-1976. 33(6);606-11
981. Goldenberg GJ, Brandes LJ In vivo and in vitro studies of immunotherapy of nasopharyngeal carcinoma with transfer factor. Cancer Res-1976. 36(2 pt 2);720-3
982. Kirkpatrick CH, et al. The identification and significance of hypoxanthine in dialyzable transfer factor. Cell Immunol-1976. 24(2);230-40
983. O'Dorisio MS, et al. Identification of hypoxanthine as the major compoenet of a chromatographic fraction of transfer factor. Cell Immunol-1976. 23(2);191-202
984. Steele RW, et al. In vivo transfer of cellular immunity to primates with transfer factor prepared from human or primate leucocytes. Cell Immunol-1976. 22(1);110-20
985. Ahern T, Sanderson CJ Stimulation of lymphocytes by antigen in microplate cultures; absence of an effect of transfer factor in vitro. Clin Exp Immunol-1976. 23(3);499-506
986. Hamblin AS, et al. Human transfer factor in vitro. II. Augmentation of lymphocyte transformation to phytohaemagglutinin. Clin Exp Immunol-1976. 23;303
987. Hamblin AS, et al. Human transfer factor in vitro. I. Augmentation of lymphocyte transformation to tuberculin PPD. Clin Exp Immunol-1976. 23;290
988. Bell PH, et al. Lymphocyte antigen sensitivity as a requirement for blastogenic response to transfer factor. In: Transfer Factor: Basic Properties and Clinical Appliations. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
989. Andron LA, Ascher MS Chromatography of transfer factor and assay of fractions in vitro. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
990. Arala-Chaves MP, et al. In vitro characterization of the target cell for transfer factor-dialyzable leukocyte extracts. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
991. Arala-Chaves MP, et al. Specific and nonspecific effects of transfer factor -- dialyzable leukocyte extracts. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
992. Ascher MS, Andron LA In vitro properties of leuckocyte dialysates containing transfer factor: Micro method and recent findings. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
993. Baram P, Condoulis W Fractionation of rhesus monkey dialyzable KLH-transfer factor and the in vitro assay of specific biologic activity using the indirect MIF assay. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
994. Basten A, et al. Experimental studies of transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
995. Burger DR, et al. Biological activity of subfractions of human transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
996. Cohen L, et al. Leucocyte dialysates require precommitted, antigen-reactive cells to augment lymphocyte proliferation. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
997. Dabrowska B, et al. Potentiating effects of transfer factor upon macrophage migration inhibition in vitro. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
998. Dunnick W, Bach FH Guniea pig 'transfer factor' in vitro. Physical and chemical properties and partial purification. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
999. Erickson AD, et al. In vitro comparison of TFdm obtained from skin test positive and negative individuals. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
1000. Gottlieb AA, et al. Use of fluorescamine to identify a nonspecific component of human "transfer factor". In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
1001. Goust JM, et al. In vitro assay for transfer factor by means of leukocyte migration test. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
1002. Hamblin A, et al. Augmentation of lymphocyte transformation by dialyzable transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
1003. Holzman RS, et al. Production of sheep erythrocyte rosette forming cells by lymphocytes cultured with leucocyte dialysates. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
1004. Huard T, Baram P Nonspecific effects of human dialyzable transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
1005. Jeter WS, et al. Correlation of in vivo and in vitro activity of guinea pig transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
1006. Khan A, et al. Fractionation of transfer factor with high-pressure liquid chromatography and E-rosette-enhancing activity of various fractions. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
1007. Kirkpatrick CH, Smith TK Effects of dialyzable transfer factor on accumulation of cyclic nucleotides by leukocytes. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
1008. Krohn K, et al. Studies on the biological and chemical nature of a component in transfer factor with immunologically non-specific activity. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
1009. Littman BH, David JR Transfer factor: In vitro effects on lymphocyte transformation. In: Transfer Factor: Basic Properties and ClinicalApplications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
1010. Paque RE In vitro transfer of cocidioidin and histoplasmin sensitivity to "nonsensitive" leucocytes utilizing whole cell lysates from skin test positive coccicioidin sensitive humans: Evidence of cross reactivity in a transfer system. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
1011. Pizza G, et al. Studies with in vitro produced transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
1012. Read SE, et al. In vitro assay for transfer factor using direct migration inhibition. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
1013. Salaman MR Specificity of transfer factor action on lymphocyte transformation. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
1014. Tomar RH Transfer factor -- Some biochemical observations In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
1015. Paquet A, et al. In vitro activity of guinea pig transfer factor released into plasma. Infect Immun-1976. 14(1);290-7
1016. Tomar RH, et al. Transfer factor: hypoxanthine is a major component of a fraction with in vivo activity. J Allergy Clin Immunol-1976. 58(1 PT. 2);190-7
1017. Cohen L, et al. Requirement of precommitted cells as targets for the augmentation of lymphocyte proliferation by leukocyte dialysates. J Exp Med-1976. 143(4);791-804
1018. Burger DR, et al. Human transfer factor: fractionation and biologic activity. J Immunol-1976. 117(3);789-96
1019. Burger DR, et al. Nicotinamide: suppression of lymphocyte transformation with a component identified in human transfer factor. J Immunol-1976. 117(3);797-801
1020. Burger DR, et al. Human transfer factor: effects on lymphocyte transformation. J Immunol-1976. 117(3);782-8
1021. Rifkind D, et al. Delayed hypersensitivity to fungal antigens in mice. II. Characterization of the active component in immunogenic RNA extracts. J Infect Dis-1976. 133(5);533-7
1022. Krohn K, et al. Fractionation studies on human leucocyte dialyzates. Demonstration of three components with transfer factor activity. Med Biol-1976. 54(5);334-40
1023. Arala-Chaves MP, Ramos MTF In vitro assay of partially purified dialyzagle leukocyte extracts fraction. Ricerca-1976. 6;5 Suppl
1024. Hamblin A The effect of Transfer Factor on cultured lymphocytes. Behring-werk Mitt-1975. 57;25
1025. Gallin JI, et al. Defective mononuclear leukocyte chemotaxis in the Chediak-Higashi syndrome of humans, mink, and cattle. Blood-1975. 45(6);863-70
1026. Park JR, et al. The effect of transfer factor on the in vitro migration of tuberculin stimulated white cells from sarcoid and normal subjects. Br J Dermatol-1975. 92(5);535-40
1027. Mendes NF, et al. Restorative effect of normal human serum, transfer factor and thymosin on the ability of heated human lymphocytes to form rosettes with sheep erythrocytes. Cell Immunol-1975. 17(2);560-6
1028. Ascher MS Andron LA In vitro properties of leucocyte dialysates containing Transfer Factor: micro-method and recent findings. Clin Res-1975. 23;287A
1029. Kirkpatrick CH, Gallin JI The chemotactic activity of dialyzable transfer factor. II. Further characterization of the activity in vivo and in vitro. In: The Phagocytic Cell in Host Resistance. Bellanti JA, Dayton DH, Eds. Raven Press, NY-1975.
1030. Gallin JI, et al. Interaction of leukocyte chemotactic factors with the cell surface. I. Chemotactic factor-induced changes in human granulocyte surface charge. J Clin Invest-1975. 55(5);967-74
1031. Sandler JA, et al. Stimulation of monocyte cGMP by leukocyte dialysates. An antigen-independent property of dialyzable transfer factor. J Clin Invest-1975. 56(5);1271-9
1032. Dunnick W, Bach FH Guinea pig transfer factor-like activity detected in vitro. Proc Natl Acad Sci U S A-1975. 72(11);4573-6
1033. Viza D, et al. In vitro production of transfer factor by lymphoblastoid cell lines. Transplant Proc-1975. 7(1);329-33
1034. Thestrup-Pedersen K, et al. Transfer factor applied to intensify the cell-mediated immunological reactions against Mycobacterium avium. Acta Allergol-1974. 29(2);101-6
1035. Agosti E, et al. Transfer factor immunotherapy in leukemia, an in vitro approach. Boll Ist Sieroter Milan-1974. 53(1);suppl:293
1036. Andolina M, et al. The in vitro estimation of transfer factor. Boll Ist Sieroter Milan-1974. 53(1);suppl:177
1037. Brandes LJ, Goldenberg GJ In vitro transfer of cellular immunity against nasopharyngeal carcinoma using transfer factor from donors with Epstein-Barr virus antibody activity. Cancer Res-1974. 34(11);3095-101
1038. Burger DR, et al. Preparation of human transfer factor: a time-saving modification for preparing dialyzable transfer factor. Cell Immunol-1974. 14(2);332-3
1039. Palmer DW, Smith RT Augmentation of PPD- and LPS-induced T-independent DNA synthesis in normal mouse spleen cells by leukocyte lysates from tuberculosis patients. Cell Immunol-1974. 13(2);196-206
1040. Salaman MR Studies on the transfer factor of delayed hypersensitivity. Effect of dialysable leucocyte extracts from people of known tuberculin sensitivity on the migration of normal guinea-pig macrophages in the presence of antigen. Immunology-1974. 26(6);1069-80
1041. Arala-Chaves M, et al. Transfer factor in vitro. Additional data concerning a new method. Int Arch Allergy Appl Immunol-1974. 46(4);612-8
1042. Ascher MS, et al. In vitro properties of leukocyte dialysates containing transfer factor. Proc Natl Acad Sci U S A-1974. 71(4);1178-82
1043. Dupont B, et al. Effect of transfer factor therapy on mixed lymphocyte culture reactivity. Proc Natl Acad Sci U S A-1974. 71(3);867-71
1044. Morison WL Effect of mitogens on leukocyte migration inhibition test in immune deficiency states and influence of transfer factor on response. Proc R Soc Med-1974. 67(7);597-8
1045. Neidhart JA, et al. Transfer factor: isolation of a biologically active component. Cell Immunol-1973. 9(2);319-23
1046. Paque RE, et al. In vitro studies with "transfer factor". II. Transfer of the cell-migration inhibition correlate of delayed hypersensitivity in humans with nondialyzable components of leucocyte lysates from humans sensitized to histoplasmin and coccidioidin. Cell Immunol-1973. 6(3);368-74
1047. Ascher MS, et al. In vitro properties of dialysates containing transfer factor. Fed Proc, Fed Amer Soc Exp Biol-1973. 32;955a
1048. Clausen JE Migration inhibitory effect of cell-free supernatants from mixed human lymphocyte cultures. J Immunol-1972. 108(2);453-9
1049. Lawrence HS, Al-Askari S The preparation and purification of transfer factor. In: In vitro Methods in Cell-Mediated Immunity. Bloom BR, Glade PR, Eds. Academic Press, NY-1971.
1050. Baram P, Condoulis W The in vitro transfer of delayed hypersensitivity to rhesus monkey and human lympocytes with transfer factor obtained from rhesus monkey peripheral white blood cells. J Immunol-1970. 104(4);769-79
1051. Green JA, et al. Inhibition of target cell proliferation by supernatants from cultures of human peripheral lymphocytes. J Immunol-1970.105(1);48-54
1052. Valentine FT, Lawrence HS Lymphocyte stimulation: transfer of cellular hypersensitivity to antigen in vitro. Science-1969. 165(897);1014-6
1053. Brot N, et al. Effect of a soluble transfer factor on the reaction of aminoacyl-tRNA with puromycin. Biochem Biophys Res Commun-1968. 31(4);563-70
1054. Arala-Chaves MP, et al. Fractionation of human leukocyte extracts transferring delayed hypersensitivity to tuberculin. Int Arch Allergy Appl Immunol-1967. 31(4);353-65
1055. Fireman P, et al. Passive transfer of tuberculin reactivity in vitro. Science-1967. 155(760);337-8
1056. Baram P, et al. Studies on the transfer of human delayed-type hypersensitivity. I. Partial purification and characterization of two active components. J Immunol-1966. 97(3);407-20
1057. David JR Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A-1966. 56(1);72-7
1058. Wattel F, et al. [Research on the in vivo and in vitro activity of the tuberculin allergy transfer factor] Ann Inst Pasteur Lille-1965. 16(0);45-54
1059. BARAM P, MOSKO MM Chromatography of the human tuberculin delayed-type hypersensitivity transfer factor. J Allergy-1962. 33(0);498-506
TF-Related
1060. Fudenberg HH Letter: Clarification The Scientist-1997. 11(9);1
1061. Viza D, Giancarlo P Letters: Transfer Factor in AIDS Patients The Scientist-1997. 11(9);1
1062. Jansak J [Trasfer factor in clinical immunology.] Klin Imunol a Alergol-1994. 4;84-7
1063. Bystron J, et al. [Combined immunostimulation with transfer factor and bacterial lysate in the treatment of recurrent herpetic infections.] Prakt Lekar-1993. 73;159-61
1064. Fucíková T., et al. Vliv jednorázové aplikace Transfer faktoru na bunìènou imunitu. Prakt. Lék.-1993. 73;154-8
1065. Barnet K Co je a co není DLE-TF. Praktický Lék.-1993. 73(4);151-3
1066. Dwyer JM, et al. Transfer factor for chronic fatigue syndrome. In: [Unknown]-1992.
1067. Fudenberg HH Dialyzable lymphocyte extract in neurocognitive dysfunction diseases: Effects on granulocytes percent and degree of donor-patient contact. In: 9th International Symposium on TF. Huo BL, Wang R, Zou ZF, Eds. Xue Yuan Press, Beijing-1992.
1068. Micula I, et al. Stabilisation of Salmonella-specific dialyzable leucocyte extracts. Vet Immunol-1992. 32;103-12
1069. Pekarek J Lecebne vyuziti pripravku Immodin Sevac (Transfer Faktor) u nekterych poruch bunecne imunity. Zpravy Sevac-1992. 1;4-18
1070. Massayuki B, et al. Postsurgical adjuvant immunotherapy for non-small cell lung carcinomas. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.
1071. Pekarek J, et al. [Leukocyte dialyzates- Transfer factor] Klin Imunol a Alegologia-1991. 1;9-15
1072. Fan ZQ Physico-chemical properties and biological activities of porcine spleen transfer factor (TF-p); Comparison to the human spleen transfer factor (TF-h). [Unknown]-1990.
1073. [Various] Proceedings of the 7th International Workshop on Transfer Factor. [Unknown], Tokyo-1990.
1074. Baolai H, et al. Eds. Research Progress on Transfer Factor--Proceedings of the fourth National Symposium on Transfer Factor. Chinese Academic Technology Press-1990.
1075. von Schilling C, Herrmann F [Transfer factor] Dtsch Med Wochenschr-1990. 115(43);1651
1076. [No Author(s)] Quality requirement "Transfer Faktor (Human)" No. 92/90 Inst. Drugs of the GDR-1990.
1077. [Various] Proceedings of the fourth Chinese workshop on Transfer Factor. Science and Technology Press, Beijing-1990.
1078. Fudenberg HH, Fudenberg HH Transfer factor: past, present and future. Annu Rev Pharmacol Toxicol-1989. 29(0);475-516
1079. Lawrence HS, Borkowsky W The nature and functions of inducer factor and suppressor factor in T cell dialysates. Immunol Lett-1989. 21(1);75-80
1080. Baolai H, et al. [Unknown] In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
1081. Dwyer JM The properties and mechanisms of action of transfer factor. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
1082. Fujisawa T, et al. Randomized controlled study of leucocyte dialysae and N-CWS as an adjunct to surgical treatment for primary non-small cell carcinoma of the lung. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
1083. Guangfa H, Yuande M Production of transfer factor from human leucocytes and its clinical application. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
1084. Klesius P, et al. Immunotherapy of cryptosporidium parvum with bovine transfer factor. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
1085. Kofranek V, et al. Radioprotective effects of DLE In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
1086. Li Z Clinical application of transfer factor in China. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
1087. Lian Y, et al. Short-term observation on administering BTF combined with 60Co radiotherapy for nasopharyngeal carcinoma. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
1088. Liu B, et al. Acute infectious polyneuritis trated with transfer factor. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
1089. Sibl O, et al. The adjuvant therapy of the nasopharyngeal tumor with transfer factor. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
1090. Xiu-li G, et al. Experimental study for treatment of rheumatism using transfer factor of horse. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.
1091. Wilson GB, Shuler RR Swine transmissible gastroenteritis specific immunity inducer (TF): Clinical efficacy and licensing by the United States Department of Agriculture. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing.-1989.
1092. Baolai H, Ed. Transfer Factor and Clinical Applications. Academic Journal Press-1988.
1093. Sinha SK, et al. Immunomodulatory components present in IMREG-1, an experimental immunosupportive biologic. Biotechnology-1988.6;810-5
1094. Goring HD, et al. [Cellular immune defect and transfer factor therapy in epidermolysis bullosa simplex of the Weber-Cockayne type] Dermatol Monatsschr-1988. 174(1);10-3
1095. Moulias R Use of murine transfer factor in AIDS. Instit Virol. Slovak Acad Sci: Bratislava-1988.
1096. Baoqun L, et al. Using TF to cure affected inflammation of Nerves. Immunol Comm-1987. 7(3);46
1097. Klesius PH Bovine transfer factor use in protozoan diseases. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987.
1098. Pekarek J, et al. Studies on the effects of commercial DLE - Transfer factor SEVAC. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987.
1099. Vlcek F, et al. Immunomodulatory therapy with dialyzable leukocyte extract (DLE) in psoriasis. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987.
1100. Sasakawa S, et al. Clinical trials of dialyzable leukocyte extract (RCTF-1) in Japan. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava..-1987.
1101. Matz AN, et al. Leukocyte dialysates and transfer factor. Institute of Virology, Slovak Acadamey of Sciences, Bratislava-1987.
1102. Busutti L, et al. Transfer factor adjuvant therapy in nonsmall-cell lung carcinoma. (NSCLC) after surgery and radiotherapy. J Exp Pathol-1987. 3(4);565-8
1103. Fazio M, et al. Treatment of cancer patients with autologous lymphocytes pre-incubated with T.F. from long survivors. J Exp Pathol-1987. 3(4);569-77
1104. Jones JF, et al. Infectious mononucleosis: immunotherapy with EBV-specific transfer factor? J Exp Pathol-1987. 3(4);399-406
1105. Mazzella G, et al. Treatment of chronic B virus hepatitis with specific transfer factor. J Exp Pathol-1987. 3(4);421-3
1106. Carey JT, Lederman MM Treatment of AIDS with transfer factor. JAMA-1987. 258(24);3515-6
1107. Mayer V, Borvak J Proceedings of the 5th International Symposium on Transfer Factor Slovak Acad Sci, Bratislava-1987.
1108. Lokaj J, et al. Dialyzable leukocyte extract in the therapy of sepsis. Leukocyte dialysates and transfer factor. Slovak Acad Sci. Bratislava-1987.
1109. Fudenberg HH Transfer factor: past, present, and future. Plenary Lecture V. International Symposium on Transfer Factor. [Unknown], Bratislava-1986.
1110. Nejtek P, St'ovicek J [Treatment of multiple sclerosis using transfer factor] Cesk Neurol Neurochir-1986. 49(6);419-20
1111. Zhang SH, et al. [Experimental observations on the efficacy of specific transfer factor and immuno-ribonucleic acid against schistosome infection] Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi-1986. 4(1);39-41
1112. Tsang KY, Fudenberg HH Transfer factor and other T-cell derived factor (non-LKs). Springer Semin Immunopathol-1986. 8(4);
1113. Tsang KY, Fudenberg HH Transfer factor and other T cell products. Springer Semin Immunopathol-1986. 9(1);19-32
1114. [Various] The 2nd meeting for the study of Transfer Factor [Unknown], Tokyo-1985.
1115. Zhenqing F The immunity-regulating agent: Transfer factor Conference for Appraisal of Transfer Factor.-1985.
1116. Fudenberg HH Opthalmologic Herpes Zoster: Complete remession in six hours with dialyzable transfer factor. J Clin Lab Immunol-1985. 18;49
1117. Bowden RA, et al. Immunologic and clinical responses to varicella-zoster virus-specific transfer factor following marrow transplantation. J Infect Dis-1985. 152(6);1324-7
1118. Stone J, ed. Dermatologic Immunology and Allergy Mosby: St. Louis, MO-1985.
1119. Fujisawa T [Transfer factor immunotherapy as an adjunct to surgery in lung cancer] Nihon Kyobu Shikkan Gakkai Zasshi-1985. 23(1);68-73
1120. Kondoh Y, Shimizu K [Transfer of delayed-type hypersensitivity to Candida albicans or Sporothrix schenkii and protection against experimental candidiasis with murine transfer factor] Nippon Saikingaku Zasshi-1985. 40(5);835-42
1121. Fudenberg HH, et al. Evaluation of "transfer factor" potency and prediction of clinical response. In: Immunomodulation: New Frontiers and Advances. Fudenberg HH, Whitten H, Ambrogi F, Eds. Plenum; NY-1984.
1122. Szalbolezy N, et al. TF therapy for psoriasis. Allergy Immunopathol-1983. 11(2);61-4
1123. Tatsuzawa O, et al. Transfer factor for the clinical trial in CMCC Blood Programme-1983. 6;511-3
1124. Xie LX, et al. E-rosette forming count determination and transfer factor treatment in herpetic simplex keratitis. Chin Med J (Engl)-1983. 96(11);860-4
1125. Zou RJ [Experimental studies on the rabbit transfer factor of schistosomiasis japonica] Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi-1983. 1(3);175
1126. Takahashi N, et al. Transfer factor in treating hepatitis B. Jpn J Pedicatric Med-1983. 15;841-6
1127. Conte R, et al. Il Transfer Factor nel trattamento de quadri clinici diversa: Candidiasis mucocutanea cronica, infectioni gravi, syndrome de Behcet. La Transfusione del Sangue-1983. 28;386-96
1128. Kirkpatrick CH, et al. Transfer factor Lymphokines-1983. 8;1-39
1129. Hori M [Clinical application of transfer factor, lymphokines and thymic factor] Nippon Rinsho-1983. 41(4);857-67
1130. Svoboda J [Clinical possibilities of the use of the transfer factor] Vnitr Lek-1983. 29(1);76-82
1131. Buc M, et al. [Changes in T-lymphocyte response under the action of transfer factor in vivo] Bratisl Lek Listy-1982. 78(1);63-73
1132. Gottlieb AA, Sutcliffe SB In vivo modification of delayed type hypersensitivity by small molecular weight components derived from human leucocytes: partial purification of components causing amplification of response. Clin Exp Immunol-1982. 50(2);434-41
1133. Wilson GB, et al. Treatment of Mycobacterium fortuitum pulmonary infection with "transfer factor" (TF): new methodology for evaluating TF potency and predicting clinical response. Clin Immunol Immunopathol-1982. 23(2);478-91
1134. Cramers M, et al. Transfer factor in atopic dermatitis. Dermatologica-1982. 164(6);369-78
1135. Giulling EV, Diugovskaia LA [Current approaches to the problem of correcting hyper-IgE antibody production] Fiziol Zh-1982. 28(4);491-5
1136. Zai-Lian L Transfer factor. Foreign Medicine (Immunology)-1982. 5(4);169
1137. Wilson GB, Fudenberg HH [Unknown] Immunol Today-1982. 162(2);124-8
1138. Fan ZQ The clinical immunology basis: Transfer factor. 1st Ed. Jiangsu Scientific and Technological Press-1982.
1139. Zhenqing F The Clinical Immunology Basis: Transfer Factor. Jiangsu Scientific and Technological Press-1982.
1140. Saito K Leukocyte dialysate (transfer factor). Jpn J Clin Immunol-1982. 5;355-64
1141. Oyamaguchi A [Studies on the mechanisms of tuberculin hypersensitivity. II. Non-dialyzable transfer factor (author's transl)] Kekkaku-1982. 57(4);225-32
1142. Khan A Transfer factor in viral disease. Lancet-1982. 2;328
1143. Garcia Urra D, et al. [Ataxia-telangiectasia: treatment with transfer factor (author's transl)] Arch Neurobiol (Madr)-1981. 44(1);3-10
1144. [No Author(s)] Immunologic studies and treatment of psoriasis with human transfer factor. Chin Med J (Engl)-1981. 94(1);41-4
1145. Allen RC, Arnaud P, eds. Electrophoresis '81 de Gruyter, NY-1981.
1146. Hainaut J Recherches sur les dialysate d'extraits leucocytaires et le facteur de transfert. These d'Etat de Biologie Humaine Faculte de Medecine Necker-Enfants Malades, Universite Paris V-1981.
1147. Schindler TE, Baram P [Unknown] Fed Proc-1981. 40(4845);1084
1148. Grob PJ, et al. Indications and limitations for TF therapy. In: Clinical Immunology and Allergy. Lugwig S, Ed. North Holland Biochemical Press-1981.
1149. Paganelli R, et al. Transfer factor and cytomegalovirus viruria. Lancet-1981. 1(8214);273-4
1150. Miksiewicz-Wasilewska H, et al. Transfer factor (TFd). Part IV. Transfer factor in mucocutaneous candidiasis treatment. Mater Med Pol-1981. 13(2);108-12
1151. Grubek-Jaworska H, Komorowska-Rycerz A [Transfer factor (TF) - a modulator of immunological activity] Postepy Hig Med Dosw-1981. 35(6);549-74
1152. Fudenberg HH, et al. "Discoid" lupus erythematosus: dramatic clinical and immunological response to dialyzable leukocyte extract (transfer factor). Trans Assoc Am Physicians-1981. 94(0);279-91
1153. Schulkind ML, Ayoub EM Transfer factor and its clinical application. Adv Pediatr-1980. 27(0);89-115
1154. del Castillo WA [Transfer factor] Alergia-1980. 27(3);111-20
1155. Ruzicka T, Goerz G Transfer factor therapy in psoriasis. Arch Dermatol Res-1980. 268(3);319-20
1156. Kvasnicka J, et al. [Transfer factor (author's transl)] Cas Lek Cesk-1980. 119(52);1427-30
1157. Zabrodsky S, et al. [Transfer factor in attempted treatment of recurrent aphthous stomatitis (author's transl)] Cas Lek Cesk-1980. 119(31-32);856-8
1158. Croft S, et al. Transfer of cell-mediated immunity with cell-free leukocyte extracts. II. Demonstration of antigen-specific and nonspecific components. Cell Immunol-1980. 56(2);427-39
1159. Sakiyama Y, Matsumoto S Transfer factor Clin Immunol-1980. 12;127-37
1160. Dunnick W, et al. Lack of antigen fragments in guinea pig transfer factor-like activity. Clin Immunol Immunopathol-1980. 17(1);55-65
1161. France GL, et al. Transfer Factor from Human Colostrum and Breast Milk Lymphocyte Clin Res-1980. 28(5);863A
1162. Goring HD, et al. [The treatment of isolated cellular immune defect with transfer factor (author's transl)] Dermatol Monatsschr-1980. 166(2);81-7
1163. Peetoom F, Florey MJ Lymphocyte marker testing in relation to the clinical use of dialyzed leukocyte extract containing transfer factor (DLE-LTF). Haematologia (Budap)-1980. 13(1-4);225-37
1164. Jamkar AV Immunotherapy of advanced carcinoma maxilla with immunosensitised porcine mesentric lymph node cells with immunospecific xenogenic lymphnode cell transfer factor. Indian J Cancer-1980. 17(1);25-30
1165. Fudenberg HH, et al. DLE therapy: Immunologic assay for donor selection and recipient monitoring. Workshop on "leukocytes dialysates". Intern Congress Immunol, Paris-1980.
1166. Gottlieb AA, et al. The effects of dialyzable products from human leukocyte extracts on cutaneous delayed-hypersensitivity response. J Immunol-1980. 124(2);885-92
1167. [No Author(s)] Immunosuppression, transfer factor, and multiple sclerosis. Lancet-1980. 2(8205);1191-2
1168. Okada S, et al. [Immunotherapy of leprosy (2nd report). Study on the therapy by means of injection of transfer factor (author's transl)] Nippon Rai Gakkai Zasshi-1980. 49(4);190-6
1169. Slowik-Gabryelska A, Krzysko R [Transfer factor (TFX) dosage and the clinical course of primary lung carcinoma] Pneumonol Pol-1980. 48(3);187-93
1170. Fudenberg HH, et al. Immunotherapy with dialyzable leukocyte extracts and studies of their antigen-specific (transfer factor) activity. Proc Virchow Pirquet Med Soc-1980. 34(0);3-87
1171. Spitler LE BCG, levamisole and transfer factor in the treatment of cancer. Prog Exp Tumor Res-1980. 25(0);178-92
1172. [No Author(s)] Transfer factor and leukaemia. S Afr Med J-1980. 58(13);505-6
1173. Deng WW [The therapeutic effects of auto-transfer-factor and iRNA in lung cancer (author's transl)] Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi-1980. 3(4);199-200
1174. Fan ZQ [The preliminary report of treating bronchial asthma with transfer factor (author's transl)] Zhonghua Nei Ke Za Zhi-1980. 19(6);413-5
1175. Tang JH [Clinical observations on the treatment of epidemic hemorrhagic fever with transfer factor (author's transl)] Zhonghua Nei Ke Za Zhi-1980. 19(1);36-8
1176. Spitler LE Therapy of stage III (Disseminated) melanoma with surgery and transfer factor. [Unknown]-1979.
1177. Khan A, Kirkpatrick CH, Hill NO, Eds. Immune Regulators in Transfer Factor Academic Press, NY-1979.
1178. Tomar RH, et al. Moniliasis and anergy in hypoparathyroidism: treatment with transfer factor. Ann Allergy-1979. 42(4);241-5
1179. Jonas S, et al. Amyotrophic lateral sclerosis: failure of transfer factor therapy. Ann Neurol-1979. 6(1);84
1180. Khan A, et al. Transfer factor in Guillain-Barre syndrome. Arch Neurol-1979. 36(6);387
1181. Weimar W, Schellekens H Prophylaxis and therapy of HBsAg positive hepatitis. Biomedicine-1979. 30(3);135-8
1182. Al-Sarraf M, Baker LH Transfer factor. Cancer Treat Rev-1979. 6(4);209-15
1183. Gerbase-DeLima M, et al. Specificity of the local transfer of cell-mediated immunity with dialyzable transfer factor. Cell Immunol-1979. 48(1);231-4
1184. Kirkpatrick CH, et al. Third international symposium on transfer factor. Cell Immunol-1979. 46(1);184-6
1185. Vlcek F, et al. [Possibilities of using the transfer factor in treatment of psoriasis (author's transl)] Cesk Dermatol-1979. 54(2);70-2
1186. Getlik A, et al. [The use of transfer factor in clinical practice] Cesk Pediatr-1979. 34(11);630-2
1187. Friedenberg WR, et al. Hyperimmunoglobulin E syndrome: response to transfer factor and ascorbic acid therapy. Clin Immunol Immunopathol-1979. 12(2);132-42
1188. Khan A Transfer factor treatment of viral diseases. Cutis-1979. 24(4);360, 379, 451 passim
1189. Ikeda T, et al. Response to transfer factor to immunodeficiency in handicaps treated with phenytoin. Eur J Pediatr-1979. 132(1);67-8
1190. Saha K Transfer factor exerts nonspecific effects? Int J Lepr Other Mycobact Dis-1979. 47(4);614-5
1191. Kirkpatrick CH Transfer of cellular immunity with transfer factor. J Allergy Clin Immunol-1979. 63(2);71-3
1192. Hamblin AS Transfer factor. J R Soc Med-1979. 72(12);927-9
1193. MacKie RM Mucocutaneous candidiasis responsive to transfer factor therapy. J R Soc Med-1979. 72(12);926-7
1194. Haracic M [Transfer factor and its clinical significance] Med Arh-1979. 33(2);177-82
1195. Pizza G, et al. Transfer factor for the treatment of chronic acute hepatitis. N Engl J Med-1979. 300(23);1332
1196. Lang I, et al. [Changes in the antibody dependent cytotoxicity under the effect of transfer factor therapy. Preliminary report] Orv Hetil-1979. 120(25);1491-5
1197. Likholetov SM Delayed hypersensitivity and transfer factor in experimental coccidioidomycosis. Sabouraudia-1979. 17(3);251-9
1198. Sakharov PP, Kudrina GP [Role of the transfer factor in transplantation immunology] Zh Mikrobiol Epidemiol Immunobiol-1979.
1199. Zachariae H, et al. IgE, T cells and transfer factor in mycosis fungoides. Br Med J-1978. 1(6116);854
1200. Kirkpatrick CH Transfer of delayed cutaneous hypersensitivity with transfer factor. Cell Immunol-1978. 41(1);62-71
1201. Littman BH, et al. Transfer factor treatment of chronic mucocutaneous candidiasis: requirement for donor reactivity to candida antigen. Clin Immunol Immunopathol-1978. 9(1);97-110
1202. Graziano FM, Dwyer JM Transfer factor--clinical enigma. Clinical uses of transfer factor (second of two parts). Conn Med-1978. 42(1);1-4
1203. Schoeder I, et al. Zur preparation und therapeutishen testung von transfer factor aus tonsillen. Dt. Gesund Vesen-1978. 33(24-5);1135
1204. Schroder I, et al. [Extraction and therapeutic testing of the transfer factor from tonsils] Dtsch Gesundheitsw-1978. 33(24);1135-9
1205. Silvino G, et al. Treatment with transfer factor of herpes zoster varicella infection in Hodgkin's disease. Haematologica-1978. 63(1);56-60
1206. Wahba A [Transfer factor: basic aspects and clinical use] Harefuah-1978. 94(12);434-5
1207. Gottlieb AA Biochemical properties of human "transfer factor." In: The Infection-Prone Hospital Patient. Burke JF, Hildick-Smith GY, Eds. Little Brown and Co. Boston.-1978.
1208. Spitler LE Transfer factor. Int J Dermatol-1978. 17(6);445-58
1209. Hastings RC Transfer factor as a probe in the immune defect in lepromatous leprosy. Int J Lepr Other Mycobact Dis-1978. 46(2);220-1
1210. Zhenqing F The isolation of transfer factor and its nature. Jiangsu Med-1978. 5;41
1211. Khan A Transfer factor in viral diseases. Lancet-1978. 1(8059);328-9
1212. Franchi F, et al. [Transfer factor and thymosin in the treatment of Wiskott-Aldrich syndrome] Minerva Pediatr-1978. 30(8);609-13
1213. Matsumoto S [Clinical significance of transfer factor] Nippon Rinsho-1978. Suppl(0);1260-1
1214. Gatenby P Transfer factor in tropical disease. P N G Med J-1978. 21(1);65-8
1215. Gelik A, et al. Our experience with TF therapy in deficiency state of cellular immunity. 19th Congress Pediat Praha-1977.
1216. Khan A Non-specificity of transfer factor. Ann Allergy-1977. 38(5);320-2
1217. Burger DR, et al. De novo appearance of KLH transfer factor following immunization. Cell Immunol-1977. 29(2);410-3
1218. Ballow M, Hyman LR Combination immunotherapy in chronic mucocutaneous candidiasis. Synergism between transfer factor and fetal thymus tissue. Clin Immunol Immunopathol-1977. 8(3);504-12
1219. Hastings RC Transfer factor as a probe of the immune defect in lepromatous leprosy. Int J Lepr Other Mycobact Dis-1977. 45(3);281-91
1220. Kirkpatrick CH Immunotherapy with transfer factor. JAMA-1977. 238(8);891
1221. Sano M, et al. Transfer factor in treating hepatitis B (cont.) N Engl J Med-1977. 296(1);53-4
1222. [No Author(s)] Lymphocyte transfer factor therapy in malnutrition and infection. Nutr Rev-1977. 35(5);102-4
1223. Lawrence HS Transfer factor in transplantation immunobiology. Transplant Proc-1977. 9(1);1319-26
1224. Zachariae H, et al. Transfer factor in mycosis fungoides. Ugeskr Laeg-1977. 139;1834-7
1225. Sachariae H, et al. [Transfer factor in mycosis fungoides] Ugeskr Laeger-1977. 139(31);1834-7
1226. Thestrup-Pedersen K, Zachariae H [Transfer factor. Fact or fantasy?] Ugeskr Laeger-1977. 139(31);1827-33
1227. Meier CR, LoBuglio AF Transfer factor: a potential agent for immunotherapy of cancer. World J Surg-1977. 1(5);617-23
1228. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Transfer Factor: Basic Properties and Clinical Application. Academic Press, NY-1976.
1229. Grohn P, et al. The effect of non-specifically acting transfer factor component on acnitis type of lupus miliaris faciei. Acta Dermatovener.-1976. 56;449
1230. Karmazsin L, et al. [Transfer factor treatment of chronic mucocutaneous candidiasis] Acta Paediatr Acad Sci Hung-1976. 17(3);183-91
1231. Escudero Gil R, et al. [Treatment of candidasis granuloma with "transfer factor"] Actas Dermosifiliogr-1976. 67(7-8);589-98
1232. Prats J, et al. [Treatment of neuroblastoma with transfer factor (author's transl)] An Esp Pediatr-1976. 9(8);41-3
1233. Khan A, et al. Asthma and T cell immunodeficiency: improvement with transfer factor and immunopeptide. Ann Allergy-1976. 37(4);267-74
1234. Smith CR, et al. Chronic pulmonary histoplasmosis: improved lymphocyte response with transfer factor. Ann Intern Med-1976. 84(6);708-9
1235. Byers VS, et al. Discussion paper: tumor-specific transfer factor therapy in osteogenic sarcoma: a two-year study. Ann N Y Acad Sci-1976. 277(00);621-7
1236. Horsmanheimo M, Virolainen M Acquisition of tuberculin sensitivity after injection of dialyzable transfer factor in sarcoidosis. Ann N Y Acad Sci-1976. 278(0);129-35
1237. Jewell WR, et al. Comparison of allogeneic tumor vaccine with leukocyte transfer and transfer factor treatment of human cancer. Ann N Y Acad Sci-1976. 277(00);516-21
1238. Zachariae H, et al. Transfer factor as therapeutic agent in mycosis fungoides. Arch Dermatol-1976. 112(9);1324-6
1239. MacKie RM Transfer factor 1975. Br J Dermatol-1976. 94(1);107-10
1240. Ng RP, Vicary FR Cell-mediated immunity and transfer factor in Crohn's disease. Br Med J-1976. 2(6027);87-8
1241. Vetto RM, et al. Transfer factor therapy in patients with cancer. Cancer-1976. 37(1);90-7
1242. Kirkpatrick CH, Smith TK Serial transfer of delayed hypersensitivity with dialyzable transfer factor. Cell Immunol-1976. 27(2);323-7
1243. Kirkpatrick CH, et al. Reconstitution of defective cellular immunity with foetal thymus and dialysable transfer factor. Long-term studies in a patient with chronic mucocutaneous candidiasis. Clin Exp Immunol-1976. 23(3);414-28
1244. Horsmanheimo M, Virolainen M Transfer of tuberculin sensitivity by transfer factor in sarcoidosis. Clin Immunol Immunopathol-1976. 6(2);231-7
1245. Stoop JW, et al. Selective severe cellular immunodeficiency. Effect of thymus transplantation and transfer factor administration. Clin Immunol Immunopathol-1976. 6(3);289-98
1246. Fumarola D, et al. [Possible contamination of preparation of transfer factor with bacterial endotoxins] G Batteriol Virol Immunol-1976. 69(7-12);229-33
1247. Gobbi M [Transfer factor : factor of transfer of the cell-mediated immunity] G Clin Med-1976. 57(7-8);223-6
1248. Baram P Transfer factor. IMJ Ill Med J-1976. 149(5);448-52, 484
1249. Ascher MS, et al. Adjuvant properties in human dialyzable leukocyte extracts containing transfer factor. In: 11th Leukocyte Culture Conference, Tuscon, Arizona-1976.
1250. Kirkpatrick CH, Smith TK Specific and non-specific activities in dialyzable transfer factor. Symposium II In: 11th Leukocyte Culture Conference, Tuscon, Arizona-1976.
1251. Jeter WS, et al. Correlation of in vivo and in vitro activity of guinea-pig transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.
1252. Hastings RC, et al. Preliminary results on the safety and efficacy of transfer factor in leprosy. Int J Lepr Other Mycobact Dis-1976. 44(1-2);275
1253. Kirkpatrick CH, Smith TK The nature of transfer factor and its clinical efficacy in the management of cutaneous disorders. J Invest Dermatol-1976. 67(3);425-30
1254. Erhan S Information density, cellular immunity and transfer factor. J Theor Biol-1976. 63(1);111-5
1255. [No Author(s)] Letter: Transfer factor in multiple sclerosis. Lancet-1976. 2(7976);99-100
1256. Alonso A Letter: Transfer factor in atopic disease. Lancet-1976. 1(7973);1352
1257. Behan PO Letter: Transfer factor in multiple sclerosis. Lancet-1976. 2(7979);258
1258. Poser CM Letter: Transfer factor therapy in multiple sclerosis. Lancet-1976. 1(7973);1352-3
1259. Scalise G, et al. The mixed leucocyte-macrophage migration test in actively sensitised and transfer factor-treated Rhesus monkeys. Preliminary observations on HBsAg specific transfer factor. Minerva Gastroenterol-1976. 22(3);257-60
1260. Szegedi G, et al. [Therapeutic experiences with transfer factor in chronic cutaneous cadidiasis treatment] Mykosen-1976. 19(5);133-40
1261. Jain S, et al. Letter: Failure of transfer-factor therapy in chronic active type B hepatitis. N Engl J Med-1976. 295(9);504
1262. Shulman ST, et al. Letter: Transfer factor in treating hepatitis B (cont.). N Engl J Med-1976. 295(16);898
1263. Tong MJ, et al. Failure to transfer-factor therapy in chronic active type B hepatitis. N Engl J Med-1976. 295(4);209-11
1264. Arala-Chaves MP, Fudenberg HH Letter: Specificity of transfer factor. Nature-1976. 262(5564);155-6
1265. Salaman MR, Valdimarsson H Letter: Specificity of transfer factor. Nature-1976. 259(5540);250
1266. Fumarola D, Panaro A [Studies on the possible contamination of transfer factor preparations with bacterial endotoxins] Pathologica-1976. 68(977-978);153-8
1267. Panizon F, et al. [Transfer factor] Pathologica-1976. 68(983-984);381-91
1268. Gorski A [Present-day problems of immunotherapy: transfer factor and levamisole] Pol Arch Med Wewn-1976. 56(5);471-6
1269. Greco RS Application of transfer factor to clinical immunotherapy. Surg Gynecol Obstet-1976. 142(5);765-78
1270. Dienst C, et al. [Therapy using the transfer factor in combined immunologic deficiency syndromes] Verh Dtsch Ges Inn Med-1976. 82 Pt 2(0);1810-2
1271. Sakharov PP, Kudrina GP [The current state of the problem of the nature and mechanism of action of "transfer factor"] Zh Mikrobiol Epidemiol Immunobiol-1976.
1272. Zachariae H, et al. Transfer factor as an additional therapeutic agent in mycosis fungoides. Acta Allergol-1975. 30(5);272-85
1273. Hanson LA Transfer factor--a new form for immunotherapy. Acta Med Scand-1975. 198(1-2);1-3
1274. Dressler D, Potter H Transfer factor: warning on uncertainty of results. Ann Intern Med-1975. 82(2);279
1275. Bleare RM, et al. Evaluation of transfer factor in ther therapy of SSPE. Arch Neurol-1975. 32;502A
1276. Griscelli C Transfer factor therapy in immunodeficiency. Birth Defects Orig Artic Ser-1975. 11(1);462-4
1277. Levin AS, et al. Transfer factor I: Methods and therapy. Birth Defects Orig Artic Ser-1975. 11(1);449-56
1278. Schlager SI, et al. Complete and apparently specif local tumor regression using syngeneic or xenogeneic "tumor-immune" RNA extracts. Cancer Res-1975. 35(8);1907-14
1279. Rytel MW, et al. Therapy of cytomegalovirus retinitis with transfer factor. Cell Immunol-1975. 19(1);8-21
1280. Graybill JR Transfer factor in coccidioidomycosis. Clin Res-1975. 23;304
1281. Nekam K, et al. [A case of chronic candidiasis treated with transfer factor] Fogorv Sz-1975. 68(12);369-72
1282. Asquith P, et al. Proceedings: Transfer factor in the treatment of Crohn's disease. Gut-1975. 16(10);832
1283. Jain S, et al. Proceedings: The effect of lymphocytic transfer factor on hepatitis B surface antigen-positive chronic liver disease. Gut-1975. 16(10);836
1284. Ascher MS. Basic properties and clinical application studies on transfer factor. In: Annual Progress Report FY 1975. Army Medical Research Institute on Infectious Diseases. Fort Detrick, MD.-1975.
1285. Spitler LE, et al. Transfer factor. In: Clinical Immunology. Bach F, Good RA, Eds. Academic Press, NY-1975. 2;153
1286. Spitler LE, et al. Transfer factor II: Results of therapy. In: Primary Immunodeficiency Diseases in Man. Bergsma D, Good RA, Finstad J, Paul NW. Nat. Foundation Press; White Plains, NY-1975.
1287. Gottlieb AA Biochemical properties of human transfer factor. In: Proceedings of Symposium on Hospital-Borne Infections and Immunity. Little, Brown, and Co. Boston-1975.
1288. Rocklin RE Partial characterization of leukocyte inhibitory factor by concanavalin A-stimulated human lymphocytes (LIF Con A). J Immunol-1975. 114(4);1161-5
1289. Strauss RG, Hake DA Letter: Combined immunodeficiency and transfer factor. J Pediatr-1975. 86(5);818-9
1290. Krohn KJ, et al. Letter: Uracil in transfer factor. Lancet-1975. 2(7946);1209
1291. Strannegard IL, et al. Letter: Transfer factor in severe atopic disease. Lancet-1975. 2(7937);702
1292. Thornes RD, et al. Letter: Transfer factor in Hodgkin's disease. Lancet-1975. 2(7944);1101
1293. Walker AM, David JR Letter: A controlled study of transfer factor in protein-calorie malnutrition. Lancet-1975. 1(7913);985
1294. Khan A, et al. Letter: Transfer factor, thymosin and E rosettes. N Engl J Med-1975. 292(16);868-9
1295. Bergsma D, Good RA, Finstad J, Paul NW, eds. Primary Immunodeficiency Diseases of Man Nat Foundation Press, White Plains, NY-1975.
1296. Fog T, et al. Proceedings: Transfer factor treatment in multiple sclerosis. Neurology-1975. 25(5);489-90
1297. Kobielowa Z [Treatment of immunologic deficiency conditions by means of transfer factor] Pediatr Pol-1975. 50(11);1393-7
1298. Levin AS, et al. Transfer factor therapy in osteogenic sarcoma. Perspect Virol-1975. 9;153
1299. Dressler D, Potter H Authors' statement: the existence and nature of "transfer factor/be/. Proc Natl Acad Sci U S A-1975. 72(1);409
1300. Levin AS Editorial: Transfer factor therapy: current status. South Med J-1975. 68(12);1465-7
1301. Warren KS, et al. Passive transfer of immunity in human Schistosomiasis mansoni: effect of transfer factor on early established infections. Trans R Soc Trop Med Hyg-1975. 69(5-6);488-93
1302. Graybill JR Transfer factor in diseases of the central nervous system. Adv Neurol-1974. 6(0);107-26
1303. Potter H, et al. Transfer factor. Ann Intern Med-1974. 81(6);838-47
1304. Huber J, et al. Proceedings: Polyclonal gammopathy and lymphoproliferation after transfer factor in severe combined
1305. immunodeficiency disease. Arch Dis Child-1974. 49(6);494-5
1306. Wong VG, Kirkpatrick CH Immune reconstitution in keratoconjunctivitis and superficial candidiasis. The role of immunocompetent lymphocyte transfusion and transfer factor. Arch Ophthalmol-1974. 92(4);335-9
1307. Longo G, et al. Clinical utilisation of transfer factor. Boll Ist Sieroter Milan-1974. 53(1);suppl:269
1308. [No Author(s)] Editorial: Transfer factor. Br Med J-1974. 2(916);397-8
1309. Sato A [Passive transfer factor of tuberculin hypersensitivity in guinea pigs] Bull Chest Dis Res Inst Kyoto Univ-1974. 7(2);135-47
1310. Krementz ET, et al. Proceedings: Immunotherapy of malignant disease: the use of viable sensitized lymphocytes or transfer factor prepared from sensitized lymphocytes. Cancer-1974. 33(2);394-401
1311. Kirkpatrick CH, Rifkind D. Meeting Report: Workshop on TF. Cell Immunol-1974. 10;165
1312. Adler LM, et al. Transfer factor and the immune system. Cleve Clin Q-1974. 41(3);127-33
1313. Valdimarsson H, et al. Restoration of T-lymphocyte deficiency with dialysable leucocyte extract. Clin Exp Immunol-1974. 16(2);141-52
1314. Spitler LE, et al. Transfer factor. Clin Immunobiol-1974. 2;153
1315. Kohler PF, et al. Immunotherapy with antibody lymphocytes and transfer factor in chronic hepatitis B. Clin Immunol
1316. Immunopathol-1974. 2;465
1317. Kohlor/Kohler PF, et al. Immunotherapy with antibody, lymphocytes and transfer factor in chronic hepatitis B. Clin Immunol Immunopathol-1974. 2;265 or 465
1318. Hau G [Transfer-factor] Hippokrates-1974. 45(3);390-2
1319. Fudenberg HH, et al. The therapeutic use of transfer factor. Hosp Pract-1974. 9;95
1320. Salaman MR Transfer Factor: Biological Properties In: Workshop 138. Second International Congress on Immunology. Brighton-1974.
1321. Hamblin AS Transfer Factor: Biological Properties In: Workshop 138. Second International Congress on Immunology. Brighton.-1974.
1322. Zuckerman KS, et al. Immunologic specificity of transfer factor. J Clin Invest-1974. 54(4);997-1000
1323. Pachman LM, et al. The lack of effect of transfer factor in thymic dysplasia with immunoglobulin synthesis. J Pediatr-1974. 84(5);681-8
1324. Strauss RG, Hake DA Combined immunodeficiency disease with response to transfer factor. J Pediatr-1974. 85(5);680-2
1325. Bernhard GC and Heim LR Transfer factor treatment of Behcet's syndrome. J Rheumatol-1974. 1;34
1326. Healey LA, et al. Letter: Transfer factor in adult rheumatoid arthritis. Lancet-1974. 2(7873);160
1327. Kass E, et al. Letter: Transfer factor in juvenile rheumatoid arthritis. Lancet-1974. 1(7858);627-8
1328. Shulman S, et al. Letter: Transfer-factor therapy of chronic active hepatitis. Lancet-1974. 2(7881);650
1329. De Moragas Vińas JM, et al. [Chronic mucocutaneous candidiasis. Transfer factor and iron metabolism] Med Cutan Ibero Lat Am-1974. 2(3);183-92
1330. Severi F, et al. [Case of severe immunologic deficiency treated with transfer factor] Minerva Pediatr-1974. 26(9);476-9
1331. Schumacher H [Attempt of transfer-factor therapy of subacute sclerosing panencephalitis] Monatsschr Kinderheilkd-1974. 122(7);429-30
1332. [No Author(s)] Letter: Problems with transfer factor. N Engl J Med-1974. 290(18);1022-4
1333. Brent L, Holborrow J, eds. Progress in Immunology II. Vol. 5 North-Holland; Amsterdam-1974.
1334. Kirkpatrick CH, Gallin JI Treatment of infectious and neoplastic diseases with transfer factor. Oncology-1974. 29(1);46-73
1335. Feigin RD, et al. Treatment of mucocutaneous candidasis with transfer factor. Pediatrics-1974. 53(1);63-70
1336. Gallin JI, Kirkpatrick CH Chemotactic activity in dialyzable transfer factor. Proc Natl Acad Sci U S A-1974. 71(2);498-502
1337. Rosenfeld S, Dressler D Transfer factor: a subcellular component that transmits information for specific immune responses. Proc Natl Acad Sci U S A-1974. 71(6);2473-7
1338. Hitzig WH, Grob PJ Therapeutic uses of transfer factor. Prog Clin Immunol-1974. 2(0);69-100
1339. Froland SS, et al. The principle of immunopotentiation in treatment of rheumatoid arthritis: effect of transfer factor. Scand J Immunol-1974. 3(2);223-8
1340. Kass E, et al. A new principle of immunotherapy in rheumatoid arthritis: treatment with transfer factor. Scand J Rheumatol-1974. 3(3);113-7
1341. Francke C, Grob PJ [Transfer factor therapy. Preliminary report] Schweiz Med Wochenschr-1974. 104(4);146-7
1342. Rosenthal M [Transfer factor and its therapeutic use] Schweiz Med Wochenschr-1974. 104(43);1501-6
1343. Neidhart JA, LoBuglio AF Transfer-factor therapy of malignancy. Semin Oncol-1974. 1(4);379-85
1344. Mutz I, et al. Biologic and clinical implications of transfer factor. South Med J-1974. 67(7);837-40
1345. Burger DR, et al. Transfer factor immunotherapy in human cancer. Surg Forum-1974. 25(0);93-5
1346. Levin AS, et al. Transfer factor therapy in osteogenic sarcoma. Trans Assoc Am Physicians-1974. 87(0);153-8
1347. Cloninger P, et al. Immunotherapy with transfer factor in disseminated coccidioidal osteomyelitis and arthritis. West J Med-1974. 120(4);322-5
1348. Drew WL, et al. Letter: Herpes zoster: transfer factor therapy. Ann Intern Med-1973. 79(5);747-8
1349. Bloom BR Immunogenic RNA in cell-mediated immunity. Introduction: transfer factor (s) and delayed-type hypersensitivity. Ann N Y Acad Sci-1973. 207(0);352-4
1350. Levin AS, et al. Transfer factor therapy in immune deficiency states. Annu Rev Med-1973. 24(0);175-208
1351. Chaves MA [Transfer factor] Arq Patol-1973. 45(1);23-6
1352. Griscelli C, et al. Transfer factor therapy in immuno-deficiencies. Biomedicine-1973. 18(3);220-7
1353. Hitzig WH [Transfer factor and its therapeutic significance] Blut-1973. 27(3);145-50
1354. Goldblum RM, et al. Transfer factor induced delayed hypersensitivity in X-linked combined immunodeficiency. Cell Immunol-1973. 9(2);297-305
1355. LoBuglio AF, et al. The effect of transfer factor therapy on tumor immunity in alveolar soft part sarcoma. Cell Immunol-1973. 7(1);159-65
1356. Mogerman SN, et al. Transfer factor therapy (TF) in X-linked recessive severe combined dual system immune deficiency disorder (SCID). Clin Res-1973. 21;310
1357. Spitler LE, et al. Transfer factor therapy of malignant melanoma. Clin Res-1973. 21;221
1358. Blaker F, et al. [Immunological defence and transfer factor therapy in chronic mucocutaneous candidiasis] Dtsch Med
1359. Wochenschr-1973. 98(9);415-20
1360. Kohn A [Editorial: Transfer factor for delayed hypersensitivity] Harefuah-1973. 85(11);528-9
1361. Spitler LE, et al. Human lymphocyte transfer factor. In: Methods in Cancer Research. Bush H, Ed. Academic Press, NY-1973.
1362. Spitler LE, et al. Studies on the characterization of transfer factor. J Clin Invest-1973. 52(6);802 or 80a
1363. Lankford J, et al. Role of transfer factor in treating complications of smallpox vaccination. J Okla State Med Assoc-1973. 66(1);7-8
1364. Ballow M, et al. Autoimmune hemolytic anemia in Wiskott-Aldrich syndrome during treatment with transfer factor. J Pediatr-1973. 83(5);772-80
1365. [No Author(s)] Editorial: Transfer factor. Lancet-1973. 2(7820);79-80
1366. Emodi G, et al. Letter: Circulating interferon after transfer-factor therapy. Lancet-1973. 2(7842);1382
1367. Fudenberg HH Letter: Transfer factor. Lancet-1973. 2(7834);914-5
1368. Jersild C, et al. Letter: Transfer-factor therapy in multiple sclerosis. Lancet-1973. 2(7842);1381-2
1369. Smith RA, et al. Lawrence transfer factor and Hodgkin's disease. Lancet-1973. 1(7800);434
1370. Spitler LE Letter: Transfer factor. Lancet-1973. 2(7844);1492
1371. [No Author(s)] Transfer factor and lepromatous leprosy. N Engl J Med-1973. 288(14);740-2
1372. Gelfand EW, et al. Polyclonal gammopathy and lymphoproliferation after transfer factor in severe combined immunodeficiency disease. N Engl J Med-1973. 289(26);1385-9
1373. Polmar SH Editorial: Transfer-factor therapy of immunodeficiencies. N Engl J Med-1973. 289(26);1420-1
1374. Wybran J, et al. Rosette-forming cells, immunologic deficiency diseases and transfer factor. N Engl J Med-1973. 288(14);710-3
1375. Kirkpatrick CH, Rifkind D, Eds. Workshop on Basic Properties and Clinical Applications of Transfer Factor NIH, USA-1973.
1376. Mutz I, Humphrey GB [Clinical significance of the transfer factor] Wien Klin Wochenschr-1973. 85(20);357-60
1377. Herman PS Transfer factor in salicylanilide contact allergy. Z Immunitatsforsch Exp Klin Immunol-1973. 146(2);93-100
1378. Muftuoglu AU, Yalcin B The specific inhibition by antigen of the passive transfer of tuberculin reaction in man by sensitized lymphocytes. Z Immunitatsforsch Exp Klin Immunol-1973. 145(5);413-7
1379. Berthaux P, et al. [Specific immunotherapy using cell-mediated immune transfer factor. Preliminary results with semi-purified transfer factor] Ann Med Interne (Paris)-1972. 123(12);1069-72
1380. Anderson LG, David JR Transfer factor and cellular immune deficiency. Br J Clin Pract-1972. 26(7);337-40
1381. Pabst HF, Swanson R Successful treatment of candidiasis with transfer factor. Br Med J-1972. 2(811);442-3
1382. Good RA Transfer factor. Cell Immunol-1972. 3(4);i-iv
1383. Valdimarsson H, et al. Immunological features in a case of chronic granulomatous candidiasis and its treatment with transfer factor. Clin Exp Immunol-1972. 11(2);151-63
1384. Levin AS, et al. Treatment of osteogenic sarcoma with tumor specific transfer factor. Clin Res-1972. 20;568
1385. Spitler LE, et al. Prediction of results of transfer factor therapy in Wiskott-Aldrich syndrome by monocyte IgG receptors. In: Sixth Annual Leukocyte Culture Conference. Schwartz MR, Ed. Academic Press, NY-1972.
1386. Arala-Chaves MP, Pinto AS Transfer factor with dinitrochlorobenzene. Several remarks. Int Arch Allergy Appl Immunol-1972. 43(3);410-8
1387. Spitler LE, et al. The Wiskott-Aldrich syndrome. Results of transfer factor therapy. J Clin Invest-1972. 51(12);3216-24
1388. Lawrence HS Editorial: Immunotherapy with transfer factor. N Engl J Med-1972. 287(21);1092-4
1389. Gunther O [Active substances of delayed reaction. 2. The transfer-factor] Dtsch Med Wochenschr-1971. 96(20);883-4
1390. Ramming KP, Pilch YH Transfer of tumor-specific immunity with RNA: inhibition of growth of murine tumor isografts. J Natl Cancer Inst-1971. 46(4);735-50
1391. Moulias R, Muller-Berat CN [The cellular immunity transfer factor (T.F.): a new possibility of selective immunotherapy] Presse Med-1971. 79(21);953-4
1392. Thompson RB Lymphocyte transfer factor. Rev Eur Etud Clin Biol-1971. 16(3);201-4
1393. Lawrence HS, Valentine FT Transfer factor in delayed hypersensitivity. Ann N Y Acad Sci-1970. 169(1);269-87
1394. Cotes JE, et al. Transfer factor in asthma. Lancet-1970. 1(7647);626-7
1395. Evans CC, Ogilvie CM Transfer factor in asthma. Lancet-1970. 1(7652);891
1396. Palmer KN Transfer factor in asthma. Lancet-1970. 1(7649);723 Lawrence HS Transfer factor and cellular immune deficiency disease. N Engl J Med-1970. 283(8);411-9
1397. Lawrence HS Transfer factor. Adv Immunol-1969. 11(0);195-266
1398. Fukuma K [Study on the transfer factor of contact hypersensitivity. 2. Antigen-specificity of the transfer factor] Bull Chest Dis Res
1399. Inst Kyoto Univ-1968. 2(1);137-46 passim
1400. [No Author(s)] Editorial: Transfer factor and leprosy. N Engl J Med-1968. 287;1092
1401. Lawrence HS, Zweiman B Transfer factor deficiency response--a mechanism of anergy in Boeck's sarcoid. Trans Assoc Am
1402. Physicians-1968. 81(0);240-8
1403. [No Author(s)] Editorial: Transfer factor and Hodgkin's disease. N Engl J Med-1967. 277;158
1404. Baram P, et al. Purification and characterization of transfer factor. J Allerg-1965. 36;203
1405. DAUSSET J [THE TRANSFER FACTOR] Nouv Rev Fr Hematol-1964. 16(0);479-82
1406. SLAVIN RG, GARVIN JE DELAYED HYPERSENSITIVITY IN MAN: TRANSFER BY LYMPHOCYTE PREPARATIONS OF PERIPHERAL
1407. BLOOD. Science-1964. 145(0);52-3
1408. SAKHAROVPPKKUDRINA GA [SIGNIFICANCE OF THE "TRANSFER FACTOR" IN LEUKOCYTES IN THE PATHOGENESIS AND
1409. DIAGNOSIS OF BACTERIAL ALLERGY] Vestn Akad Med Nauk SSSR-1964. 19(0);43-8
1410. OLIVEIRA-LIMA A Passive transfer of the delayed dermal sensitivity to tuberculin by means of blood leukocytes. Am Rev
1411. Tuberc-1958. 78(3);346-52
1412. Lawrence HS, Pappenheimer AM Effect of specific antigen on release from human leukocytes of the factor concerned in transfer of
a. delayed hypersensitivity. J Clin Invest-1957. 36;908
1413. Zhenqing F Physico-chemical properties and biological activities of porcine spleen transfer factor; Comparison to the human spleen
1414. transfer factor. [Unknown]-0.
1415. Singh SK, et al. Immunomodulatory components present in IMREG-1, an experimental immunosupportive biologic. Biotechnology-0.
1416. 6;810-5
1417. 348 TF-Related references.
1418. Wednesday, January 12, 2005 Page 55 of 55